drug1	drug2	strength	RR	severity	patients.fem.mal	description	color	onethousand	fdr
Omeprazole	Alprazolam	0.298	2.266	Moderate	22016 (16286/5730)	The metabolism of Alprazolam can be decreased when combined with Omeprazole.	#F5B4B4	3427.63907658008	1
Digoxin	Furosemide	0.331	1.034	Moderate	6986 (3944/3042)	The risk or severity of adverse effects can be increased when Furosemide is combined with Digoxin.	#F9BCBC	1087.64019753763	0
Amiodarone	Acenocoumarol	0.335	-1.429	None	5283 (2469/2814)	The therapeutic efficacy of Acenocoumarol can be increased when used in combination with Amiodarone.	#B2D0E5	822.502599998754	0
Omeprazole	Diazepam	0.215	1.717	Moderate	21348 (14579/6769)	The metabolism of Diazepam can be decreased when combined with Omeprazole.	#F7B7B7	3323.63912640042	1
Acetaminophen	Acenocoumarol	0.235	-1.125	None	25191 (13278/11913)	Acetaminophen may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	3921.95021702984	1
Rivastigmine	Quetiapine	0.313	-1.004	Moderate	1466 (814/652)		#B4D1E6	228.239411621839	0
Digoxin	Spironolactone	0.353	1.147	Minor	2121 (1251/870)	The serum concentration of Digoxin can be increased when it is combined with Spironolactone.	#F9BCBC	330.215410675252	0
Acetylsalicylic acid	Ibuprofen	0.13	-1.259	Major	23159 (11556/11603)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Ibuprofen.	#B2D0E5	3605.59108714199	1
Donepezil	Quetiapine	0.342	1.408	Moderate	1134 (724/410)		#F8BABA	176.550813628353	0
Risperidone	Donepezil	0.295	1.504	Moderate	958 (626/332)		#F7B9B9	149.149629149878	0
Alendronic acid	Ibuprofen	0.168	9.142	Moderate	7354 (6764/590)	The risk or severity of adverse effects can be increased when Ibuprofen is combined with Alendronic acid.	#DF8181	1144.93358326535	1
Acetylsalicylic acid	Gliclazide	0.367	-1.792	None	8789 (3618/5171)	Acetylsalicylic acid may increase the hypoglycemic activities of Gliclazide.	#AFCEE4	1368.34664989382	1
Haloperidol	Biperiden	0.464	1.259	Moderate	276 (169/107)		#F8BABA	42.9700392957896	1.02978474789476e-237
Omeprazole	Clonazepam	0.241	1.42	Moderate	5834 (3736/2098)		#F8BABA	908.28699004216	1
Acetylsalicylic acid	Glyburide	0.339	-1.73	Moderate	5606 (2356/3250)	Acetylsalicylic acid may increase the hypoglycemic activities of Glyburide.	#AFCEE4	872.790001058682	2.23568307209311e-15
Galantamine	Risperidone	0.296	-1.001	Moderate	525 (292/233)		#B4D1E6	81.7364877909041	1.29564227810881e-299
Trazodone	Rivastigmine	0.29	1.134	Moderate	855 (502/353)		#F9BCBC	133.113708688044	0
Acetylsalicylic acid	Insulin aspart	0.307	-1.333	Moderate	3513 (1703/1810)	Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Aspart.	#B2D0E5	546.933869732278	1.20098012470132e-30
Trazodone	Donepezil	0.303	1.405	Moderate	823 (525/298)		#F8BABA	128.131675146503	5.21647968944301e-287
Digoxin	Carvedilol	0.319	-1.469	Moderate	1481 (682/799)	Digoxin may increase the bradycardic activities of Carvedilol.	#B1CFE5	230.574739844436	8.61106438807654e-271
Omeprazole	Methotrexate	0.305	1.445	Major	2708 (1745/963)	The serum concentration of Methotrexate can be increased when it is combined with Omeprazole.	#F7B9B9	421.604588452892	6.19319171945515e-05
Allopurinol	Acenocoumarol	0.314	-3.97	None	5249 (1260/3989)	Allopurinol may increase the anticoagulant activities of Acenocoumarol.	#A0C3DD	817.209189360867	2.52328241281001e-64
Levothyroxine	Acenocoumarol	0.288	2.203	None	2988 (2194/794)	Levothyroxine may increase the anticoagulant activities of Acenocoumarol.	#F5B4B4	465.197381941374	1
Galantamine	Quetiapine	0.336	-1.154	Moderate	532 (277/255)	Galantamine may increase the QTc-prolonging activities of Quetiapine.	#B4D1E6	82.8263076281161	2.16821541920726e-262
Acetylsalicylic acid	Insulin detemir	0.33	-1.248	Moderate	2332 (1169/1163)	Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Detemir.	#B2D0E5	363.065694339787	3.89639190423468e-24
Prednisone	Acetylsalicylic acid	0.156	-1.965	Moderate	8290 (3230/5060)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Prednisone.	#AECDE3	1290.65806435542	1
Diclofenac	Alendronic acid	0.161	8.181	Moderate	2916 (2657/259)	The risk or severity of adverse effects can be increased when Diclofenac is combined with Alendronic acid.	#E18888	453.987806472907	1
Indomethacin	Methotrexate	0.288	1.27	Major	337 (207/130)	The serum concentration of Methotrexate can be increased when it is combined with Indomethacin.	#F8BABA	52.4670407343517	2.12769686407456e-145
Furosemide	Ibuprofen	0.189	1.155	Moderate	6953 (4113/2840)	The therapeutic efficacy of Furosemide can be decreased when used in combination with Ibuprofen.	#F9BCBC	1082.50247544792	1
Bisoprolol	Ibuprofen	0.126	1.026	Moderate	6362 (3580/2782)	Ibuprofen may decrease the antihypertensive activities of Bisoprolol.	#F9BCBC	990.490543477584	1
Tramadol	Citalopram	0.218	3.721	Major	2867 (2361/506)	Citalopram may increase the neuroexcitatory activities of Tramadol.	#F0A9A9	446.359067612423	1
Torasemide	Ibuprofen	0.169	1.446	Moderate	3888 (2506/1382)	The therapeutic efficacy of Torasemide can be decreased when used in combination with Ibuprofen.	#F7B9B9	605.317075297209	1
Trazodone	Galantamine	0.28	1.066	Moderate	402 (230/172)		#F9BCBC	62.5867963656065	2.44074996125457e-146
Warfarin	Amiodarone	0.321	-1.618	Major	497 (217/280)	The therapeutic efficacy of Warfarin can be increased when used in combination with Amiodarone.	#B1CFE5	77.3772084420558	3.05985468029282e-145
Mesalazine	Azathioprine	0.345	-1.777	Moderate	116 (48/68)	The metabolism of Azathioprine can be decreased when combined with Mesalazine.	#AFCEE4	18.0598715880855	8.34067925055376e-115
Citalopram	Acenocoumarol	0.319	1.312	None	2299 (1430/869)	The metabolism of Acenocoumarol can be decreased when combined with Citalopram.	#F8BABA	357.927972250073	1
Bisoprolol	Gliclazide	0.338	-1.601	None	2789 (1225/1564)	Bisoprolol may increase the hypoglycemic activities of Gliclazide.	#B1CFE5	434.215360854917	1
Propafenone	Acenocoumarol	0.308	1.442	None	511 (329/182)	The serum concentration of Acenocoumarol can be increased when it is combined with Propafenone.	#F7B9B9	79.5568481164799	4.72078249251029e-70
Atenolol	Ibuprofen	0.156	1.234	Moderate	3599 (2186/1413)	Ibuprofen may decrease the antihypertensive activities of Atenolol.	#F8BABA	560.323084875169	1
Diltiazem	Simvastatin	0.432	-1.408	Major	3329 (1568/1761)	The serum concentration of Simvastatin can be increased when it is combined with Diltiazem.	#B2D0E5	518.287176868418	1
Diltiazem	Atorvastatin	0.45	-1.796	Moderate	2267 (932/1335)	The serum concentration of Diltiazem can be increased when it is combined with Atorvastatin.	#AFCEE4	352.945938708532	1
Alendronic acid	Naproxen	0.143	11.021	Moderate	1897 (1769/128)	The risk or severity of adverse effects can be increased when Naproxen is combined with Alendronic acid.	#D87373	295.341175884467	1
Digoxin	Amiodarone	0.314	-1.507	Major	907 (412/495)	The serum concentration of Digoxin can be increased when it is combined with Amiodarone.	#B1CFE5	141.209513193048	1.39072553677554e-90
Spironolactone	Enalapril	0.324	-1.469	Major	3094 (1425/1669)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Enalapril.	#B1CFE5	481.700368047728	1
Acetaminophen	Warfarin	0.228	-1.161	Minor	2234 (1160/1074)	Acetaminophen may increase the anticoagulant activities of Warfarin.	#B4D1E6	347.808216618818	1
Prednisone	Acenocoumarol	0.163	-1.695	None	3194 (1358/1836)		#AFCEE4	497.269222865043	1
Trimethoprim	Leucovorin	0.557	-1.979	Major	232 (90/142)		#AECDE3	36.1197431761709	1.09164099381817e-161
Donepezil	Sertraline	0.418	2.115	Minor	650 (472/178)	The metabolism of Donepezil can be decreased when combined with Sertraline.	#F5B4B4	101.197556312548	3.19849160710998e-53
Tramadol	Paroxetine	0.196	4.734	Major	1970 (1686/284)	Paroxetine may increase the neuroexcitatory activities of Tramadol.	#EDA1A1	306.706439901107	1
Digoxin	Verapamil	0.368	1.045	Moderate	492 (279/213)	The metabolism of Digoxin can be decreased when combined with Verapamil.	#F9BCBC	76.5987657011901	3.4043892708478e-78
Methotrexate	Hydroxychloroquine	0.313	2.427	Minor	93 (70/23)		#F5B2B2	14.479034980103	1.48554416878817e-60
Omeprazole	Ketazolam	0.285	2.266	None	1191 (881/310)		#F5B4B4	185.425060874222	1
Bisoprolol	Salbutamol	0.166	-1.636	Moderate	3307 (1435/1872)	Bisoprolol may decrease the bronchodilatory activities of Salbutamol.	#B1CFE5	514.862028808609	1
Simvastatin	Clarithromycin	0.065	1.054	Major	2544 (1448/1096)	The serum concentration of Simvastatin can be increased when it is combined with Clarithromycin.	#F9BCBC	396.071666552495	1
Mirtazapine	Rivastigmine	0.304	1.572	Moderate	410 (272/138)		#F7B9B9	63.8323047509917	1.83539422978046e-68
Propranolol	Primidone	0.232	-1.237	Moderate	147 (74/73)	The metabolism of Propranolol can be increased when combined with Primidone.	#B2D0E5	22.8862165814531	6.08528287089361e-84
Mirtazapine	Donepezil	0.384	3.147	Moderate	371 (296/75)		#F2AEAE	57.7604513722389	7.88306604394927e-42
Ibuprofen	Acenocoumarol	0.13	-1.239	None	4710 (2369/2341)	Ibuprofen may increase the anticoagulant activities of Acenocoumarol.	#B2D0E5	733.293061895539	1
Levofloxacin	Acenocoumarol	0.105	-2.023	None	2624 (1004/1620)	Levofloxacin may increase the anticoagulant activities of Acenocoumarol.	#AECDE3	408.526750406347	1
Bisoprolol	Formoterol	0.234	-1.822	Moderate	2306 (940/1366)	Bisoprolol may decrease the bronchodilatory activities of Formoterol.	#AFCEE4	359.017792087285	1
Simvastatin	Amiodarone	0.317	-1.633	Major	2417 (1050/1367)	The serum concentration of Simvastatin can be increased when it is combined with Amiodarone.	#B1CFE5	376.299220934505	1
Acetylsalicylic acid	Ginkgo biloba	0.249	1	Moderate	1508 (839/669)	Ginkgo biloba may increase the anticoagulant activities of Acetylsalicylic acid.	#F9BCBC	234.778330645111	1
Paroxetine	Acenocoumarol	0.307	1.549	None	1433 (946/487)	Paroxetine may increase the anticoagulant activities of Acenocoumarol.	#F7B9B9	223.101689532125	1
Ranitidine	Acenocoumarol	0.283	-1.427	None	1768 (827/941)		#B2D0E5	275.25735317013	1
Ciprofloxacin	Acenocoumarol	0.103	-2.055	None	2924 (1108/1816)		#AECDE3	455.233314858292	1
Bisoprolol	Repaglinide	0.336	-1.625	Moderate	1419 (618/801)		#B1CFE5	220.922049857701	1
Digoxin	Levothyroxine	0.323	2.499	Moderate	959 (727/232)		#F5B2B2	149.305317698051	1
Spironolactone	Losartan	0.34	-1.005	Major	1250 (694/556)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Losartan.	#B4D1E6	194.610685216438	1
Bisoprolol	Insulin aspart	0.287	-1.244	Moderate	1048 (526/522)		#B2D0E5	163.161598485462	1
Omeprazole	Itraconazole	0.099	1.331	Moderate	1324 (828/496)	The serum concentration of Itraconazole can be decreased when it is combined with Omeprazole.	#F8BABA	206.131637781251	1
Propranolol	Ibuprofen	0.161	1.462	Moderate	1465 (948/517)	Ibuprofen may decrease the antihypertensive activities of Propranolol.	#F7B9B9	228.083723073666	1
Carvedilol	Insulin aspart	0.279	-1.297	Moderate	472 (232/240)		#B2D0E5	73.4849947377271	5.53702371378854e-23
Digoxin	Hydrochlorothiazide	0.298	1.093	Moderate	1667 (964/703)	The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Digoxin.	#F9BCBC	259.532809804642	1
Acetylsalicylic acid	Acenocoumarol	0.219	-2.319	None	4858 (1705/3153)	Acetylsalicylic acid may increase the anticoagulant activities of Acenocoumarol.	#ABCBE2	756.334967025165	1
Digoxin	Alprazolam	0.255	1.734	Moderate	889 (609/280)		#F7B7B7	138.407119325931	1
Atenolol	Gliclazide	0.338	-1.216	None	1103 (560/543)	Atenolol may increase the hypoglycemic activities of Gliclazide.	#B4D1E6	171.724468634985	1
Hydrocortisone	Acetylsalicylic acid	0.16	-1.189	Moderate	1586 (814/772)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Hydrocortisone.	#B4D1E6	246.922037402617	1
Valproic acid	Acetylsalicylic acid	0.377	-1.424	Moderate	803 (376/427)	The serum concentration of Valproic Acid can be increased when it is combined with Acetylsalicylic acid.	#B2D0E5	125.01790418304	1
Tramadol	Fluoxetine	0.231	4.48	Major	953 (809/144)	Fluoxetine may increase the neuroexcitatory activities of Tramadol.	#EDA3A3	148.371186409012	1
Repaglinide	Gliclazide	0.224	-1.202	None	660 (337/323)	Repaglinide may increase the hypoglycemic activities of Gliclazide.	#B4D1E6	102.754441794279	1
Propranolol	Paroxetine	0.336	2.692	Moderate	477 (368/109)	The metabolism of Propranolol can be decreased when combined with Paroxetine.	#F4B1B1	74.2634374785928	1
Pravastatin	Fenofibrate	0.734	-1.513	Major	545 (247/298)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Pravastatin.	#B1CFE5	84.8502587543671	2.39840505005581e-22
Ibuprofen	Carvedilol	0.127	-1.2	Moderate	1755 (897/858)	Ibuprofen may decrease the antihypertensive activities of Carvedilol.	#B4D1E6	273.233402043879	1
Omeprazole	Midazolam	0.277	1.212	Moderate	678 (409/269)		#F9BCBC	105.556835661396	1
Fluoxetine	Acenocoumarol	0.337	1.471	None	754 (489/265)	The metabolism of Acenocoumarol can be decreased when combined with Fluoxetine.	#F7B9B9	117.389165322556	1
Levothyroxine	Iron	0.188	3.3	Moderate	632 (509/123)	The serum concentration of Levothyroxine can be decreased when it is combined with Iron.	#F2ACAC	98.3951624454312	1
Methimazole	Acenocoumarol	0.286	1.377	None	330 (209/121)	Methimazole may decrease the anticoagulant activities of Acenocoumarol.	#F8BABA	51.3772208971397	3.82783909249534e-12
Phenytoin	Omeprazole	0.346	-1.416	Moderate	909 (427/482)	The serum concentration of Omeprazole can be decreased when it is combined with Phenytoin.	#B2D0E5	141.520890289394	1
Warfarin	Propafenone	0.275	1.344	Moderate	94 (59/35)	The serum concentration of Warfarin can be increased when it is combined with Propafenone.	#F8BABA	14.6347235282762	1.5833318118831e-30
Bisoprolol	Salmeterol	0.291	-2.602	Moderate	2103 (684/1419)	Bisoprolol may decrease the bronchodilatory activities of Salmeterol.	#A9C9E1	327.413016808136	1
Diltiazem	Amiodarone	0.338	-1.323	Major	483 (235/248)	The risk or severity of bradycardia can be increased when Diltiazem is combined with Amiodarone.	#B2D0E5	75.1975687676317	0.0300487804342323
Carbamazepine	Simvastatin	0.326	1.189	Moderate	665 (398/267)	The metabolism of Simvastatin can be increased when combined with Carbamazepine.	#F9BCBC	103.532884535145	1
Citalopram	Propranolol	0.315	2.307	Moderate	545 (405/140)	The metabolism of Propranolol can be decreased when combined with Citalopram.	#F5B2B2	84.8502587543671	1
Azithromycin	Acenocoumarol	0.106	-1.609	None	1856 (813/1043)	The metabolism of Acenocoumarol can be decreased when combined with Azithromycin.	#B1CFE5	288.957945409367	1
Tramadol	Escitalopram	0.219	2.985	Major	1015 (801/214)	Escitalopram may increase the neuroexcitatory activities of Tramadol.	#F2AEAE	158.023876395748	1
Atenolol	Glyburide	0.321	-1.306	Moderate	745 (365/380)	Atenolol may increase the hypoglycemic activities of Glyburide.	#B2D0E5	115.987968388997	1
Acetylsalicylic acid	Methylprednisolone	0.183	-1.713	Moderate	1422 (601/821)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Methylprednisolone.	#AFCEE4	221.38911550222	1
Entacapone	Apomorphine	0.228	-1.672	Moderate	7 (3/4)		#AFCEE4	1.08981983721205	1.18704947168544e-09
Bisoprolol	Insulin detemir	0.286	1.001	Moderate	609 (339/270)		#F9BCBC	94.8143258374487	1
Trimethoprim	Rifampicin	0.655	-1.287	Moderate	77 (38/39)	The metabolism of Trimethoprim can be increased when combined with Rifampicin.	#B2D0E5	11.9880182093326	2.18910819942879e-36
Ramipril	Spironolactone	0.354	-1.639	Major	646 (280/366)	The risk or severity of adverse effects can be increased when Ramipril is combined with Spironolactone.	#B1CFE5	100.574802119855	1
Galantamine	Sertraline	0.398	1.595	Moderate	276 (184/92)	The metabolism of Galantamine can be decreased when combined with Sertraline.	#F7B9B9	42.9700392957896	1.17046129605547e-16
Citalopram	Carvedilol	0.36	1.319	Moderate	661 (412/249)	The metabolism of Carvedilol can be decreased when combined with Citalopram.	#F8BABA	102.910130342453	1
Cyclosporine	Danazol	0.487	-1.254	Moderate	6 (3/3)	Danazol may increase the hepatotoxic activities of Cyclosporine.	#B2D0E5	0.934131289038903	8.05196318815066e-07
Fluconazole	Simvastatin	0.085	1.153	Major	981 (580/401)	The serum concentration of Simvastatin can be increased when it is combined with Fluconazole.	#F9BCBC	152.730465757861	1
Bisoprolol	Glyburide	0.308	-1.694	Moderate	1185 (504/681)	Bisoprolol may increase the hypoglycemic activities of Glyburide.	#AFCEE4	184.490929585183	1
Repaglinide	Carvedilol	0.331	-2.084	Moderate	559 (210/349)		#ACCCE3	87.0298984287912	3.63362539126675e-13
Gliclazide	Carvedilol	0.308	-1.741	None	738 (309/429)	Carvedilol may increase the hypoglycemic activities of Gliclazide.	#AFCEE4	114.898148551785	1
Salbutamol	Carvedilol	0.181	-2.083	Major	1123 (422/701)	Carvedilol may decrease the vasoconstricting activities of Salbutamol.	#ACCCE3	174.838239598448	1
Fenofibrate	Atorvastatin	0.415	-1.926	Major	885 (349/536)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Atorvastatin.	#AECDE3	137.784365133238	1
Propranolol	Sertraline	0.331	2.43	Moderate	429 (323/106)	The metabolism of Propranolol can be decreased when combined with Sertraline.	#F5B2B2	66.7903871662816	1
Carvedilol	Insulin detemir	0.324	-1.332	Moderate	299 (145/154)		#B2D0E5	46.550875903772	2.26159253303839e-12
Paroxetine	Risperidone	0.275	1.411	Moderate	457 (292/165)	The metabolism of Risperidone can be decreased when combined with Paroxetine.	#F8BABA	71.1496665151298	1
Trazodone	Acenocoumarol	0.264	-1.215	None	825 (419/406)		#B4D1E6	128.443052242849	1
Norfloxacin	Acenocoumarol	0.096	1.524	None	923 (606/317)	Norfloxacin may increase the anticoagulant activities of Acenocoumarol.	#F7B9B9	143.700529963818	1
Verapamil	Atorvastatin	0.397	-1.119	Moderate	564 (298/266)	Atorvastatin can cause a decrease in the absorption of Verapamil resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B4D1E6	87.8083411696569	1
Acetylsalicylic acid	Glipizide	0.354	-1.754	Moderate	475 (198/277)	Acetylsalicylic acid may increase the hypoglycemic activities of Glipizide.	#AFCEE4	73.9520603822465	1
Omeprazole	Flurazepam	0.26	1.546	Moderate	476 (314/162)		#F7B9B9	74.1077489304197	1
Digoxin	Diazepam	0.232	1.585	Moderate	690 (459/231)		#F7B9B9	107.425098239474	1
Atenolol	Salbutamol	0.168	-1.259	Moderate	1118 (558/560)	Atenolol may decrease the bronchodilatory activities of Salbutamol.	#B2D0E5	174.059796857582	1
Propranolol	Escitalopram	0.321	3.116	None	265 (211/54)		#F2AEAE	41.2574652658849	1
Paroxetine	Carvedilol	0.346	1.521	Moderate	468 (307/161)	The metabolism of Carvedilol can be decreased when combined with Paroxetine.	#F7B9B9	72.8622405450345	1
Amitriptyline	Salbutamol	0.202	1.591	Moderate	611 (407/204)	The risk or severity of adverse effects can be increased when Amitriptyline is combined with Salbutamol.	#F7B9B9	95.125702933795	1
Cholestyramine	Ursodeoxycholic acid	0.276	1.377	None	60 (38/22)	The serum concentration of Ursodeoxycholic acid can be decreased when it is combined with Cholestyramine.	#F8BABA	9.34131289038903	2.6000702618203e-24
Carbamazepine	Atorvastatin	0.348	-1.045	Moderate	352 (192/160)	The metabolism of Atorvastatin can be increased when combined with Carbamazepine.	#B4D1E6	54.802368956949	1
Alprazolam	Clarithromycin	0.128	2.775	Moderate	542 (421/121)	The serum concentration of Alprazolam can be increased when it is combined with Clarithromycin.	#F3AFAF	84.3831931098476	1
Mesalazine	Mercaptopurine	0.301	-1.045	Moderate	11 (6/5)	The metabolism of Mercaptopurine can be decreased when combined with Mesalazine.	#B4D1E6	1.71257402990466	2.70013470500652e-10
Sertraline	Carvedilol	0.355	1.238	Moderate	485 (295/190)	The metabolism of Carvedilol can be decreased when combined with Sertraline.	#F8BABA	75.508945863978	1
Phenytoin	Lamotrigine	0.515	-1.732	Moderate	50 (21/29)	The serum concentration of Lamotrigine can be decreased when it is combined with Phenytoin.	#AFCEE4	7.78442740865753	3.27417431750726e-30
Mirtazapine	Galantamine	0.394	1.66	Moderate	151 (102/49)		#F7B7B7	23.5089707741457	1.63410587203738e-11
Omeprazole	Cilostazol	0.222	-4.79	Major	1311 (272/1039)	The serum concentration of Cilostazol can be increased when it is combined with Omeprazole.	#9ABEDB	204.107686655	1
Amitriptyline	Duloxetine	0.313	4.101	Major	215 (180/35)	Duloxetine may increase the serotonergic activities of Amitriptyline.	#EFA6A6	33.4730378572274	0.881362667883172
Methotrexate	Acetylsalicylic acid	0.254	-1.216	Major	658 (334/324)	The serum concentration of Methotrexate can be increased when it is combined with Acetylsalicylic acid.	#B2D0E5	102.443064697933	1
Repaglinide	Glyburide	0.214	-1.052	None	331 (180/151)	Repaglinide may increase the hypoglycemic activities of Glyburide.	#B4D1E6	51.5329094453128	1
Dextromethorphan	Paroxetine	0.117	3.052	Major	420 (333/87)	Paroxetine may increase the serotonergic activities of Dextromethorphan.	#F2AEAE	65.3891902327232	1
Sucralfate	Lansoprazole	0.264	1.073	Moderate	190 (109/81)		#F9BCBC	29.5808241528986	7.9221224787928e-13
Olanzapine	Rivastigmine	0.331	1.487	Moderate	106 (69/37)		#F7B9B9	16.502986106354	1.30705378662407e-16
Metformin	Glucosamine	0.197	1.063	None	989 (565/424)		#F9BCBC	153.975974143246	1
Simvastatin	Colchicine	0.164	-4.002	Major	1228 (293/935)	Colchicine may increase the myopathic rhabdomyolysis activities of Simvastatin.	#A0C3DD	191.185537156629	1
Simvastatin	Fenofibrate	0.336	-1.472	Major	1011 (465/546)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Simvastatin.	#B1CFE5	157.401122203055	1
Atorvastatin	Clarithromycin	0.084	-1.251	Major	863 (432/431)	The serum concentration of Atorvastatin can be increased when it is combined with Clarithromycin.	#B2D0E5	134.359217073429	1
Digoxin	Propafenone	0.311	1.614	Moderate	127 (85/42)	The serum concentration of Digoxin can be increased when it is combined with Propafenone.	#F7B9B9	19.7724456179901	5.10706603302702e-07
Acetylsalicylic acid	Insulin glulisine	0.24	-1.669	Moderate	366 (157/209)	Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Glulisine.	#AFCEE4	56.9820086313731	1
Salmeterol	Carvedilol	0.328	-2.816	Major	740 (228/512)	Carvedilol may decrease the vasoconstricting activities of Salmeterol.	#A8C8E1	115.209525648131	1
Indomethacin	Alendronic acid	0.225	4.135	Moderate	334 (280/54)	The risk or severity of adverse effects can be increased when Indomethacin is combined with Alendronic acid.	#EFA6A6	51.9999750898323	1
Cyclosporine	Omeprazole	0.372	-1.247	Moderate	353 (177/176)	The serum concentration of Cyclosporine can be increased when it is combined with Omeprazole.	#B2D0E5	54.9580575051222	1
Fenofibrate	Acenocoumarol	0.301	-1.804	None	578 (237/341)	Fenofibrate may increase the anticoagulant activities of Acenocoumarol.	#AFCEE4	89.987980844081	1
Levothyroxine	Raloxifene	0.309	22.627	Moderate	235 (227/8)	Raloxifene can cause a decrease in the absorption of Levothyroxine resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	36.5868088206904	1
Glyburide	Carvedilol	0.294	-1.998	Moderate	459 (177/282)	Carvedilol may increase the hypoglycemic activities of Glyburide.	#AECDE3	71.4610436114761	1
Citalopram	Rasagiline	0.334	1.183	Major	231 (138/93)	The risk or severity of adverse effects can be increased when Citalopram is combined with Rasagiline.	#F9BCBC	35.9640546279978	1
Erythromycin	Simvastatin	0.083	1.427	Major	597 (383/214)	The serum concentration of Simvastatin can be increased when it is combined with Erythromycin.	#F8BABA	92.9460632593709	1
Galantamine	Paroxetine	0.345	1.765	Moderate	196 (135/61)	The metabolism of Galantamine can be decreased when combined with Paroxetine.	#F7B7B7	30.5149554419375	0.0818177274908867
Pyridostigmine	Prednisone	0.343	-2.863	Moderate	197 (60/137)	The risk or severity of adverse effects can be increased when Prednisone is combined with Pyridostigmine.	#A8C8E1	30.6706439901107	2.64533464161244e-52
Tacrolimus	Atorvastatin	0.346	-1.803	Moderate	412 (169/243)	The risk or severity of adverse effects can be increased when Tacrolimus is combined with Atorvastatin.	#AFCEE4	64.143681847338	1
Carbamazepine	Levetiracetam	0.455	-1.32	Moderate	78 (38/40)	The risk or severity of adverse effects can be increased when Carbamazepine is combined with Levetiracetam.	#B2D0E5	12.1437067575057	1.7594531075597e-21
Amitriptyline	Carbamazepine	0.349	1.456	Moderate	130 (84/46)	The metabolism of Amitriptyline can be increased when combined with Carbamazepine.	#F7B9B9	20.2395112625096	1.36878237214702e-11
Methotrexate	Naproxen	0.217	1.562	Major	284 (188/96)	The serum concentration of Methotrexate can be increased when it is combined with Naproxen.	#F7B9B9	44.2155476811748	1
Venlafaxine	Metoclopramide	0.143	3.305	Moderate	355 (286/69)	The risk or severity of adverse effects can be increased when Metoclopramide is combined with Venlafaxine.	#F2ACAC	55.2694346014685	1
Sertraline	Clarithromycin	0.13	2.861	Moderate	367 (287/80)	The metabolism of Sertraline can be decreased when combined with Clarithromycin.	#F3AFAF	57.1376971795463	1
Atenolol	Repaglinide	0.349	-1.181	Moderate	433 (223/210)		#B4D1E6	67.4131413589742	1
Omeprazole	Halazepam	0.256	1.746	Moderate	303 (208/95)		#F7B7B7	47.1736300964646	1
Meperidine	Chlorpromazine	1	Inf	Major	1 (1/0)	The metabolism of Pethidine can be decreased when combined with Chlorpromazine.	#B32020	0.155688548173151	1
Pentoxifylline	Acenocoumarol	0.323	-3.66	None	1015 (259/756)	Pentoxifylline may increase the anticoagulant activities of Acenocoumarol.	#A2C4DE	158.023876395748	1
Lidocaine	Bisoprolol	0.148	1.497	Moderate	397 (259/138)	The serum concentration of Lidocaine can be increased when it is combined with Bisoprolol.	#F7B9B9	61.8083536247408	1
Spironolactone	Tolevamer	0.258	-1.974	Moderate	121 (47/74)		#AECDE3	18.8383143289512	3.72596748732468e-14
Simvastatin	Gemfibrozil	0.23	-1.489	Major	910 (416/494)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Simvastatin.	#B1CFE5	141.676578837567	1
Fluoxetine	Clomipramine	0.362	3.051	Major	111 (88/23)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Clomipramine.	#F2AEAE	17.2814288472197	4.36367897634923e-07
Fluoxetine	Propranolol	0.319	3.087	Moderate	190 (151/39)	The metabolism of Propranolol can be decreased when combined with Fluoxetine.	#F2AEAE	29.5808241528986	1
Olanzapine	Donepezil	0.405	1.547	Moderate	97 (64/33)		#F7B9B9	15.1017891727956	3.41457526353915e-10
Atorvastatin	Gemfibrozil	0.263	-1.582	Major	554 (245/309)	The risk or severity of adverse effects can be increased when Gemfibrozil is combined with Atorvastatin.	#B1CFE5	86.2514556879254	1
Formoterol	Carvedilol	0.246	-2.357	Major	596 (207/389)	Carvedilol may decrease the vasoconstricting activities of Formoterol.	#ABCBE2	92.7903747111977	1
Moxifloxacin	Acenocoumarol	0.098	-2.14	None	701 (259/442)		#ACCCE3	109.137672269379	1
Digoxin	Telmisartan	0.3	1.01	Moderate	306 (171/135)	The serum concentration of Digoxin can be increased when it is combined with Telmisartan.	#F9BCBC	47.6406957409841	1
Fluoxetine	Dextromethorphan	0.134	3.278	Major	230 (185/45)	Fluoxetine may increase the serotonergic activities of Dextromethorphan.	#F2ACAC	35.8083660798246	1
Gemfibrozil	Acenocoumarol	0.308	-2.104	None	565 (211/354)	The metabolism of Acenocoumarol can be decreased when combined with Gemfibrozil.	#ACCCE3	87.9640297178301	1
Amiodarone	Levofloxacin	0.167	-2.407	Major	613 (210/403)	Levofloxacin may increase the QTc-prolonging activities of Amiodarone.	#ABCBE2	95.4370800301413	1
Fluconazole	Alprazolam	0.171	2.381	Major	271 (203/68)	The metabolism of Alprazolam can be decreased when combined with Fluconazole.	#F5B2B2	42.1915965549238	1
Lamotrigine	Carbamazepine	0.461	-1.145	Moderate	44 (23/21)	The risk or severity of adverse effects can be increased when Lamotrigine is combined with Carbamazepine.	#B4D1E6	6.85029611961863	1.95371441769054e-16
Digoxin	Methimazole	0.312	1.082	Moderate	132 (76/56)	The serum concentration of Digoxin can be increased when it is combined with Methimazole.	#F9BCBC	20.5508883588559	3.83207500185569e-09
Donepezil	Tolterodine	0.411	1.58	Moderate	155 (103/52)	The therapeutic efficacy of Tolterodine can be decreased when used in combination with Donepezil.	#F7B9B9	24.1317249668383	1
Simvastatin	Itraconazole	0.085	1.141	Major	479 (282/197)	The serum concentration of Simvastatin can be increased when it is combined with Itraconazole.	#F9BCBC	74.5748145749391	1
Carvedilol	Escitalopram	0.351	1.277	None	268 (165/103)		#F8BABA	41.7245309104044	1
Cyclosporine	Allopurinol	0.308	-3.057	Moderate	110 (32/78)		#A6C7E0	17.1257402990466	9.64903609038663e-18
Methotrexate	Amoxicillin	0.114	1.001	Major	512 (285/227)	The serum concentration of Methotrexate can be increased when it is combined with Amoxicillin.	#F9BCBC	79.7125366646531	1
Acetylsalicylic acid	Dexamethasone	0.181	-2.588	Moderate	910 (297/613)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Dexamethasone.	#A9C9E1	141.676578837567	1
Spironolactone	Irbesartan	0.347	-1.094	Major	294 (157/137)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Irbesartan.	#B4D1E6	45.7724331629063	1
Fluvastatin	Acenocoumarol	0.336	-1.933	None	432 (170/262)	The metabolism of Acenocoumarol can be decreased when combined with Fluvastatin.	#AECDE3	67.2574528108011	1
Levothyroxine	Warfarin	0.29	1.902	Moderate	237 (167/70)	Levothyroxine may increase the anticoagulant activities of Warfarin.	#F6B6B6	36.8981859170367	1
Phenytoin	Furosemide	0.342	-1.467	Minor	230 (106/124)	Phenytoin may decrease the diuretic activities of Furosemide.	#B1CFE5	35.8083660798246	1
Citalopram	Clarithromycin	0.092	2.304	Major	385 (286/99)	Clarithromycin may increase the QTc-prolonging activities of Citalopram.	#F5B2B2	59.940091046663	1
Diltiazem	Amlodipine	0.298	-1.535	Moderate	805 (362/443)	The metabolism of Amlodipine can be decreased when combined with Diltiazem.	#B1CFE5	125.329281279386	1
Prazosin	Nadolol	0.343	Inf	Moderate	3 (3/0)	Nadolol may increase the orthostatic hypotensive activities of Prazosin.	#B32020	0.467065644519452	0.817039684685788
Aprepitant	Dexamethasone	1	Inf	Moderate	1 (1/0)	The serum concentration of Dexamethasone can be increased when it is combined with Aprepitant.	#B32020	0.155688548173151	1
Indomethacin	Furosemide	0.207	-1.53	Moderate	524 (236/288)	The therapeutic efficacy of Furosemide can be decreased when used in combination with Indomethacin.	#B1CFE5	81.5807992427309	1
Hydrocortisone	Acenocoumarol	0.162	-1.133	None	453 (238/215)		#B4D1E6	70.5269123224372	1
Propranolol	Gliclazide	0.291	-1.283	None	348 (172/176)	Propranolol may increase the hypoglycemic activities of Gliclazide.	#B2D0E5	54.1796147642564	1
Escitalopram	Rasagiline	0.36	-1.236	Major	135 (68/67)	The risk or severity of adverse effects can be increased when Escitalopram is combined with Rasagiline.	#B2D0E5	21.0179540033753	0.000342514570089486
Fluoxetine	Carvedilol	0.37	1.162	Moderate	231 (137/94)	The metabolism of Carvedilol can be decreased when combined with Fluoxetine.	#F9BCBC	35.9640546279978	1
Clozapine	Lamotrigine	0.114	1.595	Moderate	3 (2/1)	The risk or severity of adverse effects can be increased when Clozapine is combined with Lamotrigine.	#F7B9B9	0.467065644519452	0.11851766909083
Cyclosporine	Ursodeoxycholic acid	0.406	-2.122	Minor	35 (13/22)		#ACCCE3	5.44909918606027	1.27165372480691e-21
Amitriptyline	Fluoxetine	0.323	2.937	Major	192 (151/41)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Amitriptyline.	#F3AFAF	29.8922012492449	1
Fentanyl	Amiodarone	0.289	1.204	Major	251 (151/100)	The serum concentration of Fentanyl can be increased when it is combined with Amiodarone.	#F9BCBC	39.0778255914608	1
Triamcinolone	Acetylsalicylic acid	0.099	-1.807	Moderate	603 (247/356)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Triamcinolone.	#AFCEE4	93.8801945484098	1
Valproic acid	Carbamazepine	0.442	-1.109	Moderate	49 (26/23)	The serum concentration of the active metabolites of Carbamazepine can be increased when Carbamazepine is used in combination with Valproic Acid.	#B4D1E6	7.62873886048438	6.17806372629035e-11
Donepezil	Solifenacin	0.331	-1.179	Moderate	194 (100/94)	The therapeutic efficacy of Solifenacin can be decreased when used in combination with Donepezil.	#B4D1E6	30.2035783455912	1
Erythromycin	Alprazolam	0.129	2.874	Moderate	198 (155/43)	The serum concentration of Alprazolam can be increased when it is combined with Erythromycin.	#F3AFAF	30.8263325382838	1
Duloxetine	Ciprofloxacin	0.119	1.753	Major	307 (211/96)		#F7B7B7	47.7963842891572	1
Fluoxetine	Risperidone	0.273	1.944	Moderate	165 (117/48)	The metabolism of Risperidone can be decreased when combined with Fluoxetine.	#F6B6B6	25.6886104485698	1
Sertraline	Rasagiline	0.401	-1.043	Major	163 (89/74)	The risk or severity of adverse effects can be increased when Sertraline is combined with Rasagiline.	#B4D1E6	25.3772333522235	1
Glimepiride	Gemfibrozil	0.294	-1.457	Moderate	147 (68/79)	The metabolism of Glimepiride can be decreased when combined with Gemfibrozil.	#B1CFE5	22.8862165814531	1
Propranolol	Salbutamol	0.151	-1.573	Major	496 (220/276)		#B1CFE5	77.2215198938827	1
Fluconazole	Fentanyl	0.329	-1.03	Major	204 (112/92)	The serum concentration of Fentanyl can be increased when it is combined with Fluconazole.	#B4D1E6	31.7604638273227	1
Clarithromycin	Acenocoumarol	0.092	-1.584	None	602 (266/336)	The metabolism of Acenocoumarol can be decreased when combined with Clarithromycin.	#B1CFE5	93.7245060002366	1
Lovastatin	Verapamil	0.494	1.88	Major	94 (66/28)	The serum concentration of Lovastatin can be increased when it is combined with Verapamil.	#F6B6B6	14.6347235282762	1
Citalopram	Oxycodone	0.277	2.449	Moderate	171 (129/42)	The metabolism of Oxycodone can be decreased when combined with Citalopram.	#F5B2B2	26.6227417376087	1
Atenolol	Insulin aspart	0.29	-1.063	Moderate	279 (151/128)		#B4D1E6	43.437104940309	1
Oxycodone	Sertraline	0.23	2.437	Moderate	146 (110/36)	The metabolism of Oxycodone can be decreased when combined with Sertraline.	#F5B2B2	22.73052803328	1
Propranolol	Phenobarbital	0.316	1.063	Moderate	56 (32/24)	The metabolism of Propranolol can be increased when combined with Phenobarbital.	#F9BCBC	8.71855869769643	2.65263991239617e-06
Venlafaxine	Rasagiline	0.343	1.113	Major	103 (60/43)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Rasagiline.	#F9BCBC	16.0359204618345	1
Indomethacin	Losartan	0.158	-1.108	Moderate	371 (197/174)	The metabolism of Indomethacin can be decreased when combined with Losartan.	#B4D1E6	57.7604513722389	1
Bisoprolol	Terbutaline	0.108	-1.096	Moderate	343 (183/160)	Bisoprolol may decrease the bronchodilatory activities of Terbutaline.	#B4D1E6	53.4011720233907	1
Citalopram	Warfarin	0.295	1.939	Moderate	175 (124/51)	The metabolism of Warfarin can be decreased when combined with Citalopram.	#F6B6B6	27.2454959303014	1
Nabumetone	Alendronic acid	0.183	18.66	Moderate	122 (117/5)	The risk or severity of adverse effects can be increased when Nabumetone is combined with Alendronic acid.	#BF3C3C	18.9940028771244	1
Mirtazapine	Rasagiline	0.403	-1.232	Major	111 (56/55)	The risk or severity of adverse effects can be increased when Rasagiline is combined with Mirtazapine.	#B2D0E5	17.2814288472197	0.0931977077366186
Galantamine	Methotrimeprazine	0.251	-1.254	Moderate	42 (21/21)	The metabolism of Galantamine can be decreased when combined with Methotrimeprazine.	#B2D0E5	6.53891902327232	9.91809941854276e-12
Sumatriptan	Ergotamine	0.345	1.435	Major	14 (9/5)	Ergotamine may increase the vasoconstricting activities of Sumatriptan.	#F7B9B9	2.17963967442411	2.57286335498152e-08
Methotrexate	Ibuprofen	0.165	1.427	Major	371 (238/133)	The serum concentration of Methotrexate can be increased when it is combined with Ibuprofen.	#F8BABA	57.7604513722389	1
Atorvastatin	Colchicine	0.178	-4.807	Major	551 (114/437)	The risk or severity of adverse effects can be increased when Colchicine is combined with Atorvastatin.	#9ABEDB	85.784390043406	1
Allopurinol	Warfarin	0.284	-4.08	Moderate	336 (79/257)	Allopurinol may increase the anticoagulant activities of Warfarin.	#9FC1DD	52.3113521861786	1
Atenolol	Formoterol	0.217	-1.919	Moderate	592 (234/358)	Atenolol may decrease the bronchodilatory activities of Formoterol.	#AECDE3	92.1676205185051	1
Fluconazole	Atorvastatin	0.107	-1.345	Major	371 (179/192)	The serum concentration of Atorvastatin can be increased when it is combined with Fluconazole.	#B2D0E5	57.7604513722389	1
Tramadol	Carbamazepine	0.23	1.528	Moderate	242 (159/83)	Tramadol may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine.	#F7B9B9	37.6766286579024	1
Metoprolol	Ibuprofen	0.144	1.074	Moderate	223 (128/95)	Ibuprofen may decrease the antihypertensive activities of Metoprolol.	#F9BCBC	34.7185462426126	1
Atenolol	Salmeterol	0.27	-2.152	Moderate	603 (222/381)	Atenolol may decrease the bronchodilatory activities of Salmeterol.	#ACCCE3	93.8801945484098	1
Carbamazepine	Risperidone	0.352	1.079	Moderate	80 (46/34)	The serum concentration of Risperidone can be decreased when it is combined with Carbamazepine.	#F9BCBC	12.455083853852	0.0654876213924194
Folic acid	Phenobarbital	0.247	-1.293	Moderate	65 (32/33)	The serum concentration of Phenobarbital can be decreased when it is combined with Folic Acid.	#B2D0E5	10.1197556312548	3.87713628436846e-05
Phenytoin	Diazepam	0.278	1.098	Moderate	126 (73/53)	The serum concentration of Phenytoin can be increased when it is combined with Diazepam.	#F9BCBC	19.616757069817	1
Torasemide	Indomethacin	0.199	-1.15	Moderate	255 (133/122)	The therapeutic efficacy of Torasemide can be decreased when used in combination with Indomethacin.	#B4D1E6	39.7005797841534	1
Cloxacillin	Acenocoumarol	0.08	-1.564	None	391 (174/217)	Cloxacillin may decrease the anticoagulant activities of Acenocoumarol.	#B1CFE5	60.8742223357019	1
Lorazepam	Phenytoin	0.357	-1.63	Moderate	253 (110/143)	The serum concentration of Phenytoin can be increased when it is combined with Lorazepam.	#B1CFE5	39.3892026878071	1
Prazosin	Oxprenolol	0.5	Inf	None	1 (1/0)	Oxprenolol may increase the orthostatic hypotensive activities of Prazosin.	#B32020	0.155688548173151	1
Fluvoxamine	Clomipramine	0.41	3.389	Major	21 (17/4)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Clomipramine.	#F1ABAB	3.26945951163616	4.28181803285366e-05
Azithromycin	Lovastatin	0.083	1.089	Moderate	272 (157/115)	The serum concentration of Lovastatin can be increased when it is combined with Azithromycin.	#F9BCBC	42.347285103097	1
Fluvoxamine	Olanzapine	0.466	1.276	Moderate	26 (16/10)	The metabolism of Olanzapine can be decreased when combined with Fluvoxamine.	#F8BABA	4.04790225250192	4.74682655678119e-08
Digoxin	Rabeprazole	0.232	1.04	Moderate	235 (133/102)		#F9BCBC	36.5868088206904	1
Alprazolam	Carbamazepine	0.259	1.78	Moderate	139 (96/43)	The metabolism of Alprazolam can be increased when combined with Carbamazepine.	#F7B7B7	21.6407081960679	1
Fenofibrate	Rosuvastatin	0.465	-1.844	Major	126 (51/75)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Rosuvastatin.	#AFCEE4	19.616757069817	0.0408543431781167
Donepezil	Methotrimeprazine	0.177	1.595	Moderate	45 (30/15)	The metabolism of Donepezil can be decreased when combined with Methotrimeprazine.	#F7B9B9	7.00598466779178	0.00317336962730046
Propranolol	Rizatriptan	0.268	2.03	Moderate	39 (28/11)	The serum concentration of Rizatriptan can be increased when it is combined with Propranolol.	#F6B6B6	6.07185337875287	0.00055515246770204
Lovastatin	Acenocoumarol	0.366	-1.317	None	326 (159/167)	The metabolism of Acenocoumarol can be decreased when combined with Lovastatin.	#B2D0E5	50.7544667044471	1
Erythromycin	Atorvastatin	0.128	1.213	Major	237 (143/94)	The serum concentration of Atorvastatin can be increased when it is combined with Erythromycin.	#F9BCBC	36.8981859170367	1
Haloperidol	Lithium cation	0.382	-1.106	Major	32 (17/15)	Lithium may increase the neurotoxic activities of Haloperidol.	#B4D1E6	4.98203354154082	2.68447576165358e-07
Fluoxetine	Clarithromycin	0.125	3.09	Moderate	156 (124/32)	Clarithromycin may increase the QTc-prolonging activities of Fluoxetine.	#F2AEAE	24.2874135150115	1
Warfarin	Ranitidine	0.233	-1.359	Moderate	175 (84/91)	The serum concentration of Warfarin can be increased when it is combined with Ranitidine.	#B2D0E5	27.2454959303014	1
Duloxetine	Rasagiline	0.372	2.335	Major	55 (41/14)	Rasagiline may increase the orthostatic hypotensive activities of Duloxetine.	#F5B2B2	8.56287014952328	1
Ziprasidone	Chlorpromazine	0.147	Inf	Major	2 (2/0)	Chlorpromazine may increase the QTc-prolonging activities of Ziprasidone.	#B32020	0.311377096346301	1
Glimepiride	Repaglinide	0.246	-1.36	None	148 (71/77)	Glimepiride may increase the hypoglycemic activities of Repaglinide.	#B2D0E5	23.0419051296263	1
Enalapril	Tizanidine	0.162	-1.215	Major	252 (128/124)	The risk or severity of hypotension can be increased when Tizanidine is combined with Enalapril.	#B4D1E6	39.2335141396339	1
Ciprofloxacin	Iron	0.281	-1.405	Moderate	405 (191/214)		#B2D0E5	63.053862010126	1
Tramadol	Rasagiline	0.151	-1.06	Major	251 (136/115)	Tramadol may increase the neuroexcitatory activities of Rasagiline.	#B4D1E6	39.0778255914608	1
Propranolol	Formoterol	0.213	-1.521	Major	281 (127/154)		#B1CFE5	43.7484820366553	1
Lovastatin	Diltiazem	0.432	-1.151	Major	163 (85/78)	The serum concentration of Lovastatin can be increased when it is combined with Diltiazem.	#B4D1E6	25.3772333522235	1
Prednisone	Warfarin	0.208	-1.668	Moderate	254 (109/145)	Prednisone may increase the anticoagulant activities of Warfarin.	#AFCEE4	39.5448912359802	1
Phenytoin	Dexamethasone	0.474	-1.911	Moderate	53 (21/32)	The serum concentration of Dexamethasone can be decreased when it is combined with Phenytoin.	#AECDE3	8.25149305317698	3.44731465307528e-05
Folic acid	Phenytoin	0.257	-2.234	Moderate	89 (32/57)	The serum concentration of Phenytoin can be decreased when it is combined with Folic Acid.	#ACCCE3	13.8562807874104	1.8427560128336e-06
Spironolactone	Telmisartan	0.281	1.046	Major	178 (101/77)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Telmisartan.	#F9BCBC	27.7125615748208	1
Spironolactone	Perindopril	0.387	-1.145	Major	88 (46/42)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Perindopril.	#B4D1E6	13.7005922392373	1
Phenytoin	Ciprofloxacin	0.144	-1.735	Moderate	143 (60/83)	The therapeutic efficacy of Phenytoin can be decreased when used in combination with Ciprofloxacin.	#AFCEE4	22.2634623887605	1
Phenytoin	Acenocoumarol	0.353	-1.923	None	152 (60/92)	Phenytoin may increase the anticoagulant activities of Acenocoumarol.	#AECDE3	23.6646593223189	1
Indomethacin	Atenolol	0.172	-1.348	Moderate	222 (107/115)	Indomethacin may decrease the antihypertensive activities of Atenolol.	#B2D0E5	34.5628576944394	1
Disopyramide	Bisoprolol	0.32	3.19	Major	15 (12/3)	Disopyramide may increase the bradycardic activities of Bisoprolol.	#F2ACAC	2.33532822259726	0.000988449212607065
Carbamazepine	Acenocoumarol	0.302	-1.194	None	164 (84/80)	The serum concentration of Acenocoumarol can be decreased when it is combined with Carbamazepine.	#B4D1E6	25.5329219003967	1
Propranolol	Glyburide	0.285	-1.387	Moderate	198 (94/104)	Propranolol may increase the hypoglycemic activities of Glyburide.	#B2D0E5	30.8263325382838	1
Spironolactone	Cholestyramine	0.319	-1.287	Moderate	77 (38/39)	The risk or severity of adverse effects can be increased when Cholestyramine is combined with Spironolactone.	#B2D0E5	11.9880182093326	0.122661377732039
Zolmitriptan	Ergotamine	0.386	2.392	Major	12 (9/3)	Ergotamine may increase the vasoconstricting activities of Zolmitriptan.	#F5B2B2	1.86826257807781	0.000679124693206924
Cyclosporine	Carvedilol	0.41	-1.742	Moderate	43 (18/25)	The serum concentration of Cyclosporine can be increased when it is combined with Carvedilol.	#AFCEE4	6.69460757144547	1.79196937648966e-05
Omeprazole	Triazolam	0.195	2.896	Moderate	88 (69/19)		#F3AFAF	13.7005922392373	1
Atenolol	Insulin detemir	0.268	-1.03	Moderate	173 (95/78)		#B4D1E6	26.9341188339551	1
Atenolol	Terbutaline	0.13	-1.191	Moderate	195 (100/95)	Atenolol may decrease the bronchodilatory activities of Terbutaline.	#B4D1E6	30.3592668937644	1
Levothyroxine	Cholestyramine	0.192	3.638	Moderate	89 (73/16)	The serum concentration of Levothyroxine can be decreased when it is combined with Cholestyramine.	#F0A9A9	13.8562807874104	1
Bisoprolol	Glipizide	0.32	-1.912	Moderate	154 (61/93)	Bisoprolol may increase the hypoglycemic activities of Glipizide.	#AECDE3	23.9760364186652	1
Spironolactone	Captopril	0.377	-1.338	Major	155 (75/80)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Captopril.	#B2D0E5	24.1317249668383	1
Warfarin	Phenobarbital	0.253	1.709	Major	22 (15/7)	The metabolism of Warfarin can be increased when combined with Phenobarbital.	#F7B7B7	3.42514805980931	1
Erythromycin	Acenocoumarol	0.09	-1.151	None	211 (110/101)	The serum concentration of Acenocoumarol can be increased when it is combined with Erythromycin.	#B4D1E6	32.8502836645348	1
Phenytoin	Quetiapine	0.321	-2.076	Major	77 (29/48)	The serum concentration of Quetiapine can be decreased when it is combined with Phenytoin.	#AECDE3	11.9880182093326	4.23464399572722e-05
Metoclopramide	Levodopa	0.123	1.298	Moderate	205 (127/78)	The therapeutic efficacy of Levodopa can be decreased when used in combination with Metoclopramide.	#F8BABA	31.9161523754959	1
Olanzapine	Galantamine	0.371	-1.411	Moderate	51 (24/27)		#B2D0E5	7.94011595683068	2.44840947230369e-06
Duloxetine	Nortriptyline	0.381	2.392	Major	24 (18/6)	Duloxetine may increase the serotonergic activities of Nortriptyline.	#F5B2B2	3.73652515615561	0.00055687456553161
Ziprasidone	Donepezil	0.488	-1.115	Moderate	17 (9/8)	The metabolism of Donepezil can be decreased when combined with Ziprasidone.	#B4D1E6	2.64670531894356	4.9219649352122e-06
Omeprazole	Ketoconazole	0.144	-1.379	Moderate	168 (80/88)	The serum concentration of Ketoconazole can be decreased when it is combined with Omeprazole.	#B2D0E5	26.1556760930893	1
Rivastigmine	Methotrimeprazine	0.243	1.31	Moderate	37 (23/14)		#F8BABA	5.76047628240657	0.174779973234074
Cefotaxime	Gentamicin	0.333	Inf	Moderate	1 (1/0)		#B32020	0.155688548173151	1
Naproxen	Acenocoumarol	0.099	-1.506	None	757 (344/413)	Naproxen may increase the anticoagulant activities of Acenocoumarol.	#B1CFE5	117.856230967075	1
Salbutamol	Rasagiline	0.172	-1.914	Moderate	192 (76/116)	The risk or severity of adverse effects can be increased when Rasagiline is combined with Salbutamol.	#AECDE3	29.8922012492449	1
Ciprofloxacin	Rasagiline	0.097	-2.475	Major	223 (75/148)		#ABCBE2	34.7185462426126	1
Paroxetine	Rasagiline	0.349	1.099	Major	107 (62/45)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Rasagiline.	#F9BCBC	16.6586746545271	1
Phenytoin	Alprazolam	0.35	1.687	Moderate	81 (55/26)	The serum concentration of Phenytoin can be increased when it is combined with Alprazolam.	#F7B7B7	12.6107724020252	1
Diazepam	Clarithromycin	0.213	1.399	Moderate	314 (200/114)	The metabolism of Diazepam can be decreased when combined with Clarithromycin.	#F8BABA	48.8862041263693	1
Oxycodone	Escitalopram	0.296	2.202	Moderate	79 (58/21)	Oxycodone may increase the serotonergic activities of Escitalopram.	#F5B4B4	12.2993953056789	1
Propranolol	Repaglinide	0.327	1.059	Moderate	135 (77/58)		#F9BCBC	21.0179540033753	1
Galantamine	Tolterodine	0.347	-1.222	Moderate	77 (39/38)	The therapeutic efficacy of Tolterodine can be decreased when used in combination with Galantamine.	#B2D0E5	11.9880182093326	1
Glimepiride	Pregabalin	0.225	-1.267	None	189 (94/95)	The risk or severity of heart failure can be increased when Pregabalin is combined with Glimepiride.	#B2D0E5	29.4251356047255	1
Carbamazepine	Sertraline	0.323	1.595	Moderate	93 (62/31)	The metabolism of Carbamazepine can be decreased when combined with Sertraline.	#F7B9B9	14.479034980103	1
Galantamine	Solifenacin	0.352	-1.75	Moderate	103 (43/60)	The therapeutic efficacy of Solifenacin can be decreased when used in combination with Galantamine.	#AFCEE4	16.0359204618345	1
Amitriptyline	Rasagiline	0.33	1.072	Major	75 (43/32)	Rasagiline may increase the serotonergic activities of Amitriptyline.	#F9BCBC	11.6766411129863	1
Atenolol	Diltiazem	0.309	1.014	Major	243 (136/107)	Diltiazem may increase the hypotensive activities of Atenolol.	#F9BCBC	37.8323172060756	1
Methotrexate	Diclofenac	0.211	1.165	Major	192 (114/78)	The serum concentration of Methotrexate can be increased when it is combined with Diclofenac.	#F9BCBC	29.8922012492449	1
Topiramate	Carbamazepine	0.482	1.396	Moderate	22 (14/8)	The serum concentration of Topiramate can be decreased when it is combined with Carbamazepine.	#F8BABA	3.42514805980931	0.0133697230110269
Phenytoin	Gabapentin	0.364	-1.428	Moderate	77 (36/41)	The risk or severity of adverse effects can be increased when Gabapentin is combined with Phenytoin.	#B2D0E5	11.9880182093326	1
Cyclosporine	Atorvastatin	0.438	-2.114	Major	94 (35/59)	The serum concentration of Atorvastatin can be increased when it is combined with Cyclosporine.	#ACCCE3	14.6347235282762	1
Indomethacin	Bisoprolol	0.145	-2.103	Moderate	356 (133/223)	Indomethacin may decrease the antihypertensive activities of Bisoprolol.	#ACCCE3	55.4251231496416	1
Enalapril	Lithium cation	0.294	1.736	Moderate	108 (74/34)	The serum concentration of Lithium can be increased when it is combined with Enalapril.	#F7B7B7	16.8143632027003	1
Gliclazide	Glucosamine	0.203	-1.085	None	235 (126/109)		#B4D1E6	36.5868088206904	1
Carvedilol	Insulin glulisine	0.213	-2.344	Moderate	66 (23/43)		#ABCBE2	10.2754441794279	0.000379936665063488
Rivastigmine	Clomipramine	0.331	2.024	Moderate	46 (33/13)		#F6B6B6	7.16167321596493	1
Warfarin	Acetylsalicylic acid	0.214	-2.937	Major	508 (152/356)	Acetylsalicylic acid may increase the anticoagulant activities of Warfarin.	#A8C8E1	79.0897824719605	1
Raloxifene	Estriol	0.243	Inf	None	23 (23/0)		#B32020	3.58083660798246	0.0555207441227534
Phenobarbital	Acenocoumarol	0.368	-1.226	None	87 (44/43)	The metabolism of Acenocoumarol can be increased when combined with Phenobarbital.	#B2D0E5	13.5449036910641	1
Nabumetone	Acenocoumarol	0.134	1.011	None	127 (71/56)	Nabumetone may increase the anticoagulant activities of Acenocoumarol.	#F9BCBC	19.7724456179901	1
Furosemide	Gentamicin	0.142	-1.135	Major	80 (42/38)	The serum concentration of Gentamicin can be increased when it is combined with Furosemide.	#B4D1E6	12.455083853852	1
Propranolol	Salmeterol	0.252	-1.981	Major	258 (100/158)		#AECDE3	40.1676454286728	1
Dihydroergotamine	Almotriptan	0.171	4.785	Major	7 (6/1)	Dihydroergotamine may increase the vasoconstricting activities of Almotriptan.	#EDA1A1	1.08981983721205	0.0835381585745555
Sulfasalazine	Azathioprine	0.623	Inf	Moderate	4 (4/0)		#B32020	0.622754192692602	1
Hydroxyzine	Donepezil	0.193	1.766	Moderate	90 (62/28)		#F7B7B7	14.0119693355836	1
Salbutamol	Clomipramine	0.143	1.576	Moderate	125 (83/42)	The risk or severity of adverse effects can be increased when Clomipramine is combined with Salbutamol.	#F7B9B9	19.4610685216438	1
Bisoprolol	Insulin glulisine	0.24	-1.646	Moderate	111 (48/63)		#B1CFE5	17.2814288472197	1
Biperiden	Rivastigmine	0.259	-1.015	Moderate	38 (21/17)	The therapeutic efficacy of Biperiden can be decreased when used in combination with Rivastigmine.	#B4D1E6	5.91616483057972	0.0584956735677984
Warfarin	Ibuprofen	0.143	-1.292	Major	339 (167/172)	Ibuprofen may increase the anticoagulant activities of Warfarin.	#B2D0E5	52.778417830698	1
Warfarin	Levofloxacin	0.111	-2.19	Major	195 (71/124)	Levofloxacin may increase the anticoagulant activities of Warfarin.	#ACCCE3	30.3592668937644	1
Metoprolol	Gliclazide	0.384	-1.106	None	64 (34/30)	Metoprolol may increase the hypoglycemic activities of Gliclazide.	#B4D1E6	9.96406708308164	1
Lidocaine	Atenolol	0.148	2.392	Moderate	120 (90/30)	The serum concentration of Lidocaine can be increased when it is combined with Atenolol.	#F5B2B2	18.6826257807781	1
Digoxin	Indapamide	0.259	1.159	Moderate	157 (93/64)	The risk or severity of adverse effects can be increased when Indapamide is combined with Digoxin.	#F9BCBC	24.4431020631846	1
Digoxin	Methotrexate	0.218	1.402	Moderate	80 (51/29)	Digoxin may decrease the cardiotoxic activities of Methotrexate.	#F8BABA	12.455083853852	1
Oxycodone	Paroxetine	0.294	2.98	Moderate	90 (71/19)	The metabolism of Oxycodone can be decreased when combined with Paroxetine.	#F2AEAE	14.0119693355836	1
Pantoprazole	Itraconazole	0.149	1.18	Moderate	119 (71/48)	The serum concentration of Itraconazole can be decreased when it is combined with Pantoprazole.	#F9BCBC	18.5269372326049	1
Warfarin	Paroxetine	0.298	2.147	Moderate	96 (70/26)	Paroxetine may increase the anticoagulant activities of Warfarin.	#F5B4B4	14.9461006246225	1
Fluconazole	Haloperidol	0.49	-1.218	Major	69 (35/34)	The metabolism of Haloperidol can be decreased when combined with Fluconazole.	#B2D0E5	10.7425098239474	1
Ciprofloxacin	Methotrexate	0.106	-1.086	Moderate	153 (82/71)	The serum concentration of Methotrexate can be increased when it is combined with Ciprofloxacin.	#B4D1E6	23.820347870492	1
Cyclosporine	Sirolimus	0.371	-3.762	Moderate	4 (1/3)	The risk or severity of adverse effects can be increased when Sirolimus is combined with Cyclosporine.	#A2C4DE	0.622754192692602	0.00453409395569658
Ciprofloxacin	Warfarin	0.132	-1.828	Major	204 (83/121)		#AFCEE4	31.7604638273227	1
Simvastatin	Fusidic acid	0.078	-1.102	None	139 (74/65)	The serum concentration of Simvastatin can be increased when it is combined with Fusidic Acid.	#B4D1E6	21.6407081960679	1
Haloperidol	Carbamazepine	0.352	1.032	Moderate	39 (22/17)	The metabolism of Haloperidol can be increased when combined with Carbamazepine.	#F9BCBC	6.07185337875287	1
Amiodarone	Flecainide	0.192	-1.143	Major	86 (45/41)	The serum concentration of Flecainide can be increased when it is combined with Amiodarone.	#B4D1E6	13.3892151428909	1
Bisoprolol	Ergotamine	0.197	2.492	Moderate	66 (50/16)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#F5B2B2	10.2754441794279	1
Dextromethorphan	Memantine	0.135	1.794	Minor	91 (63/28)	The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Memantine.	#F7B7B7	14.1676578837567	1
Pyridostigmine	Fludrocortisone	0.36	-1.254	Moderate	4 (2/2)	The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Pyridostigmine.	#B2D0E5	0.622754192692602	0.623714913872832
Alprazolam	Itraconazole	0.109	2.193	Major	105 (77/28)	The serum concentration of Alprazolam can be increased when it is combined with Itraconazole.	#F5B4B4	16.3472975581808	1
Lovastatin	Clarithromycin	0.062	1.527	Major	102 (67/35)	The serum concentration of Lovastatin can be increased when it is combined with Clarithromycin.	#F7B9B9	15.8802319136614	1
Haloperidol	Propranolol	0.242	1.032	Moderate	78 (44/34)	The metabolism of Propranolol can be decreased when combined with Haloperidol.	#F9BCBC	12.1437067575057	1
Fluconazole	Acenocoumarol	0.1	-1.053	None	184 (100/84)	The serum concentration of Acenocoumarol can be increased when it is combined with Fluconazole.	#B4D1E6	28.6466928638597	1
Cyclosporine	Nifedipine	0.346	-2.257	Moderate	28 (10/18)	The metabolism of Nifedipine can be decreased when combined with Cyclosporine.	#ACCCE3	4.35927934884822	8.84256389052637e-06
Atenolol	Ergotamine	0.282	1.937	Moderate	48 (34/14)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#F6B6B6	7.47305031231123	1
Methylprednisolone	Clarithromycin	0.465	-1.083	Major	123 (66/57)	The serum concentration of Methylprednisolone can be increased when it is combined with Clarithromycin.	#B4D1E6	19.1496914252975	1
Fluoxetine	Oxycodone	0.239	3.899	Moderate	53 (44/9)	The metabolism of Oxycodone can be decreased when combined with Fluoxetine.	#F0A7A7	8.25149305317698	1
Propranolol	Maprotiline	0.392	4.785	Minor	21 (18/3)		#EDA1A1	3.26945951163616	1
Glyburide	Glucosamine	0.245	-1.178	None	161 (83/78)		#B4D1E6	25.0658562558772	1
Cyclosporine	Ciprofloxacin	0.08	-1.592	Moderate	59 (26/33)		#B1CFE5	9.18562434221588	1
Sertraline	Propafenone	0.289	2.205	Moderate	64 (47/17)	Sertraline may increase the QTc-prolonging activities of Propafenone.	#F5B4B4	9.96406708308164	1
Digoxin	Clarithromycin	0.157	-1.001	Major	169 (94/75)	The metabolism of Digoxin can be decreased when combined with Clarithromycin.	#B4D1E6	26.3113646412624	1
Ibuprofen	Lithium cation	0.148	1.422	Moderate	103 (66/37)	The serum concentration of Lithium can be increased when it is combined with Ibuprofen.	#F8BABA	16.0359204618345	1
Amitriptyline	Donepezil	0.313	3.402	Moderate	79 (64/15)		#F1ABAB	12.2993953056789	1
Ranolazine	Simvastatin	0.387	-3.358	Major	217 (59/158)	The serum concentration of Simvastatin can be increased when it is combined with Ranolazine.	#A5C6DF	33.7844149535737	1
Imipramine	Moclobemide	0.333	Inf	None	1 (1/0)	Moclobemide may increase the serotonergic activities of Imipramine.	#B32020	0.155688548173151	1
Paroxetine	Rizatriptan	0.254	4.12	Major	37 (31/6)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Rizatriptan.	#EFA6A6	5.76047628240657	1
Atorvastatin	Itraconazole	0.127	-1.346	Major	170 (82/88)	The risk or severity of adverse effects can be increased when Itraconazole is combined with Atorvastatin.	#B2D0E5	26.4670531894356	1
Clozapine	Haloperidol	0.101	Inf	Major	2 (2/0)	Clozapine may increase the QTc-prolonging activities of Haloperidol.	#B32020	0.311377096346301	1
Paroxetine	Propafenone	0.302	2.445	Moderate	61 (46/15)	The serum concentration of Propafenone can be increased when it is combined with Paroxetine.	#F5B2B2	9.49700143856218	1
Acarbose	Digoxin	0.374	1.005	Moderate	52 (29/23)	The serum concentration of Digoxin can be decreased when it is combined with Acarbose.	#F9BCBC	8.09580450500383	1
Disopyramide	Atenolol	0.528	4.785	Major	7 (6/1)	Disopyramide may increase the bradycardic activities of Atenolol.	#EDA1A1	1.08981983721205	1
Diclofenac	Warfarin	0.16	-1.386	Major	200 (95/105)	Diclofenac may increase the anticoagulant activities of Warfarin.	#B2D0E5	31.1377096346301	1
Trazodone	Ginkgo biloba	0.221	1.65	Moderate	89 (60/29)		#F7B7B7	13.8562807874104	1
Zolmitriptan	Escitalopram	0.313	2.392	Major	32 (24/8)	The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Escitalopram.	#F5B2B2	4.98203354154082	1
Celecoxib	Acenocoumarol	0.127	-1.091	None	303 (162/141)	Celecoxib may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	47.1736300964646	1
Amitriptyline	Rivastigmine	0.251	1.377	Moderate	90 (57/33)		#F8BABA	14.0119693355836	1
Enalapril	Rifampicin	0.186	-1.6	None	132 (58/74)	The metabolism of Enalapril can be increased when combined with Rifampicin.	#B1CFE5	20.5508883588559	1
Ezetimibe	Cholestyramine	0.255	1.082	Moderate	33 (19/14)	Cholestyramine can cause a decrease in the absorption of Ezetimibe resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F9BCBC	5.13772208971397	1
Spironolactone	Lisinopril	0.301	-1.383	Major	225 (107/118)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Lisinopril.	#B2D0E5	35.0299233389589	1
Rizatriptan	Escitalopram	0.262	2.924	Major	28 (22/6)	The risk or severity of adverse effects can be increased when Rizatriptan is combined with Escitalopram.	#F3AFAF	4.35927934884822	1
Paroxetine	Almotriptan	0.232	Inf	Major	24 (24/0)	The metabolism of Almotriptan can be decreased when combined with Paroxetine.	#B32020	3.73652515615561	1
Tacrolimus	Nifedipine	0.336	-3.108	Moderate	80 (23/57)	The serum concentration of Tacrolimus can be increased when it is combined with Nifedipine.	#A6C7E0	12.455083853852	0.000685400496466266
Propranolol	Ergotamine	0.217	1.994	Moderate	28 (20/8)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#F6B6B6	4.35927934884822	1
Bisoprolol	Verapamil	0.255	-1.001	Major	178 (99/79)	The metabolism of Bisoprolol can be decreased when combined with Verapamil.	#B4D1E6	27.7125615748208	1
Erythromycin	Citalopram	0.096	2.704	Major	101 (78/23)	The metabolism of Citalopram can be decreased when combined with Erythromycin.	#F4B1B1	15.7245433654882	1
Clarithromycin	Solifenacin	0.101	-1.254	Major	150 (75/75)	The metabolism of Solifenacin can be decreased when combined with Clarithromycin.	#B2D0E5	23.3532822259726	1
Atorvastatin	Josamycin	0.089	1.595	None	54 (36/18)	The risk or severity of adverse effects can be increased when Josamycin is combined with Atorvastatin.	#F7B9B9	8.40718160135013	1
Azathioprine	Acenocoumarol	0.345	-1.525	None	82 (37/45)	Azathioprine may decrease the anticoagulant activities of Acenocoumarol.	#B1CFE5	12.7664609501983	1
Trihexyphenidyl	Haloperidol	0.422	-1.433	Moderate	15 (7/8)		#B1CFE5	2.33532822259726	0.0104540503014741
Moclobemide	Clomipramine	0.033	Inf	None	2 (2/0)	Moclobemide may increase the serotonergic activities of Clomipramine.	#B32020	0.311377096346301	1
Betamethasone	Acetylsalicylic acid	0.089	-1.379	Moderate	147 (70/77)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Betamethasone.	#B2D0E5	22.8862165814531	1
Cyclosporine	Simvastatin	0.324	-1.39	Major	97 (46/51)	The serum concentration of Simvastatin can be increased when it is combined with Cyclosporine.	#B2D0E5	15.1017891727956	1
Citalopram	Rizatriptan	0.239	4.519	Major	40 (34/6)	The risk or severity of adverse effects can be increased when Citalopram is combined with Rizatriptan.	#EDA3A3	6.22754192692602	1
Prednisone	Phenobarbital	0.174	-1.184	Moderate	70 (36/34)	The serum concentration of Prednisone can be decreased when it is combined with Phenobarbital.	#B4D1E6	10.8981983721205	1
Sucralfate	Levothyroxine	0.171	3.987	Minor	78 (65/13)	The serum concentration of Levothyroxine can be decreased when it is combined with Sucralfate.	#F0A7A7	12.1437067575057	1
Terbutaline	Carvedilol	0.107	-2.064	Major	127 (48/79)	Carvedilol may decrease the vasoconstricting activities of Terbutaline.	#AECDE3	19.7724456179901	1
Almotriptan	Escitalopram	0.242	4.519	Major	20 (17/3)	The risk or severity of adverse effects can be increased when Almotriptan is combined with Escitalopram.	#EDA3A3	3.11377096346301	1
Repaglinide	Gemfibrozil	0.257	-1.881	Major	115 (46/69)	The serum concentration of Repaglinide can be increased when it is combined with Gemfibrozil.	#AECDE3	17.9041830399123	1
Phenytoin	Oxcarbazepine	0.492	-1.672	Moderate	14 (6/8)	The serum concentration of the active metabolites of Oxcarbazepine can be reduced when Oxcarbazepine is used in combination with Phenytoin resulting in a loss in efficacy.	#AFCEE4	2.17963967442411	0.0341151153445031
Levofloxacin	Iron	0.24	-1.856	Moderate	253 (102/151)	The serum concentration of Levofloxacin can be decreased when it is combined with Iron.	#AFCEE4	39.3892026878071	1
Pravastatin	Gemfibrozil	0.242	-1.482	Major	144 (66/78)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Pravastatin.	#B1CFE5	22.4191509369337	1
Fluvoxamine	Tramadol	0.264	3.19	Major	70 (56/14)	Fluvoxamine may increase the neuroexcitatory activities of Tramadol.	#F2ACAC	10.8981983721205	1
Ropinirole	Ciprofloxacin	0.13	-1.473	Moderate	87 (40/47)	The serum concentration of Ropinirole can be increased when it is combined with Ciprofloxacin.	#B1CFE5	13.5449036910641	1
Acetaminophen	Isoniazid	0.193	-1.76	Moderate	137 (57/80)	The risk or severity of adverse effects can be increased when Isoniazid is combined with Acetaminophen.	#AFCEE4	21.3293310997216	1
Phenytoin	Sertraline	0.324	-1.368	Moderate	69 (33/36)	The serum concentration of Phenytoin can be increased when it is combined with Sertraline.	#B2D0E5	10.7425098239474	1
Lidocaine	Propranolol	0.124	2.499	Moderate	62 (47/15)	The serum concentration of Lidocaine can be increased when it is combined with Propranolol.	#F5B2B2	9.65268998673534	1
Clomipramine	Rasagiline	0.434	1.823	Major	23 (16/7)	Rasagiline may increase the serotonergic activities of Clomipramine.	#F7B7B7	3.58083660798246	1
Metoprolol	Glyburide	0.323	-1.314	Moderate	43 (21/22)	Metoprolol may increase the hypoglycemic activities of Glyburide.	#B2D0E5	6.69460757144547	1
Phenytoin	Mirtazapine	0.332	1.349	Moderate	35 (22/13)	Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.	#F8BABA	5.44909918606027	1
Theophylline	Clarithromycin	0.323	-1.908	Moderate	58 (23/35)	The metabolism of Theophylline can be decreased when combined with Clarithromycin.	#AECDE3	9.02993579404273	1
Pregabalin	Pioglitazone	0.232	1.475	Moderate	57 (37/20)	The risk or severity of heart failure can be increased when Pregabalin is combined with Pioglitazone.	#F7B9B9	8.87424724586958	1
Fluconazole	Diazepam	0.229	1.631	Moderate	134 (90/44)	The metabolism of Diazepam can be decreased when combined with Fluconazole.	#F7B9B9	20.8622654552022	1
Fluoxetine	Nortriptyline	0.383	5.981	Major	17 (15/2)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Nortriptyline.	#E89898	2.64670531894356	1
Biperiden	Donepezil	0.302	1.305	Moderate	29 (18/11)	The therapeutic efficacy of Biperiden can be decreased when used in combination with Donepezil.	#F8BABA	4.51496789702137	1
Ziprasidone	Galantamine	0.396	1.063	Moderate	7 (4/3)	Galantamine may increase the QTc-prolonging activities of Ziprasidone.	#F9BCBC	1.08981983721205	0.432873624068063
Sotalol	Ibuprofen	0.128	1.028	Moderate	103 (58/45)	Ibuprofen may decrease the antihypertensive activities of Sotalol.	#F9BCBC	16.0359204618345	1
Fluoxetine	Doxepin	0.404	5.582	Major	8 (7/1)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Doxepin.	#EA9B9B	1.2455083853852	1
Verapamil	Midazolam	0.479	3.456	Moderate	16 (13/3)	The metabolism of Midazolam can be decreased when combined with Verapamil.	#F1ABAB	2.49101677077041	1
Erythromycin	Diazepam	0.196	2.304	Moderate	105 (78/27)	The metabolism of Diazepam can be decreased when combined with Erythromycin.	#F5B2B2	16.3472975581808	1
Piroxicam	Alendronic acid	0.217	7.376	None	41 (37/4)	The risk or severity of adverse effects can be increased when Piroxicam is combined with Alendronic acid.	#E48E8E	6.38323047509917	1
Donepezil	Clomipramine	0.326	2.392	Moderate	36 (27/9)	The metabolism of Donepezil can be decreased when combined with Clomipramine.	#F5B2B2	5.60478773423342	1
Erythromycin	Sertraline	0.126	1.994	Moderate	84 (60/24)	The risk or severity of adverse effects can be increased when Erythromycin is combined with Sertraline.	#F6B6B6	13.0778380465446	1
Fluconazole	Amitriptyline	0.173	2.392	Moderate	64 (48/16)	Amitriptyline may increase the QTc-prolonging activities of Fluconazole.	#F5B2B2	9.96406708308164	1
Trazodone	Warfarin	0.256	-1.39	Minor	78 (37/41)	Trazodone may decrease the anticoagulant activities of Warfarin.	#B2D0E5	12.1437067575057	1
Phenytoin	Topiramate	0.618	-2.508	Moderate	21 (7/14)	The serum concentration of Phenytoin can be increased when it is combined with Topiramate.	#ABCBE2	3.26945951163616	3.11691731832384e-05
Norfloxacin	Iron	0.275	1.578	None	140 (93/47)	The serum concentration of Norfloxacin can be decreased when it is combined with Iron.	#F7B9B9	21.7963967442411	1
Trospium	Solifenacin	0.22	-1.568	Moderate	36 (16/20)	The risk or severity of adverse effects can be increased when Trospium is combined with Solifenacin.	#B1CFE5	5.60478773423342	1
Phenytoin	Levodopa	0.41	-1.549	Moderate	38 (17/21)	The therapeutic efficacy of Levodopa can be decreased when used in combination with Phenytoin.	#B1CFE5	5.91616483057972	1
Warfarin	Fenofibrate	0.319	-1.705	Major	59 (25/34)	Fenofibrate may increase the anticoagulant activities of Warfarin.	#AFCEE4	9.18562434221588	1
Spironolactone	Eprosartan	0.296	1.227	Major	66 (40/26)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Eprosartan.	#F8BABA	10.2754441794279	1
Zolmitriptan	Dihydroergotamine	0.38	Inf	Major	6 (6/0)	Dihydroergotamine may increase the vasoconstricting activities of Zolmitriptan.	#B32020	0.934131289038903	1
Imipramine	Fluoxetine	0.501	2.552	Major	21 (16/5)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Imipramine.	#F4B1B1	3.26945951163616	1
Indomethacin	Carvedilol	0.152	-2.052	Moderate	116 (44/72)	Indomethacin may decrease the antihypertensive activities of Carvedilol.	#AECDE3	18.0598715880855	1
Hydroxyzine	Galantamine	0.198	1.652	Moderate	43 (29/14)		#F7B7B7	6.69460757144547	1
Zolmitriptan	Paroxetine	0.282	4.466	Major	33 (28/5)	The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Paroxetine.	#EDA3A3	5.13772208971397	1
Fludrocortisone	Acetylsalicylic acid	0.296	-1.858	Moderate	67 (27/40)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Fludrocortisone.	#AFCEE4	10.4311327276011	1
Diltiazem	Carbamazepine	0.23	1.36	Major	46 (29/17)	The serum concentration of Carbamazepine can be increased when it is combined with Diltiazem.	#F8BABA	7.16167321596493	1
Glipizide	Carvedilol	0.302	-1.672	Moderate	42 (18/24)	Carvedilol may increase the hypoglycemic activities of Glipizide.	#AFCEE4	6.53891902327232	1
Lidocaine	Carvedilol	0.115	1.158	Moderate	76 (45/31)	The serum concentration of Lidocaine can be increased when it is combined with Carvedilol.	#F9BCBC	11.8323296611594	1
Glyburide	Oxprenolol	0.355	1.595	None	9 (6/3)	Oxprenolol may increase the hypoglycemic activities of Glyburide.	#F7B9B9	1.40119693355836	1
Spironolactone	Eplerenone	0.144	-3.021	Major	75 (22/53)	Eplerenone may increase the hyperkalemic activities of Spironolactone.	#A6C7E0	11.6766411129863	1
Fludrocortisone	Rifampicin	0.281	1.595	Moderate	3 (2/1)	The serum concentration of Fludrocortisone can be decreased when it is combined with Rifampicin.	#F7B9B9	0.467065644519452	1
Metronidazole	Acenocoumarol	0.083	-1.778	None	191 (79/112)	The serum concentration of Acenocoumarol can be increased when it is combined with Metronidazole.	#AFCEE4	29.7365127010718	1
Ibandronate	Iron	0.173	4.685	Moderate	55 (47/8)		#EDA1A1	8.56287014952328	1
Repaglinide	Clarithromycin	0.093	1.075	Moderate	108 (62/46)	The serum concentration of Repaglinide can be increased when it is combined with Clarithromycin.	#F9BCBC	16.8143632027003	1
Lovastatin	Carbamazepine	0.229	1.196	None	35 (21/14)	The metabolism of Lovastatin can be increased when combined with Carbamazepine.	#F9BCBC	5.44909918606027	1
Cyclosporine	Ezetimibe	0.454	-1.568	Moderate	18 (8/10)	The serum concentration of Cyclosporine can be increased when it is combined with Ezetimibe.	#B1CFE5	2.80239386711671	1
Rifabutin	Clarithromycin	0.376	2.392	Moderate	4 (3/1)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Rifabutin.	#F5B2B2	0.622754192692602	1
Pravastatin	Colchicine	0.159	-5.052	Major	176 (35/141)	Colchicine may increase the myopathic rhabdomyolysis activities of Pravastatin.	#99BDDA	27.4011844784745	1
Omeprazole	Quazepam	0.234	2.126	Moderate	33 (24/9)	The metabolism of Quazepam can be decreased when combined with Omeprazole.	#F5B4B4	5.13772208971397	1
Diltiazem	Propranolol	0.256	1.033	Major	101 (57/44)	The metabolism of Propranolol can be decreased when combined with Diltiazem.	#F9BCBC	15.7245433654882	1
Fluconazole	Clonazepam	0.189	1.595	None	57 (38/19)	The metabolism of Clonazepam can be decreased when combined with Fluconazole.	#F7B9B9	8.87424724586958	1
Selegiline	Escitalopram	0.167	2.924	Major	14 (11/3)	The risk or severity of adverse effects can be increased when Escitalopram is combined with Selegiline.	#F3AFAF	2.17963967442411	1
Glyburide	Nadolol	0.335	-1.254	Moderate	28 (14/14)	Nadolol may increase the hypoglycemic activities of Glyburide.	#B2D0E5	4.35927934884822	1
Fluvoxamine	Mirtazapine	0.376	1.043	Major	30 (17/13)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Mirtazapine.	#F9BCBC	4.67065644519452	1
Fluoxetine	Carbamazepine	0.389	1.025	Moderate	48 (27/21)	The metabolism of Carbamazepine can be decreased when combined with Fluoxetine.	#F9BCBC	7.47305031231123	1
Metoprolol	Salbutamol	0.164	-1.482	Moderate	72 (33/39)	Metoprolol may decrease the bronchodilatory activities of Salbutamol.	#B1CFE5	11.2095754684668	1
Cyclosporine	Methotrexate	0.304	2.392	Moderate	8 (6/2)	The serum concentration of Methotrexate can be increased when it is combined with Cyclosporine.	#F5B2B2	1.2455083853852	1
Colestipol	Warfarin	0.368	1.329	Minor	8 (5/3)	Colestipol can cause a decrease in the absorption of Warfarin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F8BABA	1.2455083853852	1
Metoprolol	Fluoxetine	0.292	1.435	Moderate	28 (18/10)	The serum concentration of Metoprolol can be increased when it is combined with Fluoxetine.	#F7B9B9	4.35927934884822	1
Theophylline	Verapamil	0.34	-1.986	Moderate	31 (12/19)	The metabolism of Theophylline can be decreased when combined with Verapamil.	#AECDE3	4.82634499336767	1
Fluconazole	Tolterodine	0.186	1.808	Moderate	49 (34/15)	The metabolism of Tolterodine can be decreased when combined with Fluconazole.	#F7B7B7	7.62873886048438	1
Lansoprazole	Itraconazole	0.243	1.093	Moderate	64 (37/27)	The serum concentration of Itraconazole can be decreased when it is combined with Lansoprazole.	#F9BCBC	9.96406708308164	1
Chlorpropamide	Acetylsalicylic acid	0.408	-1.447	None	28 (13/15)	Acetylsalicylic acid may increase the hypoglycemic activities of Chlorpropamide.	#B1CFE5	4.35927934884822	1
Zolmitriptan	Fluoxetine	0.24	2.711	Major	22 (17/5)	The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Fluoxetine.	#F4B1B1	3.42514805980931	1
Simvastatin	Rifampicin	0.116	-1.654	Major	109 (47/62)	The metabolism of Simvastatin can be increased when combined with Rifampicin.	#AFCEE4	16.9700517508734	1
Hydrochlorothiazide	Lithium cation	0.209	2.972	Major	52 (41/11)	Hydrochlorothiazide may decrease the excretion rate of Lithium which could result in a higher serum level.	#F2AEAE	8.09580450500383	1
Phenytoin	Prednisone	0.131	-1.938	Moderate	84 (33/51)	The serum concentration of Prednisone can be decreased when it is combined with Phenytoin.	#AECDE3	13.0778380465446	1
Galantamine	Clomipramine	0.321	2.99	Moderate	19 (15/4)	The metabolism of Galantamine can be decreased when combined with Clomipramine.	#F2AEAE	2.95808241528986	1
Spironolactone	Quinapril	0.387	-1.688	Major	61 (26/35)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Quinapril.	#AFCEE4	9.49700143856218	1
Erythromycin	Fluoxetine	0.118	5.582	Moderate	40 (35/5)	The metabolism of Fluoxetine can be decreased when combined with Erythromycin.	#EA9B9B	6.22754192692602	1
Alendronic acid	Ketoprofen	0.175	22.328	Moderate	29 (28/1)	The risk or severity of adverse effects can be increased when Ketoprofen is combined with Alendronic acid.	#B32121	4.51496789702137	1
Dihydroergotamine	Atenolol	0.28	6.911	Moderate	29 (26/3)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#E69191	4.51496789702137	1
Atenolol	Glipizide	0.3	-1.306	Moderate	49 (24/25)	Atenolol may increase the hypoglycemic activities of Glipizide.	#B2D0E5	7.62873886048438	1
Fluoxetine	Lithium cation	0.292	1.24	Major	23 (14/9)	Lithium may increase the serotonergic activities of Fluoxetine.	#F8BABA	3.58083660798246	1
Fluoxetine	Propafenone	0.322	2.293	Moderate	31 (23/8)	Propafenone may increase the QTc-prolonging activities of Fluoxetine.	#F5B4B4	4.82634499336767	1
Indomethacin	Acenocoumarol	0.117	-2.339	None	212 (74/138)	Indomethacin may increase the anticoagulant activities of Acenocoumarol.	#ABCBE2	33.0059722127079	1
Cyclosporine	Amiodarone	0.292	-1.533	Moderate	20 (9/11)	The serum concentration of Cyclosporine can be increased when it is combined with Amiodarone.	#B1CFE5	3.11377096346301	1
Bisoprolol	Rifampicin	0.159	-1.533	Moderate	60 (27/33)	The metabolism of Bisoprolol can be increased when combined with Rifampicin.	#B1CFE5	9.34131289038903	1
Dexamethasone	Acenocoumarol	0.19	-2.392	None	189 (65/124)		#ABCBE2	29.4251356047255	1
Acenocoumarol	Cholestyramine	0.183	-1.22	None	73 (37/36)	Cholestyramine can cause a decrease in the absorption of Acenocoumarol resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B2D0E5	11.36526401664	1
Duloxetine	Flecainide	0.281	2.392	Moderate	40 (30/10)	The metabolism of Flecainide can be decreased when combined with Duloxetine.	#F5B2B2	6.22754192692602	1
Torasemide	Gentamicin	0.222	1.794	Major	26 (18/8)	The serum concentration of Gentamicin can be increased when it is combined with Torasemide.	#F7B7B7	4.04790225250192	1
Fluoxetine	Warfarin	0.327	1.766	Moderate	45 (31/14)	The metabolism of Warfarin can be decreased when combined with Fluoxetine.	#F7B7B7	7.00598466779178	1
Ergotamine	Naratriptan	0.167	Inf	Major	1 (1/0)	Ergotamine may increase the vasoconstricting activities of Naratriptan.	#B32020	0.155688548173151	1
Venlafaxine	Propafenone	0.388	2.734	Moderate	31 (24/7)	The serum concentration of Venlafaxine can be increased when it is combined with Propafenone.	#F3AFAF	4.82634499336767	1
Methylphenidate	Rasagiline	0.189	-1.505	Moderate	11 (5/6)	Rasagiline may increase the hypertensive activities of Methylphenidate.	#B1CFE5	1.71257402990466	1
Disopyramide	Omeprazole	0.349	3.19	None	20 (16/4)		#F2ACAC	3.11377096346301	1
Ciprofloxacin	Sevelamer	0.204	-2.069	Moderate	53 (20/33)		#AECDE3	8.25149305317698	1
Atomoxetine	Terbinafine	1	Inf	Moderate	1 (1/0)	The serum concentration of Atomoxetine can be increased when it is combined with Terbinafine.	#B32020	0.155688548173151	1
Citalopram	Zolmitriptan	0.243	3.721	Major	34 (28/6)	The risk or severity of adverse effects can be increased when Citalopram is combined with Zolmitriptan.	#F0A9A9	5.29341063788712	1
Imipramine	Carbamazepine	0.292	4.785	Moderate	7 (6/1)	The metabolism of Imipramine can be increased when combined with Carbamazepine.	#EDA1A1	1.08981983721205	1
Cyclosporine	Chloroquine	0.261	Inf	Moderate	1 (1/0)	Chloroquine may increase the nephrotoxic activities of Cyclosporine.	#B32020	0.155688548173151	1
Fluconazole	Midazolam	0.304	1.754	Major	16 (11/5)	The metabolism of Midazolam can be decreased when combined with Fluconazole.	#F7B7B7	2.49101677077041	1
Chlorthalidone	Digoxin	0.241	-1.223	Moderate	81 (41/40)	The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Digoxin.	#B2D0E5	12.6107724020252	1
Clarithromycin	Quetiapine	0.115	1.396	Major	88 (56/32)	The serum concentration of Quetiapine can be increased when it is combined with Clarithromycin.	#F8BABA	13.7005922392373	1
Methotrexate	Cloxacillin	0.107	2.62	Major	30 (23/7)	The serum concentration of Methotrexate can be increased when it is combined with Cloxacillin.	#F4B1B1	4.67065644519452	1
Trospium	Tolterodine	0.336	1.063	Moderate	21 (12/9)	The risk or severity of adverse effects can be increased when Trospium is combined with Tolterodine.	#F9BCBC	3.26945951163616	1
Bupropion	Rasagiline	0.262	2.392	Major	8 (6/2)	The risk or severity of adverse effects can be increased when Rasagiline is combined with Bupropion.	#F5B2B2	1.2455083853852	1
Atenolol	Verapamil	0.311	-1.028	Major	91 (50/41)	Verapamil may increase the hypotensive activities of Atenolol.	#B4D1E6	14.1676578837567	1
Chlorpromazine	Galantamine	0.266	-1.568	Moderate	9 (4/5)	The metabolism of Galantamine can be decreased when combined with Chlorpromazine.	#B1CFE5	1.40119693355836	1
Amitriptyline	Clonidine	0.114	Inf	Major	3 (3/0)	Amitriptyline may decrease the antihypertensive activities of Clonidine.	#B32020	0.467065644519452	1
Galantamine	Biperiden	0.277	-1.533	Moderate	20 (9/11)	The therapeutic efficacy of Biperiden can be decreased when used in combination with Galantamine.	#B1CFE5	3.11377096346301	1
Dihydroergotamine	Fluoxetine	0.225	4.519	Major	20 (17/3)	The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Fluoxetine.	#EDA3A3	3.11377096346301	1
Fluoxetine	Ergotamine	0.329	3.19	Major	20 (16/4)	The risk or severity of adverse effects can be increased when Ergotamine is combined with Fluoxetine.	#F2ACAC	3.11377096346301	1
Cyclosporine	Methylphenidate	0.362	Inf	Minor	2 (2/0)		#B32020	0.311377096346301	1
Levofloxacin	Methotrimeprazine	0.257	-2.074	Moderate	69 (26/43)	Methotrimeprazine may increase the QTc-prolonging activities of Levofloxacin.	#AECDE3	10.7425098239474	1
Amiodarone	Clarithromycin	0.139	-1.906	Major	126 (50/76)	Clarithromycin may increase the QTc-prolonging activities of Amiodarone.	#AECDE3	19.616757069817	1
Primidone	Acenocoumarol	0.264	-2.687	None	66 (21/45)	The metabolism of Acenocoumarol can be increased when combined with Primidone.	#A9C9E1	10.2754441794279	1
Trospium	Quetiapine	0.229	-1.543	Moderate	29 (13/16)		#B1CFE5	4.51496789702137	1
Fluoxetine	Rizatriptan	0.262	2.233	Major	19 (14/5)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Rizatriptan.	#F5B4B4	2.95808241528986	1
Itraconazole	Budesonide	0.266	-1.354	Major	104 (50/54)	The serum concentration of Budesonide can be increased when it is combined with Itraconazole.	#B2D0E5	16.1916090100077	1
Clozapine	Clonazepam	0.319	-1.881	Moderate	5 (2/3)	The risk or severity of adverse effects can be increased when Clonazepam is combined with Clozapine.	#AECDE3	0.778442740865753	0.319987166223444
Ramipril	Tizanidine	0.111	1.063	Major	35 (20/15)	The risk or severity of hypotension can be increased when Tizanidine is combined with Ramipril.	#F9BCBC	5.44909918606027	1
Metoprolol	Paroxetine	0.385	1.667	Moderate	34 (23/11)	The serum concentration of Metoprolol can be increased when it is combined with Paroxetine.	#F7B7B7	5.29341063788712	1
Fenofibrate	Ursodeoxycholic acid	0.266	1.435	None	28 (18/10)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Fenofibrate.	#F7B9B9	4.35927934884822	1
Fenofibrate	Fluvastatin	0.347	-1.938	Major	56 (22/34)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Fluvastatin.	#AECDE3	8.71855869769643	1
Cyclosporine	Norfloxacin	0.115	2.791	Moderate	18 (14/4)	The metabolism of Cyclosporine can be decreased when combined with Norfloxacin.	#F3AFAF	2.80239386711671	1
Doxycycline	Acenocoumarol	0.111	-1.505	None	77 (35/42)	The metabolism of Acenocoumarol can be decreased when combined with Doxycycline.	#B1CFE5	11.9880182093326	1
Glimepiride	Glucosamine	0.258	1.01	None	68 (38/30)		#F9BCBC	10.5868212757742	1
Sumatriptan	Paroxetine	0.183	4.785	Major	21 (18/3)	The risk or severity of adverse effects can be increased when Sumatriptan is combined with Paroxetine.	#EDA1A1	3.26945951163616	1
Theophylline	Ciprofloxacin	0.18	-5.285	Major	146 (28/118)		#97BCD9	22.73052803328	1
Erythromycin	Digoxin	0.137	1.085	Moderate	59 (34/25)	The metabolism of Digoxin can be decreased when combined with Erythromycin.	#F9BCBC	9.18562434221588	1
Diazepam	Itraconazole	0.222	2.848	Moderate	64 (50/14)	The metabolism of Diazepam can be decreased when combined with Itraconazole.	#F3AFAF	9.96406708308164	1
Pyridostigmine	Methylprednisolone	0.287	1.396	Moderate	11 (7/4)	The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Pyridostigmine.	#F8BABA	1.71257402990466	1
Cyclosporine	Pravastatin	0.533	-2.09	Major	32 (12/20)	The serum concentration of Pravastatin can be increased when it is combined with Cyclosporine.	#ACCCE3	4.98203354154082	1
Rifabutin	Tacrolimus	0.553	-1.254	None	2 (1/1)	The serum concentration of Tacrolimus can be decreased when it is combined with Rifabutin.	#B2D0E5	0.311377096346301	1
Erythromycin	Levofloxacin	0.591	1.121	Moderate	77 (45/32)	Erythromycin may increase the QTc-prolonging activities of Levofloxacin.	#F9BCBC	11.9880182093326	1
Amitriptyline	Terbutaline	0.225	1.475	Moderate	57 (37/20)	The risk or severity of adverse effects can be increased when Amitriptyline is combined with Terbutaline.	#F7B9B9	8.87424724586958	1
Citalopram	Metoprolol	0.426	1.885	Moderate	37 (26/11)	The serum concentration of Metoprolol can be increased when it is combined with Citalopram.	#F6B6B6	5.76047628240657	1
Diclofenac	Lithium cation	0.168	1.718	Moderate	41 (28/13)	The serum concentration of Lithium can be increased when it is combined with Diclofenac.	#F7B7B7	6.38323047509917	1
Dextropropoxyphene	Acenocoumarol	0.367	Inf	None	7 (7/0)		#B32020	1.08981983721205	1
Propranolol	Terbutaline	0.123	-1.901	Major	78 (31/47)		#AECDE3	12.1437067575057	1
Ergotamine	Rizatriptan	0.071	1.063	Major	7 (4/3)	Ergotamine may increase the vasoconstricting activities of Rizatriptan.	#F9BCBC	1.08981983721205	1
Acenocoumarol	Etoricoxib	0.119	-1.109	None	179 (95/84)	Etoricoxib may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	27.868250122994	1
Citalopram	Selegiline	0.284	1.24	Major	23 (14/9)	The risk or severity of adverse effects can be increased when Citalopram is combined with Selegiline.	#F8BABA	3.58083660798246	1
Paroxetine	Selegiline	0.411	1.595	Major	18 (12/6)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Selegiline.	#F7B9B9	2.80239386711671	1
Dihydroergotamine	Propranolol	0.293	1.861	Moderate	20 (14/6)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#F7B7B7	3.11377096346301	1
Terbinafine	Acenocoumarol	0.13	-1.415	None	83 (39/44)		#B2D0E5	12.9221494983715	1
Sucralfate	Ibandronate	0.229	13.556	Moderate	18 (17/1)		#D06060	2.80239386711671	1
Phenytoin	Sirolimus	0.09	-1.254	Major	2 (1/1)	The serum concentration of Sirolimus can be decreased when it is combined with Phenytoin.	#B2D0E5	0.311377096346301	1
Cyclosporine	Tacrolimus	0.162	1.595	Major	6 (4/2)	Tacrolimus may increase the nephrotoxic activities of Cyclosporine.	#F7B9B9	0.934131289038903	1
Trospium	Donepezil	0.304	1.994	Moderate	14 (10/4)	The therapeutic efficacy of Trospium can be decreased when used in combination with Donepezil.	#F6B6B6	2.17963967442411	1
Venlafaxine	Almotriptan	0.204	4.386	Major	13 (11/2)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Almotriptan.	#EEA4A4	2.02395112625096	1
Carbamazepine	Aripiprazole	0.249	Inf	Moderate	5 (5/0)	The serum concentration of Aripiprazole can be decreased when it is combined with Carbamazepine.	#B32020	0.778442740865753	1
Itraconazole	Acenocoumarol	0.093	-1.254	None	90 (45/45)	The serum concentration of Acenocoumarol can be increased when it is combined with Itraconazole.	#B2D0E5	14.0119693355836	1
Trazodone	Itraconazole	0.189	1.534	Moderate	38 (25/13)	The metabolism of Trazodone can be decreased when combined with Itraconazole.	#F7B9B9	5.91616483057972	1
Losartan	Lithium cation	0.252	1.329	Moderate	40 (25/15)	The serum concentration of Lithium can be increased when it is combined with Losartan.	#F8BABA	6.22754192692602	1
Doxycycline	Amoxicillin	0.412	-1.336	Moderate	126 (61/65)	The therapeutic efficacy of Amoxicillin can be decreased when used in combination with Doxycycline.	#B2D0E5	19.616757069817	1
Fluvoxamine	Duloxetine	0.26	1.096	Major	19 (11/8)	The serum concentration of Duloxetine can be increased when it is combined with Fluvoxamine.	#F9BCBC	2.95808241528986	1
Digoxin	Cholestyramine	0.218	1.165	Moderate	32 (19/13)	Cholestyramine can cause a decrease in the absorption of Digoxin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F9BCBC	4.98203354154082	1
Lovastatin	Warfarin	0.326	-1.066	Moderate	37 (20/17)	The metabolism of Warfarin can be decreased when combined with Lovastatin.	#B4D1E6	5.76047628240657	1
Tobramycin	Cefonicid	0.2	-1.254	Moderate	2 (1/1)		#B2D0E5	0.311377096346301	1
Valproic acid	Nimodipine	0.307	1.096	Minor	19 (11/8)		#F9BCBC	2.95808241528986	1
Rifampicin	Acenocoumarol	0.151	-1.505	None	44 (20/24)	The metabolism of Acenocoumarol can be increased when combined with Rifampicin.	#B1CFE5	6.85029611961863	1
Rifampicin	Leflunomide	0.092	Inf	Major	3 (3/0)	The serum concentration of the active metabolites of Leflunomide can be increased when Leflunomide is used in combination with Rifampicin.	#B32020	0.467065644519452	1
Triamcinolone	Acenocoumarol	0.141	-2.252	None	137 (49/88)		#ACCCE3	21.3293310997216	1
Indomethacin	Propranolol	0.148	-1.672	Moderate	70 (30/40)	Indomethacin may decrease the antihypertensive activities of Propranolol.	#AFCEE4	10.8981983721205	1
Ergotamine	Almotriptan	0.246	-1.672	Major	7 (3/4)	Ergotamine may increase the vasoconstricting activities of Almotriptan.	#AFCEE4	1.08981983721205	0.0602386390929471
Sotalol	Levofloxacin	0.142	-1.992	Major	44 (17/27)	Levofloxacin may increase the QTc-prolonging activities of Sotalol.	#AECDE3	6.85029611961863	1
Fluoxetine	Sumatriptan	0.154	2.193	Major	15 (11/4)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Sumatriptan.	#F5B4B4	2.33532822259726	1
Nabumetone	Methotrexate	0.122	2.193	Major	15 (11/4)	The serum concentration of Methotrexate can be increased when it is combined with Nabumetone.	#F5B4B4	2.33532822259726	1
Rivastigmine	Oxybutynin	0.297	-1.15	Moderate	23 (12/11)	The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Rivastigmine.	#B4D1E6	3.58083660798246	1
Paroxetine	Pimozide	0.165	Inf	Major	6 (6/0)	The serum concentration of Pimozide can be increased when it is combined with Paroxetine.	#B32020	0.934131289038903	1
Phenytoin	Methylprednisolone	0.122	-1.026	Moderate	20 (11/9)	The serum concentration of Methylprednisolone can be decreased when it is combined with Phenytoin.	#B4D1E6	3.11377096346301	1
Midazolam	Itraconazole	0.347	2.791	Major	9 (7/2)	The serum concentration of Midazolam can be increased when it is combined with Itraconazole.	#F3AFAF	1.40119693355836	1
Verapamil	Colchicine	0.219	-2.315	Major	37 (13/24)	The serum concentration of Colchicine can be increased when it is combined with Verapamil.	#ABCBE2	5.76047628240657	1
Trospium	Amitriptyline	0.216	1.481	Moderate	20 (13/7)		#F7B9B9	3.11377096346301	1
Rabeprazole	Itraconazole	0.247	1.472	Moderate	37 (24/13)	The serum concentration of Itraconazole can be decreased when it is combined with Rabeprazole.	#F7B9B9	5.76047628240657	1
Warfarin	Norfloxacin	0.141	2.525	Major	50 (38/12)	Norfloxacin may increase the anticoagulant activities of Warfarin.	#F4B1B1	7.78442740865753	1
Ergotamine	Frovatriptan	0.5	Inf	Major	1 (1/0)	Ergotamine may increase the vasoconstricting activities of Frovatriptan.	#B32020	0.155688548173151	1
Rifampicin	Atorvastatin	0.149	-1.824	Major	54 (22/32)	The metabolism of Atorvastatin can be increased when combined with Rifampicin.	#AFCEE4	8.40718160135013	1
Erythromycin	Lovastatin	0.062	1.522	Major	32 (21/11)	The serum concentration of Lovastatin can be increased when it is combined with Erythromycin.	#F7B9B9	4.98203354154082	1
Fluconazole	Tacrolimus	0.546	11.164	Major	15 (14/1)	The serum concentration of Tacrolimus can be increased when it is combined with Fluconazole.	#D87373	2.33532822259726	1
Fentanyl	Rifampicin	0.226	-1.254	Major	26 (13/13)	The serum concentration of Fentanyl can be decreased when it is combined with Rifampicin.	#B2D0E5	4.04790225250192	1
Diclofenac	Rifampicin	0.356	-1.463	Moderate	52 (24/28)	The serum concentration of Diclofenac can be decreased when it is combined with Rifampicin.	#B1CFE5	8.09580450500383	1
Alendronic acid	Flurbiprofen	0.175	11.164	Moderate	15 (14/1)	The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Alendronic acid.	#D87373	2.33532822259726	1
Salmeterol	Nadolol	0.233	-1.64	Major	30 (13/17)		#B1CFE5	4.67065644519452	1
Metoprolol	Sertraline	0.321	1.063	Moderate	35 (20/15)	The serum concentration of Metoprolol can be increased when it is combined with Sertraline.	#F9BCBC	5.44909918606027	1
Esomeprazole	Itraconazole	0.24	1.276	Moderate	39 (24/15)	The serum concentration of Itraconazole can be decreased when it is combined with Esomeprazole.	#F8BABA	6.07185337875287	1
Trihexyphenidyl	Rivastigmine	0.369	-1.003	Moderate	9 (5/4)	The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Rivastigmine.	#B4D1E6	1.40119693355836	1
Atenolol	Piroxicam	0.141	2.711	Moderate	22 (17/5)	Piroxicam may decrease the antihypertensive activities of Atenolol.	#F4B1B1	3.42514805980931	1
Lovastatin	Niacin	0.119	Inf	Major	2 (2/0)	The risk or severity of rhabdomyolysis can be increased when Niacin is combined with Lovastatin.	#B32020	0.311377096346301	1
Fluvoxamine	Lithium cation	0.473	1.196	Major	5 (3/2)	Lithium may increase the serotonergic activities of Fluvoxamine.	#F9BCBC	0.778442740865753	1
Moxifloxacin	Amiodarone	0.156	-3.876	Major	135 (33/102)	Moxifloxacin may increase the QTc-prolonging activities of Amiodarone.	#A0C3DD	21.0179540033753	1
Cyclosporine	Fluvastatin	0.281	-2.257	Moderate	14 (5/9)	The serum concentration of Fluvastatin can be increased when it is combined with Cyclosporine.	#ACCCE3	2.17963967442411	1
Pioglitazone	Gemfibrozil	0.267	-1.986	Major	31 (12/19)	The metabolism of Pioglitazone can be decreased when combined with Gemfibrozil.	#AECDE3	4.82634499336767	1
Gentamicin	Cefuroxime	0.56	-1.026	Moderate	20 (11/9)		#B4D1E6	3.11377096346301	1
Propranolol	Hydralazine	0.348	1.435	Minor	28 (18/10)	Hydralazine may increase the hypotensive activities of Propranolol.	#F7B9B9	4.35927934884822	1
Eletriptan	Escitalopram	0.06	Inf	Major	4 (4/0)	The risk or severity of adverse effects can be increased when Eletriptan is combined with Escitalopram.	#B32020	0.622754192692602	1
Phenytoin	Amiodarone	0.373	-1.986	Moderate	31 (12/19)	The serum concentration of Phenytoin can be increased when it is combined with Amiodarone.	#AECDE3	4.82634499336767	1
Ranolazine	Diltiazem	0.41	-3.887	Major	41 (10/31)	The serum concentration of Ranolazine can be increased when it is combined with Diltiazem.	#A0C3DD	6.38323047509917	1
Duloxetine	Propafenone	0.376	3.987	Moderate	18 (15/3)	The serum concentration of Duloxetine can be increased when it is combined with Propafenone.	#F0A7A7	2.80239386711671	1
Fluoxetine	Rasagiline	0.274	1.683	Major	28 (19/9)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Rasagiline.	#F7B7B7	4.35927934884822	1
Azithromycin	Warfarin	0.13	-2.12	Moderate	113 (42/71)	The metabolism of Warfarin can be decreased when combined with Azithromycin.	#ACCCE3	17.592805943566	1
Colestipol	Levothyroxine	0.204	1.728	Moderate	19 (13/6)	The serum concentration of Levothyroxine can be decreased when it is combined with Colestipol.	#F7B7B7	2.95808241528986	1
Piroxicam	Labetalol	0.333	Inf	Moderate	1 (1/0)	Piroxicam may decrease the antihypertensive activities of Labetalol.	#B32020	0.155688548173151	1
Ketoconazole	Rabeprazole	0.213	1.861	Moderate	10 (7/3)	The serum concentration of Ketoconazole can be decreased when it is combined with Rabeprazole.	#F7B7B7	1.55688548173151	1
Lovastatin	Itraconazole	0.076	1.506	Major	26 (17/9)	The serum concentration of Lovastatin can be increased when it is combined with Itraconazole.	#F7B9B9	4.04790225250192	1
Imipramine	Duloxetine	0.213	2.392	Major	12 (9/3)	Duloxetine may increase the serotonergic activities of Imipramine.	#F5B2B2	1.86826257807781	1
Cyclosporine	Metoclopramide	0.129	-1.15	Moderate	23 (12/11)	Metoclopramide can cause an increase in the absorption of Cyclosporine resulting in an increased serum concentration and potentially a worsening of adverse effects.	#B4D1E6	3.58083660798246	1
Ibuprofen	Oxprenolol	0.153	1.861	None	20 (14/6)	Ibuprofen may decrease the antihypertensive activities of Oxprenolol.	#F7B7B7	3.11377096346301	1
Dihydroergotamine	Bisoprolol	0.197	2.03	Moderate	39 (28/11)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#F6B6B6	6.07185337875287	1
Trospium	Cetirizine	0.166	2.259	None	23 (17/6)		#F5B4B4	3.58083660798246	1
Rosuvastatin	Gemfibrozil	0.276	-1.452	Major	41 (19/22)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Rosuvastatin.	#B1CFE5	6.38323047509917	1
Cyclosporine	Diltiazem	0.347	1.063	Moderate	14 (8/6)	The metabolism of Cyclosporine can be decreased when combined with Diltiazem.	#F9BCBC	2.17963967442411	1
Nortriptyline	Salbutamol	0.179	4.519	Moderate	20 (17/3)	The risk or severity of adverse effects can be increased when Nortriptyline is combined with Salbutamol.	#EDA3A3	3.11377096346301	1
Cyclosporine	Repaglinide	0.314	-1.254	Major	14 (7/7)	The serum concentration of Repaglinide can be increased when it is combined with Cyclosporine.	#B2D0E5	2.17963967442411	1
Losartan	Rifampicin	0.126	-1.135	Moderate	40 (21/19)	The serum concentration of Losartan can be decreased when it is combined with Rifampicin.	#B4D1E6	6.22754192692602	1
Verapamil	Primidone	0.215	4.785	Moderate	7 (6/1)	The metabolism of Verapamil can be increased when combined with Primidone.	#EDA1A1	1.08981983721205	1
Tolterodine	Itraconazole	0.096	1.104	Moderate	31 (18/13)	The serum concentration of Tolterodine can be increased when it is combined with Itraconazole.	#F9BCBC	4.82634499336767	1
Fluvoxamine	Acenocoumarol	0.284	-1.015	None	38 (21/17)	The metabolism of Acenocoumarol can be decreased when combined with Fluvoxamine.	#B4D1E6	5.91616483057972	1
Leflunomide	Acenocoumarol	0.316	-1.373	None	44 (21/23)	Leflunomide may increase the anticoagulant activities of Acenocoumarol.	#B2D0E5	6.85029611961863	1
Phenytoin	Fluoxetine	0.351	-2.122	Moderate	35 (13/22)	The serum concentration of Phenytoin can be increased when it is combined with Fluoxetine.	#ACCCE3	5.44909918606027	1
Ibuprofen	Nadolol	0.176	1.096	Moderate	57 (33/24)	Ibuprofen may decrease the antihypertensive activities of Nadolol.	#F9BCBC	8.87424724586958	1
Dihydroergotamine	Nadolol	0.265	Inf	Moderate	3 (3/0)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Nadolol.	#B32020	0.467065644519452	1
Repaglinide	Glucosamine	0.18	-1.158	None	75 (39/36)		#B4D1E6	11.6766411129863	1
Metoprolol	Repaglinide	0.463	-1.596	Moderate	25 (11/14)		#B1CFE5	3.89221370432876	1
Cyclosporine	Azithromycin	0.05	-1.254	Moderate	26 (13/13)	The metabolism of Cyclosporine can be decreased when combined with Azithromycin.	#B2D0E5	4.04790225250192	1
Diltiazem	Tacrolimus	0.143	-1.716	Moderate	45 (19/26)	The metabolism of Tacrolimus can be decreased when combined with Diltiazem.	#AFCEE4	7.00598466779178	1
Cyclosporine	Ibuprofen	0.107	-1.495	Moderate	57 (26/31)	Ibuprofen may increase the nephrotoxic activities of Cyclosporine.	#B1CFE5	8.87424724586958	1
Erythromycin	Moxifloxacin	0.511	1.522	Major	32 (21/11)	Erythromycin may increase the QTc-prolonging activities of Moxifloxacin.	#F7B9B9	4.98203354154082	1
Alprazolam	Ketoconazole	0.22	1.595	Major	18 (12/6)	The serum concentration of Alprazolam can be increased when it is combined with Ketoconazole.	#F7B9B9	2.80239386711671	1
Sotalol	Formoterol	0.237	-1.35	Major	27 (13/14)	Formoterol may increase the QTc-prolonging activities of Sotalol.	#B2D0E5	4.20359080067507	1
Eletriptan	Ergotamine	0.286	-1.254	Major	2 (1/1)	Ergotamine may increase the vasoconstricting activities of Eletriptan.	#B2D0E5	0.311377096346301	1
Colestipol	Ursodeoxycholic acid	0.374	1.196	None	5 (3/2)	The serum concentration of Ursodeoxycholic acid can be decreased when it is combined with Colestipol.	#F9BCBC	0.778442740865753	1
Citalopram	Almotriptan	0.183	2.99	Major	19 (15/4)	The risk or severity of adverse effects can be increased when Citalopram is combined with Almotriptan.	#F2AEAE	2.95808241528986	1
Prednisone	Primidone	0.135	-1.568	Moderate	36 (16/20)	The serum concentration of Prednisone can be decreased when it is combined with Primidone.	#B1CFE5	5.60478773423342	1
Metoprolol	Salmeterol	0.299	-1.756	Moderate	36 (15/21)	Metoprolol may decrease the bronchodilatory activities of Salmeterol.	#AFCEE4	5.60478773423342	1
Celecoxib	Warfarin	0.18	2.304	Moderate	35 (26/9)	Celecoxib may increase the anticoagulant activities of Warfarin.	#F5B2B2	5.44909918606027	1
Simvastatin	Ketoconazole	0.087	-1.425	Major	47 (22/25)	The serum concentration of Simvastatin can be increased when it is combined with Ketoconazole.	#B2D0E5	7.31736176413808	1
Lamotrigine	Norethisterone	0.053	Inf	Moderate	1 (1/0)		#B32020	0.155688548173151	1
Galantamine	Maprotiline	0.466	1.994	Moderate	7 (5/2)		#F6B6B6	1.08981983721205	1
Clonidine	Carvedilol	0.405	-1.254	Major	4 (2/2)	Clonidine may increase the atrioventricular blocking (AV block) activities of Carvedilol.	#B2D0E5	0.622754192692602	1
Amitriptyline	Galantamine	0.26	3.349	Moderate	26 (21/5)		#F2ACAC	4.04790225250192	1
Itraconazole	Solifenacin	0.157	-1.254	Major	38 (19/19)	The metabolism of Solifenacin can be decreased when combined with Itraconazole.	#B2D0E5	5.91616483057972	1
Verapamil	Phenobarbital	0.429	5.582	Moderate	8 (7/1)	The metabolism of Verapamil can be increased when combined with Phenobarbital.	#EA9B9B	1.2455083853852	1
Minocycline	Acenocoumarol	0.103	-1.724	None	38 (16/22)	Minocycline may increase the anticoagulant activities of Acenocoumarol.	#AFCEE4	5.91616483057972	1
Lovastatin	Fenofibrate	0.249	-1.075	Major	39 (21/18)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Lovastatin.	#B4D1E6	6.07185337875287	1
Gemfibrozil	Ursodeoxycholic acid	0.313	-1.075	None	26 (14/12)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Gemfibrozil.	#B4D1E6	4.04790225250192	1
Phenytoin	Megestrol acetate	0.471	-1.254	Moderate	12 (6/6)		#B2D0E5	1.86826257807781	1
Phenytoin	Trimethoprim	0.125	-1.724	Moderate	19 (8/11)	The serum concentration of Phenytoin can be increased when it is combined with Trimethoprim.	#AFCEE4	2.95808241528986	1
Tacrolimus	Itraconazole	0.546	1.794	Major	13 (9/4)	The serum concentration of Tacrolimus can be increased when it is combined with Itraconazole.	#F7B7B7	2.02395112625096	1
Methylprednisolone	Phenobarbital	0.074	1.595	Moderate	12 (8/4)	The serum concentration of Methylprednisolone can be decreased when it is combined with Phenobarbital.	#F7B9B9	1.86826257807781	1
Propranolol	Propafenone	0.241	1.116	Moderate	24 (14/10)	The serum concentration of Propranolol can be increased when it is combined with Propafenone.	#F9BCBC	3.73652515615561	1
Isoniazid	Acenocoumarol	0.157	-1.254	None	22 (11/11)	The metabolism of Acenocoumarol can be decreased when combined with Isoniazid.	#B2D0E5	3.42514805980931	1
Verapamil	Carvedilol	0.297	-1.097	Major	45 (24/21)	The metabolism of Carvedilol can be decreased when combined with Verapamil.	#B4D1E6	7.00598466779178	1
Carbamazepine	Verapamil	0.412	1.462	Major	17 (11/6)	The serum concentration of Carbamazepine can be increased when it is combined with Verapamil.	#F7B9B9	2.64670531894356	1
Metoprolol	Prazosin	0.426	Inf	Moderate	1 (1/0)	Metoprolol may increase the orthostatic hypotensive activities of Prazosin.	#B32020	0.155688548173151	1
Trospium	Galantamine	0.304	1.994	Moderate	7 (5/2)	The therapeutic efficacy of Trospium can be decreased when used in combination with Galantamine.	#F6B6B6	1.08981983721205	1
Cimetidine	Propranolol	0.075	Inf	Moderate	3 (3/0)	The metabolism of Propranolol can be decreased when combined with Cimetidine.	#B32020	0.467065644519452	1
Diazepam	Rifampicin	0.243	-1.033	Minor	31 (17/14)	The metabolism of Diazepam can be increased when combined with Rifampicin.	#B4D1E6	4.82634499336767	1
Folic acid	Primidone	0.208	-1.411	Moderate	17 (8/9)	The serum concentration of Primidone can be decreased when it is combined with Folic Acid.	#B2D0E5	2.64670531894356	1
Cyclosporine	Sulfamethoxazole	0.155	-1.568	Major	9 (4/5)	Sulfamethoxazole may increase the nephrotoxic activities of Cyclosporine.	#B1CFE5	1.40119693355836	1
Prazosin	Propranolol	0.461	1.196	Moderate	5 (3/2)	Propranolol may increase the orthostatic hypotensive activities of Prazosin.	#F9BCBC	0.778442740865753	1
Repaglinide	Glipizide	0.25	-2.383	None	29 (10/19)	Repaglinide may increase the hypoglycemic activities of Glipizide.	#ABCBE2	4.51496789702137	1
Sucralfate	Levofloxacin	0.377	-1.154	Moderate	48 (25/23)	The serum concentration of Levofloxacin can be decreased when it is combined with Sucralfate.	#B4D1E6	7.47305031231123	1
Methotrexate	Flurbiprofen	0.147	-1.672	Major	7 (3/4)	The serum concentration of Methotrexate can be increased when it is combined with Flurbiprofen.	#AFCEE4	1.08981983721205	1
Digoxin	Hydroxychloroquine	0.262	1.396	Moderate	22 (14/8)	The serum concentration of Digoxin can be increased when it is combined with Hydroxychloroquine.	#F8BABA	3.42514805980931	1
Chlorpromazine	Rivastigmine	0.23	-1.254	Moderate	8 (4/4)		#B2D0E5	1.2455083853852	1
Fluoxetine	Almotriptan	0.267	Inf	Major	8 (8/0)	The metabolism of Almotriptan can be decreased when combined with Fluoxetine.	#B32020	1.2455083853852	1
Pseudoephedrine	Clomipramine	0.149	7.177	None	10 (9/1)	Clomipramine may decrease the antihypertensive activities of Pseudoephedrine.	#E59090	1.55688548173151	1
Warfarin	Pentoxifylline	0.268	-4.131	Moderate	73 (17/56)	Pentoxifylline may increase the anticoagulant activities of Warfarin.	#9FC1DD	11.36526401664	1
Tizanidine	Donepezil	0.236	3.987	Moderate	12 (10/2)	Tizanidine may increase the bradycardic activities of Donepezil.	#F0A7A7	1.86826257807781	1
Nortriptyline	Galantamine	0.425	3.19	Moderate	5 (4/1)		#F2ACAC	0.778442740865753	1
Metoprolol	Escitalopram	0.31	1.063	Minor	21 (12/9)	The serum concentration of Metoprolol can be increased when it is combined with Escitalopram.	#F9BCBC	3.26945951163616	1
Fluvastatin	Gemfibrozil	0.314	-1.568	Major	36 (16/20)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Fluvastatin.	#B1CFE5	5.60478773423342	1
Moxifloxacin	Iron	0.311	-1.588	Moderate	68 (30/38)		#B1CFE5	10.5868212757742	1
Rosuvastatin	Colchicine	0.149	-2.633	Moderate	31 (10/21)	Colchicine may increase the myopathic rhabdomyolysis activities of Rosuvastatin.	#A9C9E1	4.82634499336767	1
Paroxetine	Frovatriptan	0.298	3.19	None	5 (4/1)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Frovatriptan.	#F2ACAC	0.778442740865753	1
Trifluoperazine	Donepezil	0.039	Inf	Moderate	2 (2/0)		#B32020	0.311377096346301	1
Fluconazole	Carbamazepine	0.093	2.193	Moderate	15 (11/4)	The serum concentration of Carbamazepine can be increased when it is combined with Fluconazole.	#F5B4B4	2.33532822259726	1
Alprazolam	Josamycin	0.142	1.823	None	23 (16/7)	The serum concentration of Alprazolam can be increased when it is combined with Josamycin.	#F7B7B7	3.58083660798246	1
Ciprofloxacin	Tizanidine	0.27	-1.309	Major	47 (23/24)	Tizanidine may increase the QTc-prolonging activities of Ciprofloxacin.	#B2D0E5	7.31736176413808	1
Sotalol	Glyburide	0.265	-1.115	Moderate	17 (9/8)	Sotalol may increase the hypoglycemic activities of Glyburide.	#B4D1E6	2.64670531894356	1
Imipramine	Donepezil	0.399	5.582	Moderate	8 (7/1)	The metabolism of Donepezil can be decreased when combined with Imipramine.	#EA9B9B	1.2455083853852	1
Disopyramide	Galantamine	0.886	Inf	Moderate	1 (1/0)	Galantamine may increase the QTc-prolonging activities of Disopyramide.	#B32020	0.155688548173151	1
Ranitidine	Itraconazole	0.142	-2.006	Moderate	65 (25/40)	The serum concentration of Itraconazole can be decreased when it is combined with Ranitidine.	#AECDE3	10.1197556312548	1
Theophylline	Phenobarbital	0.192	-2.09	Moderate	8 (3/5)	The metabolism of Theophylline can be increased when combined with Phenobarbital.	#ACCCE3	1.2455083853852	1
Sertraline	Cilostazol	0.264	-2.956	Moderate	47 (14/33)	The serum concentration of Cilostazol can be increased when it is combined with Sertraline.	#A6C7E0	7.31736176413808	1
Moxifloxacin	Warfarin	0.155	-2.434	Major	50 (17/33)		#ABCBE2	7.78442740865753	1
Amitriptyline	Moclobemide	0.151	Inf	None	2 (2/0)	The risk or severity of adverse effects can be increased when Amitriptyline is combined with Moclobemide.	#B32020	0.311377096346301	1
Fluconazole	Fluvastatin	0.125	1.495	Moderate	23 (15/8)	The serum concentration of Fluvastatin can be increased when it is combined with Fluconazole.	#F7B9B9	3.58083660798246	1
Cimetidine	Diazepam	0.253	-1.254	Moderate	12 (6/6)	The metabolism of Diazepam can be decreased when combined with Cimetidine.	#B2D0E5	1.86826257807781	1
Hydroxyzine	Rivastigmine	0.203	-1.254	Moderate	46 (23/23)		#B2D0E5	7.16167321596493	1
Indomethacin	Warfarin	0.154	-2.15	Major	38 (14/24)	Indomethacin may increase the anticoagulant activities of Warfarin.	#ACCCE3	5.91616483057972	1
Erythromycin	Verapamil	0.071	1.396	Major	22 (14/8)	The metabolism of Verapamil can be decreased when combined with Erythromycin.	#F8BABA	3.42514805980931	1
Imipramine	Salbutamol	0.201	1.276	Moderate	26 (16/10)	The risk or severity of adverse effects can be increased when Imipramine is combined with Salbutamol.	#F8BABA	4.04790225250192	1
Gentamicin	Cefonicid	0.458	-1.254	Moderate	4 (2/2)		#B2D0E5	0.622754192692602	1
Atorvastatin	Fusidic acid	0.079	-1.98	None	49 (19/30)	The serum concentration of Atorvastatin can be increased when it is combined with Fusidic Acid.	#AECDE3	7.62873886048438	1
Betamethasone	Pyridostigmine	0.044	Inf	Moderate	2 (2/0)	The risk or severity of adverse effects can be increased when Betamethasone is combined with Pyridostigmine.	#B32020	0.311377096346301	1
Fluvoxamine	Doxepin	0.533	-1.254	Major	2 (1/1)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Doxepin.	#B2D0E5	0.311377096346301	1
Triazolam	Clarithromycin	0.24	3.987	Moderate	6 (5/1)	The serum concentration of Triazolam can be increased when it is combined with Clarithromycin.	#F0A7A7	0.934131289038903	1
Dihydroergotamine	Rizatriptan	0.385	2.392	Major	4 (3/1)	Dihydroergotamine may increase the vasoconstricting activities of Rizatriptan.	#F5B2B2	0.622754192692602	1
Theophylline	Norfloxacin	0.262	1.418	Moderate	25 (16/9)	The metabolism of Theophylline can be decreased when combined with Norfloxacin.	#F8BABA	3.89221370432876	1
Cyproheptadine	Donepezil	0.262	1.595	Moderate	3 (2/1)		#F7B9B9	0.467065644519452	1
Sucralfate	Ciprofloxacin	0.252	-1.344	Moderate	58 (28/30)		#B2D0E5	9.02993579404273	1
Clonazepam	Itraconazole	0.198	1.418	None	25 (16/9)	The metabolism of Clonazepam can be decreased when combined with Itraconazole.	#F8BABA	3.89221370432876	1
Valsartan	Lithium cation	0.26	1.087	Moderate	26 (15/11)	The serum concentration of Lithium can be increased when it is combined with Valsartan.	#F9BCBC	4.04790225250192	1
Levofloxacin	Josamycin	0.801	2.392	None	16 (12/4)		#F5B2B2	2.49101677077041	1
Eletriptan	Venlafaxine	0.388	Inf	Major	3 (3/0)	The serum concentration of Eletriptan can be increased when it is combined with Venlafaxine.	#B32020	0.467065644519452	1
Warfarin	Hydrocortisone	0.165	2.711	Moderate	22 (17/5)	Hydrocortisone may increase the anticoagulant activities of Warfarin.	#F4B1B1	3.42514805980931	1
Phenytoin	Flurazepam	0.333	Inf	Moderate	3 (3/0)	The serum concentration of Phenytoin can be increased when it is combined with Flurazepam.	#B32020	0.467065644519452	1
Midazolam	Clarithromycin	0.168	2.193	Moderate	15 (11/4)	The serum concentration of Midazolam can be increased when it is combined with Clarithromycin.	#F5B4B4	2.33532822259726	1
Cyclobenzaprine	Rasagiline	0.121	3.588	Major	11 (9/2)	Cyclobenzaprine may increase the serotonergic activities of Rasagiline.	#F1ABAB	1.71257402990466	1
Cimetidine	Nitrendipine	0.217	-1.254	None	2 (1/1)	The serum concentration of Nitrendipine can be increased when it is combined with Cimetidine.	#B2D0E5	0.311377096346301	1
Metoprolol	Formoterol	0.228	-1.929	Moderate	33 (13/20)	The metabolism of Formoterol can be decreased when combined with Metoprolol.	#AECDE3	5.13772208971397	1
Eprosartan	Lithium cation	0.203	Inf	Moderate	5 (5/0)	The serum concentration of Lithium can be increased when it is combined with Eprosartan.	#B32020	0.778442740865753	1
Ticlopidine	Acetylsalicylic acid	0.215	-3.057	Moderate	55 (16/39)	The risk or severity of adverse effects can be increased when Ticlopidine is combined with Acetylsalicylic acid.	#A6C7E0	8.56287014952328	1
Lovastatin	Gemfibrozil	0.285	-1.045	Major	33 (18/15)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Lovastatin.	#B4D1E6	5.13772208971397	1
Fluvoxamine	Nortriptyline	0.246	Inf	Major	2 (2/0)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Nortriptyline.	#B32020	0.311377096346301	1
Trospium	Biperiden	0.181	2.392	Moderate	4 (3/1)	The risk or severity of adverse effects can be increased when Biperiden is combined with Trospium.	#F5B2B2	0.622754192692602	1
Tenoxicam	Alendronic acid	0.197	3.19	None	15 (12/3)	The risk or severity of adverse effects can be increased when Tenoxicam is combined with Alendronic acid.	#F2ACAC	2.33532822259726	1
Warfarin	Gemfibrozil	0.244	-1.833	Major	32 (13/19)	The metabolism of Warfarin can be decreased when combined with Gemfibrozil.	#AFCEE4	4.98203354154082	1
Carbamazepine	Metronidazole	0.279	1.994	Moderate	14 (10/4)	The metabolism of Metronidazole can be increased when combined with Carbamazepine.	#F6B6B6	2.17963967442411	1
Terbutaline	Clomipramine	0.092	1.595	Moderate	18 (12/6)	The risk or severity of adverse effects can be increased when Clomipramine is combined with Terbutaline.	#F7B9B9	2.80239386711671	1
Phenytoin	Prednisolone	0.083	Inf	Moderate	1 (1/0)	The serum concentration of Prednisolone can be decreased when it is combined with Phenytoin.	#B32020	0.155688548173151	1
Fluvoxamine	Carbamazepine	0.34	-1.254	Moderate	8 (4/4)	The metabolism of Carbamazepine can be decreased when combined with Fluvoxamine.	#B2D0E5	1.2455083853852	1
Colestipol	Acenocoumarol	0.204	-1.115	None	17 (9/8)	Colestipol can cause a decrease in the absorption of Acenocoumarol resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B4D1E6	2.64670531894356	1
Diltiazem	Midazolam	0.392	-1.881	Moderate	25 (10/15)	The metabolism of Midazolam can be decreased when combined with Diltiazem.	#AECDE3	3.89221370432876	1
Acitretin	Methotrexate	0.164	-1.254	Major	4 (2/2)	Acitretin may increase the hepatotoxic activities of Methotrexate.	#B2D0E5	0.622754192692602	1
Prednisone	Itraconazole	0.35	-2.387	Moderate	90 (31/59)	The serum concentration of Prednisone can be increased when it is combined with Itraconazole.	#ABCBE2	14.0119693355836	1
Repaglinide	Josamycin	0.075	2.791	None	9 (7/2)	The serum concentration of Repaglinide can be increased when it is combined with Josamycin.	#F3AFAF	1.40119693355836	1
Hydrocortisone	Phenobarbital	0.142	-1.097	Moderate	15 (8/7)	The serum concentration of Hydrocortisone can be decreased when it is combined with Phenobarbital.	#B4D1E6	2.33532822259726	1
Atorvastatin	Bezafibrate	0.384	-1.324	None	37 (18/19)	Bezafibrate may increase the myopathic rhabdomyolysis activities of Atorvastatin.	#B2D0E5	5.76047628240657	1
Clozapine	Rivastigmine	0.295	-3.762	Moderate	4 (1/3)		#A2C4DE	0.622754192692602	0.615897903438982
Warfarin	Azathioprine	0.34	1.994	Moderate	7 (5/2)	Azathioprine may decrease the anticoagulant activities of Warfarin.	#F6B6B6	1.08981983721205	1
Imipramine	Galantamine	0.147	1.595	Moderate	6 (4/2)	The metabolism of Galantamine can be decreased when combined with Imipramine.	#F7B9B9	0.934131289038903	1
Omeprazole	Chlordiazepoxide	0.204	2.392	Moderate	8 (6/2)		#F5B2B2	1.2455083853852	1
Warfarin	Fluvastatin	0.294	-2.622	Minor	34 (11/23)	The metabolism of Warfarin can be decreased when combined with Fluvastatin.	#A9C9E1	5.29341063788712	1
Phenytoin	Hydrocortisone	0.269	-1.951	Moderate	23 (9/14)	The serum concentration of Hydrocortisone can be decreased when it is combined with Phenytoin.	#AECDE3	3.58083660798246	1
Eplerenone	Clarithromycin	0.166	-2.613	Major	37 (12/25)	The serum concentration of Eplerenone can be increased when it is combined with Clarithromycin.	#A9C9E1	5.76047628240657	1
Amitriptyline	Cimetidine	0.392	Inf	Moderate	3 (3/0)	The metabolism of Amitriptyline can be decreased when combined with Cimetidine.	#B32020	0.467065644519452	1
Pregabalin	Rosiglitazone	0.26	1.914	Moderate	17 (12/5)	The risk or severity of heart failure can be increased when Pregabalin is combined with Rosiglitazone.	#F6B6B6	2.64670531894356	1
Atenolol	Prazosin	0.29	1.063	Moderate	7 (4/3)	Atenolol may increase the orthostatic hypotensive activities of Prazosin.	#F9BCBC	1.08981983721205	1
Donepezil	Oxybutynin	0.284	-1.951	Moderate	23 (9/14)	The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Donepezil.	#AECDE3	3.58083660798246	1
Metoprolol	Dihydroergotamine	0.08	Inf	Moderate	3 (3/0)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Metoprolol.	#B32020	0.467065644519452	1
Spironolactone	Fosinopril	0.37	-1.881	Major	25 (10/15)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Fosinopril.	#AECDE3	3.89221370432876	1
Theophylline	Pentoxifylline	0.33	-7.367	Moderate	55 (8/47)	The serum concentration of Theophylline can be increased when it is combined with Pentoxifylline.	#88B0D3	8.56287014952328	1
Pimozide	Escitalopram	0.373	2.392	Major	4 (3/1)	The risk or severity of QTc prolongation can be increased when Pimozide is combined with Escitalopram.	#F5B2B2	0.622754192692602	1
Erythromycin	Quetiapine	0.084	1.305	Major	29 (18/11)	The metabolism of Quetiapine can be decreased when combined with Erythromycin.	#F8BABA	4.51496789702137	1
Phenytoin	Theophylline	0.294	-3.762	Moderate	12 (3/9)	The serum concentration of Theophylline can be decreased when it is combined with Phenytoin.	#A2C4DE	1.86826257807781	1
Verapamil	Eplerenone	0.416	-1.971	Moderate	18 (7/11)	The serum concentration of Eplerenone can be increased when it is combined with Verapamil.	#AECDE3	2.80239386711671	1
Salbutamol	Nadolol	0.256	-1.736	Major	31 (13/18)		#AFCEE4	4.82634499336767	1
Ranolazine	Amiodarone	0.394	-3.553	Major	23 (6/17)	The serum concentration of Ranolazine can be increased when it is combined with Amiodarone.	#A3C5DF	3.58083660798246	1
Verapamil	Lithium cation	0.49	1.994	Moderate	7 (5/2)	Verapamil may increase the neurotoxic activities of Lithium.	#F6B6B6	1.08981983721205	1
Erythromycin	Repaglinide	0.107	-1.033	Moderate	31 (17/14)	The serum concentration of Repaglinide can be increased when it is combined with Erythromycin.	#B4D1E6	4.82634499336767	1
Carbamazepine	Oxybutynin	0.367	-1.003	None	9 (5/4)	The metabolism of Oxybutynin can be increased when combined with Carbamazepine.	#B4D1E6	1.40119693355836	1
Almotriptan	Sertraline	0.234	3.987	Major	12 (10/2)	The risk or severity of adverse effects can be increased when Almotriptan is combined with Sertraline.	#F0A7A7	1.86826257807781	1
Warfarin	Rifampicin	0.153	1.595	Major	6 (4/2)	The metabolism of Warfarin can be increased when combined with Rifampicin.	#F7B9B9	0.934131289038903	1
Trospium	Oxybutynin	0.371	-1.254	Moderate	6 (3/3)	The risk or severity of adverse effects can be increased when Trospium is combined with Oxybutynin.	#B2D0E5	0.934131289038903	1
Phenytoin	Betamethasone	0.061	Inf	Moderate	3 (3/0)	The serum concentration of Betamethasone can be decreased when it is combined with Phenytoin.	#B32020	0.467065644519452	1
Rivastigmine	Periciazine	0.182	Inf	None	1 (1/0)		#B32020	0.155688548173151	1
Fluoxetine	Cilostazol	0.186	-1.097	Moderate	15 (8/7)	The serum concentration of Cilostazol can be increased when it is combined with Fluoxetine.	#B4D1E6	2.33532822259726	1
Fluvoxamine	Amitriptyline	0.214	3.588	Major	11 (9/2)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Amitriptyline.	#F1ABAB	1.71257402990466	1
Methotrexate	Cholestyramine	0.229	2.392	None	8 (6/2)	Cholestyramine can cause a decrease in the absorption of Methotrexate resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F5B2B2	1.2455083853852	1
Carbamazepine	Midazolam	0.527	1.595	Moderate	6 (4/2)	The metabolism of Midazolam can be increased when combined with Carbamazepine.	#F7B9B9	0.934131289038903	1
Metoprolol	Primidone	0.399	-1.254	Moderate	4 (2/2)	The serum concentration of Metoprolol can be decreased when it is combined with Primidone.	#B2D0E5	0.622754192692602	1
Fluconazole	Lovastatin	0.063	-1.332	Major	33 (16/17)	The serum concentration of Lovastatin can be increased when it is combined with Fluconazole.	#B2D0E5	5.13772208971397	1
Propranolol	Verapamil	0.206	-1.115	Major	34 (18/16)	The metabolism of Propranolol can be decreased when combined with Verapamil.	#B4D1E6	5.29341063788712	1
Trospium	Olanzapine	0.25	3.19	Moderate	5 (4/1)		#F2ACAC	0.778442740865753	1
Naratriptan	Escitalopram	0.122	Inf	Major	2 (2/0)	The risk or severity of adverse effects can be increased when Naratriptan is combined with Escitalopram.	#B32020	0.311377096346301	1
Prednisone	Rifampicin	0.222	-2.508	Moderate	39 (13/26)	The serum concentration of Prednisone can be decreased when it is combined with Rifampicin.	#ABCBE2	6.07185337875287	1
Cyclophosphamide	Acenocoumarol	0.239	-2.665	None	25 (8/17)		#A9C9E1	3.89221370432876	1
Felodipine	Josamycin	0.112	1.595	None	3 (2/1)		#F7B9B9	0.467065644519452	1
Esomeprazole	Ketoconazole	0.318	1.994	Moderate	7 (5/2)	The serum concentration of Ketoconazole can be decreased when it is combined with Esomeprazole.	#F6B6B6	1.08981983721205	1
Rivastigmine	Flavoxate	0.417	Inf	Moderate	2 (2/0)		#B32020	0.311377096346301	1
Diltiazem	Cilostazol	0.262	-8.778	Major	64 (8/56)	The serum concentration of Cilostazol can be increased when it is combined with Diltiazem.	#7FA9CF	9.96406708308164	1
Prednisolone	Acetylsalicylic acid	0.138	1.435	Moderate	14 (9/5)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Prednisolone.	#F7B9B9	2.17963967442411	1
Erythromycin	Warfarin	0.089	1.329	Major	16 (10/6)	The serum concentration of Warfarin can be increased when it is combined with Erythromycin.	#F8BABA	2.49101677077041	1
Glipizide	Nadolol	0.211	Inf	Moderate	2 (2/0)	Nadolol may increase the hypoglycemic activities of Glipizide.	#B32020	0.311377096346301	1
Fluconazole	Celecoxib	0.288	3.19	Moderate	30 (24/6)	The metabolism of Celecoxib can be decreased when combined with Fluconazole.	#F2ACAC	4.67065644519452	1
Risperidone	Itraconazole	0.155	1.296	None	21 (13/8)	The metabolism of Risperidone can be decreased when combined with Itraconazole.	#F8BABA	3.26945951163616	1
Theophylline	Carbamazepine	0.213	-3.449	Moderate	15 (4/11)	The serum concentration of Theophylline can be decreased when it is combined with Carbamazepine.	#A3C5DF	2.33532822259726	1
Moxifloxacin	Ziprasidone	0.113	-1.254	Major	6 (3/3)	Moxifloxacin may increase the QTc-prolonging activities of Ziprasidone.	#B2D0E5	0.934131289038903	1
Fluconazole	Imipramine	0.233	1.329	Moderate	8 (5/3)	The metabolism of Imipramine can be decreased when combined with Fluconazole.	#F8BABA	1.2455083853852	1
Cyclosporine	Digoxin	0.171	-2.299	Moderate	17 (6/11)	The serum concentration of Digoxin can be increased when it is combined with Cyclosporine.	#ABCBE2	2.64670531894356	1
Warfarin	Methimazole	0.183	-1.791	Moderate	17 (7/10)	Methimazole may decrease the anticoagulant activities of Warfarin.	#AFCEE4	2.64670531894356	1
Phenobarbital	Dexamethasone	0.316	-2.006	Moderate	13 (5/8)	The serum concentration of Dexamethasone can be decreased when it is combined with Phenobarbital.	#AECDE3	2.02395112625096	1
Citalopram	Josamycin	0.066	1.914	None	17 (12/5)		#F6B6B6	2.64670531894356	1
Ofloxacin	Acenocoumarol	0.096	-2.964	None	37 (11/26)		#A6C7E0	5.76047628240657	1
Carbamazepine	Clarithromycin	0.087	1.595	Major	21 (14/7)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Carbamazepine.	#F7B9B9	3.26945951163616	1
Phenytoin	Warfarin	0.332	-1.254	Moderate	10 (5/5)	Phenytoin may increase the anticoagulant activities of Warfarin.	#B2D0E5	1.55688548173151	1
Dextromethorphan	Rasagiline	0.097	-1.075	Major	26 (14/12)	Rasagiline may increase the serotonergic activities of Dextromethorphan.	#B4D1E6	4.04790225250192	1
Atenolol	Insulin glulisine	0.268	-1.368	Moderate	23 (11/12)		#B2D0E5	3.58083660798246	1
Warfarin	Dexamethasone	0.15	-1.003	Moderate	18 (10/8)	Dexamethasone may increase the anticoagulant activities of Warfarin.	#B4D1E6	2.80239386711671	1
Tizanidine	Lisinopril	0.161	-1.075	Major	26 (14/12)	Tizanidine may increase the hypotensive activities of Lisinopril.	#B4D1E6	4.04790225250192	1
Fluorouracil	Acenocoumarol	0.093	-2.665	None	25 (8/17)	The serum concentration of Acenocoumarol can be increased when it is combined with Fluorouracil.	#A9C9E1	3.89221370432876	1
Fentanyl	Itraconazole	0.224	1.435	Major	28 (18/10)	The serum concentration of Fentanyl can be increased when it is combined with Itraconazole.	#F7B9B9	4.35927934884822	1
Fludrocortisone	Acenocoumarol	0.263	-1.971	None	18 (7/11)		#AECDE3	2.80239386711671	1
Erythromycin	Methylprednisolone	0.328	1.296	Moderate	21 (13/8)	The metabolism of Methylprednisolone can be decreased when combined with Erythromycin.	#F8BABA	3.26945951163616	1
Warfarin	Clarithromycin	0.11	-1.549	Major	38 (17/21)	The metabolism of Warfarin can be decreased when combined with Clarithromycin.	#B1CFE5	5.91616483057972	1
Tobramycin	Furosemide	0.137	-2.257	Major	14 (5/9)	The serum concentration of Tobramycin can be increased when it is combined with Furosemide.	#ACCCE3	2.17963967442411	1
Megestrol acetate	Primidone	0.249	1.196	Moderate	5 (3/2)		#F9BCBC	0.778442740865753	1
Irbesartan	Lithium cation	0.304	1.396	Moderate	11 (7/4)	The serum concentration of Lithium can be increased when it is combined with Irbesartan.	#F8BABA	1.71257402990466	1
Imipramine	Terbinafine	0.166	2.392	Moderate	4 (3/1)	The metabolism of Imipramine can be decreased when combined with Terbinafine.	#F5B2B2	0.622754192692602	1
Theophylline	Josamycin	0.1	Inf	None	2 (2/0)	The metabolism of Theophylline can be decreased when combined with Josamycin.	#B32020	0.311377096346301	1
Maprotiline	Rivastigmine	0.356	1.994	Moderate	7 (5/2)		#F6B6B6	1.08981983721205	1
Amikacin	Furosemide	0.147	1.196	Major	5 (3/2)	The serum concentration of Amikacin can be increased when it is combined with Furosemide.	#F9BCBC	0.778442740865753	1
Captopril	Lithium cation	0.287	1.994	Moderate	7 (5/2)	The serum concentration of Lithium can be increased when it is combined with Captopril.	#F6B6B6	1.08981983721205	1
Rifampicin	Clarithromycin	0.589	-1.971	Moderate	18 (7/11)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Rifampicin.	#AECDE3	2.80239386711671	1
Ketoconazole	Acenocoumarol	0.155	-1.881	None	20 (8/12)	The serum concentration of Acenocoumarol can be increased when it is combined with Ketoconazole.	#AECDE3	3.11377096346301	1
Donepezil	Flavoxate	0.212	Inf	Moderate	2 (2/0)		#B32020	0.311377096346301	1
Sotalol	Gliclazide	0.357	-2.09	None	24 (9/15)	Sotalol may increase the hypoglycemic activities of Gliclazide.	#ACCCE3	3.73652515615561	1
Cyclosporine	Sevelamer	0.13	-3.762	Moderate	4 (1/3)	The serum concentration of Cyclosporine can be decreased when it is combined with Sevelamer.	#A2C4DE	0.622754192692602	1
Pioglitazone	Glucosamine	0.231	1.096	None	19 (11/8)		#F9BCBC	2.95808241528986	1
Perphenazine	Rivastigmine	0.196	Inf	Moderate	3 (3/0)		#B32020	0.467065644519452	1
Cyclosporine	Fluoxetine	0.321	-1.003	Moderate	9 (5/4)	The metabolism of Fluoxetine can be decreased when combined with Cyclosporine.	#B4D1E6	1.40119693355836	1
Lovastatin	Colchicine	0.105	-2.229	Major	25 (9/16)	The serum concentration of Colchicine can be increased when it is combined with Lovastatin.	#ACCCE3	3.89221370432876	1
Ketoconazole	Atorvastatin	0.092	-1.951	Major	23 (9/14)	The serum concentration of Atorvastatin can be increased when it is combined with Ketoconazole.	#AECDE3	3.58083660798246	1
Rivastigmine	Doxepin	0.358	Inf	Moderate	2 (2/0)		#B32020	0.311377096346301	1
Halazepam	Ketoconazole	0.056	-2.508	None	3 (1/2)		#ABCBE2	0.467065644519452	1
Bisoprolol	Chlorpropamide	0.352	1.063	Moderate	7 (4/3)	Bisoprolol may increase the hypoglycemic activities of Chlorpropamide.	#F9BCBC	1.08981983721205	1
Raloxifene	Cholestyramine	0.227	Inf	Moderate	6 (6/0)	Cholestyramine can cause a decrease in the absorption of Raloxifene resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	0.934131289038903	1
Sumatriptan	Escitalopram	0.161	2.791	Major	9 (7/2)	The risk or severity of adverse effects can be increased when Sumatriptan is combined with Escitalopram.	#F3AFAF	1.40119693355836	1
Nifedipine	Phenobarbital	0.507	3.987	Major	6 (5/1)	The serum concentration of Nifedipine can be decreased when it is combined with Phenobarbital.	#F0A7A7	0.934131289038903	1
Theophylline	Lithium cation	0.172	-1.881	Moderate	5 (2/3)	The serum concentration of Lithium can be decreased when it is combined with Theophylline.	#AECDE3	0.778442740865753	1
Glimepiride	Ketoconazole	0.475	Inf	None	3 (3/0)	The metabolism of Glimepiride can be decreased when combined with Ketoconazole.	#B32020	0.467065644519452	1
Dihydroergotamine	Sumatriptan	0.667	-1.254	Major	4 (2/2)	Dihydroergotamine may increase the vasoconstricting activities of Sumatriptan.	#B2D0E5	0.622754192692602	1
Meloxicam	Acenocoumarol	0.167	-1.734	None	81 (34/47)	Meloxicam may increase the anticoagulant activities of Acenocoumarol.	#AFCEE4	12.6107724020252	1
Salbutamol	Doxepin	0.206	-1.756	Moderate	12 (5/7)	The risk or severity of adverse effects can be increased when Doxepin is combined with Salbutamol.	#AFCEE4	1.86826257807781	1
Rosiglitazone	Gemfibrozil	0.312	-4.013	Moderate	21 (5/16)	The metabolism of Rosiglitazone can be decreased when combined with Gemfibrozil.	#A0C3DD	3.26945951163616	1
Carbamazepine	Bupropion	0.582	2.392	Moderate	4 (3/1)	The metabolism of Bupropion can be increased when combined with Carbamazepine.	#F5B2B2	0.622754192692602	1
Chlorpropamide	Glucosamine	0.365	Inf	None	2 (2/0)		#B32020	0.311377096346301	1
Amitriptyline	Pseudoephedrine	0.224	2.073	None	18 (13/5)	Amitriptyline may decrease the antihypertensive activities of Pseudoephedrine.	#F6B6B6	2.80239386711671	1
Lovastatin	Tacrolimus	0.102	-1.672	Moderate	21 (9/12)	The serum concentration of Lovastatin can be increased when it is combined with Tacrolimus.	#AFCEE4	3.26945951163616	1
Moxifloxacin	Sucralfate	0.226	-1.254	Moderate	20 (10/10)		#B2D0E5	3.11377096346301	1
Cimetidine	Ketazolam	0.024	Inf	None	1 (1/0)		#B32020	0.155688548173151	1
Methotrexate	Sulfamethoxazole	0.182	1.276	Moderate	13 (8/5)	The risk or severity of adverse effects can be increased when Sulfamethoxazole is combined with Methotrexate.	#F8BABA	2.02395112625096	1
Nortriptyline	Rivastigmine	0.259	1.063	Moderate	7 (4/3)		#F9BCBC	1.08981983721205	1
Ramipril	Lithium cation	0.246	1.116	Moderate	12 (7/5)	The serum concentration of Lithium can be increased when it is combined with Ramipril.	#F9BCBC	1.86826257807781	1
Lansoprazole	Ketoconazole	0.322	-1.505	Moderate	11 (5/6)	The serum concentration of Ketoconazole can be decreased when it is combined with Lansoprazole.	#B1CFE5	1.71257402990466	1
Imipramine	Ketoconazole	0.029	Inf	Moderate	1 (1/0)	The metabolism of Imipramine can be decreased when combined with Ketoconazole.	#B32020	0.155688548173151	1
Donepezil	Cyclobenzaprine	0.142	2.392	Moderate	16 (12/4)		#F5B2B2	2.49101677077041	1
Clozapine	Alprazolam	0.52	Inf	Major	2 (2/0)	The risk or severity of adverse effects can be increased when Alprazolam is combined with Clozapine.	#B32020	0.311377096346301	1
Rifampicin	Nifedipine	0.272	-1.568	Major	9 (4/5)	The serum concentration of Nifedipine can be decreased when it is combined with Rifampicin.	#B1CFE5	1.40119693355836	1
Griseofulvin	Acetylsalicylic acid	0.038	1.595	Minor	6 (4/2)		#F7B9B9	0.934131289038903	1
Naproxen	Lithium cation	0.157	1.367	Major	19 (12/7)	The serum concentration of Lithium can be increased when it is combined with Naproxen.	#F8BABA	2.95808241528986	1
Dihydroergotamine	Nitroglycerin	0.161	1.462	Moderate	17 (11/6)	The bioavailability of Dihydroergotamine can be increased when combined with Nitroglycerin.	#F7B9B9	2.64670531894356	1
Warfarin	Cholestyramine	0.246	-1.505	Moderate	11 (5/6)	Cholestyramine can cause a decrease in the absorption of Warfarin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B1CFE5	1.71257402990466	1
Cyclosporine	Primidone	0.173	-2.508	Moderate	3 (1/2)	The metabolism of Cyclosporine can be increased when combined with Primidone.	#ABCBE2	0.467065644519452	1
Metformin	Cimetidine	0.279	-2.508	Moderate	18 (6/12)	The serum concentration of Metformin can be increased when it is combined with Cimetidine.	#ABCBE2	2.80239386711671	1
Metoprolol	Propafenone	0.326	1.196	Moderate	5 (3/2)	The serum concentration of Metoprolol can be increased when it is combined with Propafenone.	#F9BCBC	0.778442740865753	1
Trospium	Hydroxyzine	0.32	4.785	Moderate	7 (6/1)		#EDA1A1	1.08981983721205	1
Propranolol	Epinephrine	0.053	3.19	Major	5 (4/1)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#F2ACAC	0.778442740865753	1
Warfarin	Primidone	0.233	-1.254	Major	6 (3/3)	The metabolism of Warfarin can be increased when combined with Primidone.	#B2D0E5	0.934131289038903	1
Trospium	Haloperidol	0.333	-1.568	Moderate	9 (4/5)		#B1CFE5	1.40119693355836	1
Erythromycin	Amiodarone	0.094	-1.35	Major	27 (13/14)	Erythromycin may increase the QTc-prolonging activities of Amiodarone.	#B2D0E5	4.20359080067507	1
Carbamazepine	Warfarin	0.403	-2.09	Moderate	16 (6/10)	The serum concentration of Warfarin can be decreased when it is combined with Carbamazepine.	#ACCCE3	2.49101677077041	1
Danazol	Acenocoumarol	0.208	-1.254	None	6 (3/3)	Danazol may increase the anticoagulant activities of Acenocoumarol.	#B2D0E5	0.934131289038903	1
Prednisolone	Estriol	0.067	Inf	None	1 (1/0)	The serum concentration of Prednisolone can be increased when it is combined with Estriol.	#B32020	0.155688548173151	1
Theophylline	Propafenone	0.39	-2.926	Moderate	10 (3/7)	The serum concentration of Theophylline can be increased when it is combined with Propafenone.	#A8C8E1	1.55688548173151	1
Digoxin	Penicillamine	0.391	Inf	Moderate	1 (1/0)	The serum concentration of Digoxin can be decreased when it is combined with Penicillamine.	#B32020	0.155688548173151	1
Citalopram	Sumatriptan	0.286	1.994	Major	14 (10/4)	The risk or severity of adverse effects can be increased when Citalopram is combined with Sumatriptan.	#F6B6B6	2.17963967442411	1
Amitriptyline	Rifampicin	0.163	-1.045	Minor	11 (6/5)	The metabolism of Amitriptyline can be increased when combined with Rifampicin.	#B4D1E6	1.71257402990466	1
Ergotamine	Nitroglycerin	0.137	-1.003	Moderate	18 (10/8)	The bioavailability of Ergotamine can be increased when combined with Nitroglycerin.	#B4D1E6	2.80239386711671	1
Warfarin	Naproxen	0.155	-1.302	Major	53 (26/27)	Naproxen may increase the anticoagulant activities of Warfarin.	#B2D0E5	8.25149305317698	1
Cyclosporine	Fluconazole	0.155	1.196	Moderate	5 (3/2)	The serum concentration of Cyclosporine can be increased when it is combined with Fluconazole.	#F9BCBC	0.778442740865753	1
Hydrocortisone	Rifampicin	0.251	-1.756	Moderate	12 (5/7)	The serum concentration of Hydrocortisone can be decreased when it is combined with Rifampicin.	#AFCEE4	1.86826257807781	1
Gliclazide	Oxprenolol	0.522	2.392	None	4 (3/1)	Oxprenolol may increase the hypoglycemic activities of Gliclazide.	#F5B2B2	0.622754192692602	1
Topiramate	Lithium cation	0.458	-1.254	Moderate	4 (2/2)	The serum concentration of Lithium can be increased when it is combined with Topiramate.	#B2D0E5	0.622754192692602	1
Phenytoin	Fludrocortisone	0.237	-1.254	Moderate	2 (1/1)	The serum concentration of Fludrocortisone can be decreased when it is combined with Phenytoin.	#B2D0E5	0.311377096346301	1
Verapamil	Triazolam	0.315	-1.254	Moderate	4 (2/2)	The metabolism of Triazolam can be decreased when combined with Verapamil.	#B2D0E5	0.622754192692602	1
Metoprolol	Indomethacin	0.126	-2.257	Moderate	14 (5/9)	Indomethacin may decrease the antihypertensive activities of Metoprolol.	#ACCCE3	2.17963967442411	1
Capecitabine	Acenocoumarol	0.212	-1.411	None	17 (8/9)	The serum concentration of Acenocoumarol can be increased when it is combined with Capecitabine.	#B2D0E5	2.64670531894356	1
Fluvoxamine	Ropinirole	0.12	-1.881	Moderate	5 (2/3)	Fluvoxamine may increase the sedative activities of Ropinirole.	#AECDE3	0.778442740865753	1
Cyclosporine	Rifampicin	0.353	-1.254	Major	2 (1/1)	The metabolism of Cyclosporine can be increased when combined with Rifampicin.	#B2D0E5	0.311377096346301	1
Sotalol	Terbutaline	0.054	1.063	Major	7 (4/3)	Terbutaline may increase the QTc-prolonging activities of Sotalol.	#F9BCBC	1.08981983721205	1
Cyclosporine	Ketoprofen	0.02	-1.254	Moderate	2 (1/1)	Ketoprofen may increase the nephrotoxic activities of Cyclosporine.	#B2D0E5	0.311377096346301	1
Imipramine	Terbutaline	0.16	1.595	Moderate	6 (4/2)	The risk or severity of adverse effects can be increased when Imipramine is combined with Terbutaline.	#F7B9B9	0.934131289038903	1
Terbutaline	Rasagiline	0.067	-2.329	Moderate	20 (7/13)	The risk or severity of adverse effects can be increased when Rasagiline is combined with Terbutaline.	#ABCBE2	3.11377096346301	1
Epinephrine	Carvedilol	0.08	1.063	Major	7 (4/3)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Carvedilol.	#F9BCBC	1.08981983721205	1
Labetalol	Ibuprofen	0.205	1.396	Moderate	11 (7/4)	Ibuprofen may decrease the antihypertensive activities of Labetalol.	#F8BABA	1.71257402990466	1
Lithium cation	Etoricoxib	0.096	4.785	None	7 (6/1)	The serum concentration of Lithium can be increased when it is combined with Etoricoxib.	#EDA1A1	1.08981983721205	1
Clozapine	Fluoxetine	0.029	Inf	Moderate	1 (1/0)	The serum concentration of Clozapine can be increased when it is combined with Fluoxetine.	#B32020	0.155688548173151	1
Pravastatin	Bezafibrate	0.288	-1.411	None	17 (8/9)	Bezafibrate may increase the myopathic rhabdomyolysis activities of Pravastatin.	#B2D0E5	2.64670531894356	1
Warfarin	Isoniazid	0.231	-1.881	Moderate	5 (2/3)	The metabolism of Warfarin can be decreased when combined with Isoniazid.	#AECDE3	0.778442740865753	1
Warfarin	Cloxacillin	0.129	-1.881	Moderate	25 (10/15)	Cloxacillin may decrease the anticoagulant activities of Warfarin.	#AECDE3	3.89221370432876	1
Lisinopril	Lithium cation	0.277	1.276	Moderate	13 (8/5)	The serum concentration of Lithium can be increased when it is combined with Lisinopril.	#F8BABA	2.02395112625096	1
Gliclazide	Nadolol	0.319	-2.508	None	21 (7/14)	Nadolol may increase the hypoglycemic activities of Gliclazide.	#ABCBE2	3.26945951163616	1
Doxycycline	Rifampicin	0.718	1.595	Moderate	3 (2/1)	The serum concentration of Doxycycline can be decreased when it is combined with Rifampicin.	#F7B9B9	0.467065644519452	1
Dihydroergotamine	Clarithromycin	0.335	2.126	Major	11 (8/3)	The serum concentration of Dihydroergotamine can be increased when it is combined with Clarithromycin.	#F5B4B4	1.71257402990466	1
Digoxin	Josamycin	0.213	-1.045	None	11 (6/5)	The serum concentration of Digoxin can be increased when it is combined with Josamycin.	#B4D1E6	1.71257402990466	1
Betamethasone	Acenocoumarol	0.107	1.037	None	23 (13/10)		#F9BCBC	3.58083660798246	1
Digoxin	Bumetanide	0.263	-1.254	Moderate	4 (2/2)	The risk or severity of adverse effects can be increased when Bumetanide is combined with Digoxin.	#B2D0E5	0.622754192692602	1
Trimethoprim	Methotrexate	0.173	1.063	Major	14 (8/6)	The risk or severity of adverse effects can be increased when Trimethoprim is combined with Methotrexate.	#F9BCBC	2.17963967442411	1
Methylprednisolone	Rifampicin	0.422	-1.254	Moderate	8 (4/4)	The serum concentration of Methylprednisolone can be decreased when it is combined with Rifampicin.	#B2D0E5	1.2455083853852	1
Megestrol acetate	Phenobarbital	0.351	1.196	Moderate	5 (3/2)		#F9BCBC	0.778442740865753	1
Chlorpromazine	Levofloxacin	0.317	-3.762	Moderate	20 (5/15)	Chlorpromazine may increase the QTc-prolonging activities of Levofloxacin.	#A2C4DE	3.11377096346301	1
Metoprolol	Ergotamine	0.332	Inf	Moderate	2 (2/0)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Metoprolol.	#B32020	0.311377096346301	1
Naratriptan	Sertraline	0.187	Inf	Major	2 (2/0)	The risk or severity of adverse effects can be increased when Naratriptan is combined with Sertraline.	#B32020	0.311377096346301	1
Sotalol	Clarithromycin	0.111	-1.463	Major	13 (6/7)	Clarithromycin may increase the QTc-prolonging activities of Sotalol.	#B1CFE5	2.02395112625096	1
Donepezil	Zuclopenthixol	0.19	1.595	None	3 (2/1)		#F7B9B9	0.467065644519452	1
Chlorpromazine	Propranolol	0.141	-1.254	Moderate	6 (3/3)	The metabolism of Propranolol can be decreased when combined with Chlorpromazine.	#B2D0E5	0.934131289038903	1
Triamcinolone	Warfarin	0.146	-1.254	Moderate	14 (7/7)	Triamcinolone may increase the anticoagulant activities of Warfarin.	#B2D0E5	2.17963967442411	1
Colestipol	Raloxifene	0.387	Inf	Moderate	2 (2/0)	Colestipol can cause a decrease in the absorption of Raloxifene resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	0.311377096346301	1
Perphenazine	Levofloxacin	0.136	1.994	Moderate	7 (5/2)		#F6B6B6	1.08981983721205	1
Piroxicam	Bisoprolol	0.215	1.063	Moderate	21 (12/9)	Piroxicam may decrease the antihypertensive activities of Bisoprolol.	#F9BCBC	3.26945951163616	1
Dextromethorphan	Selegiline	0.091	3.19	Major	5 (4/1)	Selegiline may increase the serotonergic activities of Dextromethorphan.	#F2ACAC	0.778442740865753	1
Colestipol	Fluvastatin	0.261	-1.254	Moderate	4 (2/2)	Colestipol can cause a decrease in the absorption of Fluvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B2D0E5	0.622754192692602	1
Bisoprolol	Epinephrine	0.068	-2.351	Moderate	23 (8/15)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#ABCBE2	3.58083660798246	1
Sucralfate	Itraconazole	0.32	3.987	None	6 (5/1)	Sucralfate can cause a decrease in the absorption of Itraconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F0A7A7	0.934131289038903	1
Hydrocortisone	Cholestyramine	0.285	-1.433	Moderate	15 (7/8)	Cholestyramine can cause a decrease in the absorption of Hydrocortisone resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B1CFE5	2.33532822259726	1
Metronidazole	Phenobarbital	0.06	-2.195	Moderate	11 (4/7)	The serum concentration of Metronidazole can be decreased when it is combined with Phenobarbital.	#ACCCE3	1.71257402990466	1
Eplerenone	Tolevamer	0.215	-6.27	None	12 (2/10)		#90B6D6	1.86826257807781	1
Glyburide	Rifampicin	0.17	-1.254	Moderate	10 (5/5)	The serum concentration of Glyburide can be decreased when it is combined with Rifampicin.	#B2D0E5	1.55688548173151	1
Cyclosporine	Bupropion	0.059	Inf	Moderate	1 (1/0)	The metabolism of Bupropion can be decreased when combined with Cyclosporine.	#B32020	0.155688548173151	1
Trospium	Rivastigmine	0.239	-1.881	Moderate	10 (4/6)	The therapeutic efficacy of Trospium can be decreased when used in combination with Rivastigmine.	#AECDE3	1.55688548173151	1
Warfarin	Metronidazole	0.206	1.063	Major	14 (8/6)	The serum concentration of Warfarin can be increased when it is combined with Metronidazole.	#F9BCBC	2.17963967442411	1
Haloperidol	Rifampicin	0.187	-1.672	Major	7 (3/4)	The metabolism of Haloperidol can be increased when combined with Rifampicin.	#AFCEE4	1.08981983721205	1
Fluoxetine	Josamycin	0.128	1.994	None	7 (5/2)		#F6B6B6	1.08981983721205	1
Minocycline	Amoxicillin	0.298	-1.254	Moderate	32 (16/16)	The therapeutic efficacy of Amoxicillin can be decreased when used in combination with Minocycline.	#B2D0E5	4.98203354154082	1
Diltiazem	Rifampicin	0.177	-1.254	Major	10 (5/5)	The serum concentration of Diltiazem can be decreased when it is combined with Rifampicin.	#B2D0E5	1.55688548173151	1
Piroxicam	Propranolol	0.104	3.987	Moderate	6 (5/1)	Piroxicam may decrease the antihypertensive activities of Propranolol.	#F0A7A7	0.934131289038903	1
Ticlopidine	Phenytoin	0.449	-3.762	Moderate	4 (1/3)	The serum concentration of Phenytoin can be increased when it is combined with Ticlopidine.	#A2C4DE	0.622754192692602	1
Thiethylperazine	Levofloxacin	0.473	-1.09	None	43 (23/20)		#B4D1E6	6.69460757144547	1
Erythromycin	Dihydroergotamine	0.125	3.19	Major	5 (4/1)	The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Erythromycin.	#F2ACAC	0.778442740865753	1
Trospium	Ipratropium	0.259	-2.229	Moderate	25 (9/16)	The risk or severity of adverse effects can be increased when Ipratropium bromide is combined with Trospium.	#ACCCE3	3.89221370432876	1
Nortriptyline	Carbamazepine	0.378	-1.881	Moderate	5 (2/3)	The metabolism of Nortriptyline can be increased when combined with Carbamazepine.	#AECDE3	0.778442740865753	1
Flurazepam	Itraconazole	0.107	-1.672	None	7 (3/4)	The metabolism of Flurazepam can be decreased when combined with Itraconazole.	#AFCEE4	1.08981983721205	1
Prednisone	Estriol	0.265	Inf	None	16 (16/0)	The serum concentration of Prednisone can be increased when it is combined with Estriol.	#B32020	2.49101677077041	1
Cimetidine	Warfarin	0.091	Inf	Moderate	1 (1/0)	Cimetidine may increase the anticoagulant activities of Warfarin.	#B32020	0.155688548173151	1
Doxycycline	Cloxacillin	0.67	-1.672	Moderate	14 (6/8)	The therapeutic efficacy of Cloxacillin can be decreased when used in combination with Doxycycline.	#AFCEE4	2.17963967442411	1
Fluconazole	Cyclophosphamide	0.806	-1.254	None	4 (2/2)	The metabolism of Cyclophosphamide can be decreased when combined with Fluconazole.	#B2D0E5	0.622754192692602	1
Rifampicin	Dexamethasone	0.46	-1.672	Moderate	7 (3/4)	The serum concentration of Dexamethasone can be decreased when it is combined with Rifampicin.	#AFCEE4	1.08981983721205	1
Ketoconazole	Solifenacin	0.283	2.392	Major	4 (3/1)	The metabolism of Solifenacin can be decreased when combined with Ketoconazole.	#F5B2B2	0.622754192692602	1
Donepezil	Maprotiline	0.492	1.063	Moderate	7 (4/3)		#F9BCBC	1.08981983721205	1
Tizanidine	Perindopril	0.22	-2.508	Major	9 (3/6)	The risk or severity of hypotension can be increased when Tizanidine is combined with Perindopril.	#ABCBE2	1.40119693355836	1
Formoterol	Nadolol	0.188	-2.299	Major	17 (6/11)		#ABCBE2	2.64670531894356	1
Fluconazole	Nortriptyline	0.049	Inf	Moderate	3 (3/0)	The metabolism of Nortriptyline can be decreased when combined with Fluconazole.	#B32020	0.467065644519452	1
Doxycycline	Insulin aspart	0.155	-1.672	Moderate	14 (6/8)		#AFCEE4	2.17963967442411	1
Cyclosporine	Clarithromycin	0.083	1.063	Major	7 (4/3)	The metabolism of Cyclosporine can be decreased when combined with Clarithromycin.	#F9BCBC	1.08981983721205	1
Primidone	Nifedipine	0.214	-2.09	Major	8 (3/5)	The serum concentration of Nifedipine can be decreased when it is combined with Primidone.	#ACCCE3	1.2455083853852	1
Ampicillin	Acenocoumarol	0.05	-1.505	None	11 (5/6)	Ampicillin may increase the anticoagulant activities of Acenocoumarol.	#B1CFE5	1.71257402990466	1
Fluoxetine	Trimipramine	0.5	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Trimipramine.	#B32020	0.155688548173151	1
Diazepam	Josamycin	0.195	3.588	None	11 (9/2)		#F1ABAB	1.71257402990466	1
Alprazolam	Telithromycin	0.63	2.392	Moderate	4 (3/1)	The serum concentration of Alprazolam can be increased when it is combined with Telithromycin.	#F5B2B2	0.622754192692602	1
Rifampicin	Amiodarone	0.279	-2.195	Major	11 (4/7)	The serum concentration of Amiodarone can be decreased when it is combined with Rifampicin.	#ACCCE3	1.71257402990466	1
Galantamine	Doxepin	0.227	Inf	Moderate	1 (1/0)		#B32020	0.155688548173151	1
Atenolol	Chlorpropamide	0.708	-3.135	Moderate	7 (2/5)	Atenolol may increase the hypoglycemic activities of Chlorpropamide.	#A6C7E0	1.08981983721205	1
Repaglinide	Nadolol	0.251	1.063	Moderate	7 (4/3)		#F9BCBC	1.08981983721205	1
Rifampicin	Gliclazide	0.151	-1.881	None	15 (6/9)	The serum concentration of Gliclazide can be decreased when it is combined with Rifampicin.	#AECDE3	2.33532822259726	1
Sucralfate	Norfloxacin	0.208	1.037	Moderate	23 (13/10)	The serum concentration of Norfloxacin can be decreased when it is combined with Sucralfate.	#F9BCBC	3.58083660798246	1
Digoxin	Itraconazole	0.17	1.096	Major	19 (11/8)	The serum concentration of Digoxin can be increased when it is combined with Itraconazole.	#F9BCBC	2.95808241528986	1
Allopurinol	Azathioprine	0.134	-3.344	Major	22 (6/16)	The serum concentration of the active metabolites of Azathioprine can be increased when Azathioprine is used in combination with Allopurinol.	#A5C6DF	3.42514805980931	1
Ethinylestradiol	Amoxicillin	0.14	Inf	Moderate	2 (2/0)		#B32020	0.311377096346301	1
Cyclosporine	Diclofenac	0.099	-1.254	Moderate	16 (8/8)	Diclofenac may increase the nephrotoxic activities of Cyclosporine.	#B2D0E5	2.49101677077041	1
Erythromycin	Cilostazol	0.245	1.196	Major	5 (3/2)	The serum concentration of Cilostazol can be increased when it is combined with Erythromycin.	#F9BCBC	0.778442740865753	1
Haloperidol	Itraconazole	0.374	-1.254	Moderate	12 (6/6)	The metabolism of Haloperidol can be decreased when combined with Itraconazole.	#B2D0E5	1.86826257807781	1
Tacrolimus	Rifampicin	0.391	-1.254	Major	4 (2/2)	The serum concentration of Tacrolimus can be decreased when it is combined with Rifampicin.	#B2D0E5	0.622754192692602	1
Labetalol	Salbutamol	0.172	2.392	Major	4 (3/1)	Labetalol may decrease the vasoconstricting activities of Salbutamol.	#F5B2B2	0.622754192692602	1
Moxifloxacin	Sotalol	0.175	-1.881	Major	10 (4/6)	Moxifloxacin may increase the QTc-prolonging activities of Sotalol.	#AECDE3	1.55688548173151	1
Fluoxetine	Moclobemide	0.417	Inf	None	1 (1/0)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Moclobemide.	#B32020	0.155688548173151	1
Warfarin	Etoricoxib	0.098	-1.026	None	20 (11/9)	Etoricoxib may increase the anticoagulant activities of Warfarin.	#B4D1E6	3.11377096346301	1
Fluconazole	Halazepam	0.128	-1.672	None	7 (3/4)		#AFCEE4	1.08981983721205	1
Cyproheptadine	Rivastigmine	0.5	Inf	Moderate	1 (1/0)		#B32020	0.155688548173151	1
Tetracycline	Amoxicillin	0.715	1.728	Moderate	19 (13/6)		#F7B7B7	2.95808241528986	1
Fluconazole	Rifampicin	0.603	Inf	Major	3 (3/0)	The metabolism of Rifampicin can be decreased when combined with Fluconazole.	#B32020	0.467065644519452	1
Propranolol	Glipizide	0.218	-2.508	Moderate	15 (5/10)	Propranolol may increase the hypoglycemic activities of Glipizide.	#ABCBE2	2.33532822259726	1
Fluconazole	Phenytoin	0.093	-1.568	Moderate	9 (4/5)	The serum concentration of Phenytoin can be increased when it is combined with Fluconazole.	#B1CFE5	1.40119693355836	1
Mirtazapine	Clonidine	0.077	Inf	Moderate	1 (1/0)	Mirtazapine may decrease the antihypertensive activities of Clonidine.	#B32020	0.155688548173151	1
Metoprolol	Epinephrine	0.032	Inf	Moderate	1 (1/0)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Metoprolol.	#B32020	0.155688548173151	1
Erythromycin	Carbamazepine	0.113	1.994	Major	7 (5/2)	The metabolism of Carbamazepine can be decreased when combined with Erythromycin.	#F6B6B6	1.08981983721205	1
Cyclosporine	Glipizide	0.707	-1.254	Moderate	2 (1/1)	The metabolism of Glipizide can be decreased when combined with Cyclosporine.	#B2D0E5	0.311377096346301	1
Trazodone	Ketoconazole	0.161	2.392	Moderate	4 (3/1)	The metabolism of Trazodone can be decreased when combined with Ketoconazole.	#F5B2B2	0.622754192692602	1
Clonidine	Bisoprolol	0.225	-1.254	Major	4 (2/2)	Clonidine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#B2D0E5	0.622754192692602	1
Dextromethorphan	Terbinafine	0.391	1.794	Major	13 (9/4)	The metabolism of Dextromethorphan can be decreased when combined with Terbinafine.	#F7B7B7	2.02395112625096	1
Cyclobenzaprine	Rivastigmine	0.188	3.19	Moderate	10 (8/2)		#F2ACAC	1.55688548173151	1
Spironolactone	Benazepril	0.237	-2.508	Major	6 (2/4)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Benazepril.	#ABCBE2	0.934131289038903	1
Ergotamine	Clarithromycin	0.088	1.196	Major	10 (6/4)	The serum concentration of Ergotamine can be increased when it is combined with Clarithromycin.	#F9BCBC	1.55688548173151	1
Bumetanide	Ibuprofen	0.173	-1.003	Moderate	9 (5/4)	The therapeutic efficacy of Bumetanide can be decreased when used in combination with Ibuprofen.	#B4D1E6	1.40119693355836	1
Prednisone	Ethinylestradiol	0.045	Inf	Moderate	1 (1/0)	The serum concentration of Prednisone can be increased when it is combined with Ethinyl Estradiol.	#B32020	0.155688548173151	1
Medroxyprogesterone acetate	Acenocoumarol	0.138	Inf	None	3 (3/0)	Medroxyprogesterone acetate may decrease the anticoagulant activities of Acenocoumarol.	#B32020	0.467065644519452	1
Ethinylestradiol	Acenocoumarol	0.231	Inf	None	1 (1/0)	Ethinyl Estradiol may decrease the anticoagulant activities of Acenocoumarol.	#B32020	0.155688548173151	1
Sotalol	Repaglinide	0.302	-2.195	Moderate	11 (4/7)		#ACCCE3	1.71257402990466	1
Phenytoin	Methotrexate	0.298	2.392	Moderate	4 (3/1)	The serum concentration of Phenytoin can be decreased when it is combined with Methotrexate.	#F5B2B2	0.622754192692602	1
Trospium	Fexofenadine	0.087	-1.254	None	2 (1/1)		#B2D0E5	0.311377096346301	1
Amitriptyline	Ketoconazole	0.187	2.392	Moderate	4 (3/1)	The metabolism of Amitriptyline can be decreased when combined with Ketoconazole.	#F5B2B2	0.622754192692602	1
Amikacin	Cefuroxime	1	Inf	Moderate	1 (1/0)		#B32020	0.155688548173151	1
Warfarin	Ceftriaxone	0.026	Inf	Moderate	1 (1/0)	Ceftriaxone may increase the anticoagulant activities of Warfarin.	#B32020	0.155688548173151	1
Simvastatin	Telithromycin	0.137	-2.759	Major	16 (5/11)	The serum concentration of Simvastatin can be increased when it is combined with Telithromycin.	#A8C8E1	2.49101677077041	1
Nortriptyline	Donepezil	0.473	1.196	Moderate	5 (3/2)		#F9BCBC	0.778442740865753	1
Telmisartan	Lithium cation	0.263	-2.508	Moderate	12 (4/8)	The serum concentration of Lithium can be increased when it is combined with Telmisartan.	#ABCBE2	1.86826257807781	1
Imipramine	Pseudoephedrine	0.391	-1.254	None	4 (2/2)	Imipramine may decrease the antihypertensive activities of Pseudoephedrine.	#B2D0E5	0.622754192692602	1
Galantamine	Zuclopenthixol	0.076	-2.508	None	3 (1/2)	Galantamine may increase the QTc-prolonging activities of Zuclopenthixol.	#ABCBE2	0.467065644519452	1
Labetalol	Gliclazide	0.159	-1.881	None	5 (2/3)	Labetalol may increase the hypoglycemic activities of Gliclazide.	#AECDE3	0.778442740865753	1
Cyclosporine	Rosuvastatin	0.404	-1.881	Major	5 (2/3)	The serum concentration of Rosuvastatin can be increased when it is combined with Cyclosporine.	#AECDE3	0.778442740865753	1
Chlorpromazine	Donepezil	0.16	1.595	Moderate	3 (2/1)	The metabolism of Donepezil can be decreased when combined with Chlorpromazine.	#F7B9B9	0.467065644519452	1
Imipramine	Rivastigmine	0.325	-1.254	Moderate	6 (3/3)		#B2D0E5	0.934131289038903	1
Lovastatin	Rifampicin	0.158	2.392	Major	4 (3/1)	The metabolism of Lovastatin can be increased when combined with Rifampicin.	#F5B2B2	0.622754192692602	1
Cyclosporine	Verapamil	0.425	-3.762	Moderate	8 (2/6)	The metabolism of Cyclosporine can be decreased when combined with Verapamil.	#A2C4DE	1.2455083853852	1
Nateglinide	Glucosamine	0.208	-1.254	None	2 (1/1)		#B2D0E5	0.311377096346301	1
Cimetidine	Nifedipine	0.044	-1.254	Moderate	2 (1/1)	The serum concentration of Nifedipine can be increased when it is combined with Cimetidine.	#B2D0E5	0.311377096346301	1
Galantamine	Oxybutynin	0.221	-4.598	Moderate	14 (3/11)	The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Galantamine.	#9CBFDB	2.17963967442411	1
Ranolazine	Clarithromycin	0.152	-1.881	Major	10 (4/6)	The serum concentration of Ranolazine can be increased when it is combined with Clarithromycin.	#AECDE3	1.55688548173151	1
Clozapine	Lisinopril	0.371	-2.508	Moderate	3 (1/2)	The risk or severity of adverse effects can be increased when Clozapine is combined with Lisinopril.	#ABCBE2	0.467065644519452	1
Prazosin	Bisoprolol	0.391	-3.762	Moderate	12 (3/9)	Bisoprolol may increase the orthostatic hypotensive activities of Prazosin.	#A2C4DE	1.86826257807781	1
Naltrexone	Fentanyl	0.333	Inf	Major	1 (1/0)	The therapeutic efficacy of Fentanyl can be decreased when used in combination with Naltrexone.	#B32020	0.155688548173151	1
Lovastatin	Ketoconazole	0.034	1.595	Major	3 (2/1)	The serum concentration of Lovastatin can be increased when it is combined with Ketoconazole.	#F7B9B9	0.467065644519452	1
Itraconazole	Josamycin	0.733	1.595	None	3 (2/1)		#F7B9B9	0.467065644519452	1
Rifampicin	Clomipramine	0.156	1.595	Minor	3 (2/1)	The metabolism of Clomipramine can be increased when combined with Rifampicin.	#F7B9B9	0.467065644519452	1
Disopyramide	Clarithromycin	0.043	Inf	Major	1 (1/0)	Clarithromycin may increase the QTc-prolonging activities of Disopyramide.	#B32020	0.155688548173151	1
Dihydroergotamine	Carvedilol	0.139	3.987	Moderate	6 (5/1)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Carvedilol.	#F0A7A7	0.934131289038903	1
Metoprolol	Diltiazem	0.39	-1.505	Major	11 (5/6)	The serum concentration of Metoprolol can be increased when it is combined with Diltiazem.	#B1CFE5	1.71257402990466	1
Ranolazine	Digoxin	0.257	-3.762	Moderate	16 (4/12)	The serum concentration of Digoxin can be increased when it is combined with Ranolazine.	#A2C4DE	2.49101677077041	1
Trihexyphenidyl	Donepezil	0.243	1.595	Moderate	3 (2/1)	The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Donepezil.	#F7B9B9	0.467065644519452	1
Verapamil	Oxprenolol	0.043	Inf	None	1 (1/0)	Verapamil may increase the hypotensive activities of Oxprenolol.	#B32020	0.155688548173151	1
Warfarin	Minocycline	0.106	Inf	Moderate	2 (2/0)	Minocycline may increase the anticoagulant activities of Warfarin.	#B32020	0.311377096346301	1
Rivastigmine	Pimozide	0.193	-1.254	Moderate	2 (1/1)		#B2D0E5	0.311377096346301	1
Indomethacin	Labetalol	0.022	Inf	Moderate	1 (1/0)	Indomethacin may decrease the antihypertensive activities of Labetalol.	#B32020	0.155688548173151	1
Erythromycin	Theophylline	0.263	-4.598	Moderate	14 (3/11)	The metabolism of Theophylline can be decreased when combined with Erythromycin.	#9CBFDB	2.17963967442411	1
Tacrolimus	Metronidazole	0.341	1.329	Moderate	8 (5/3)		#F8BABA	1.2455083853852	1
Eletriptan	Sertraline	0.488	Inf	Major	2 (2/0)	The risk or severity of adverse effects can be increased when Eletriptan is combined with Sertraline.	#B32020	0.311377096346301	1
Miglitol	Glucosamine	0.288	1.196	None	5 (3/2)		#F9BCBC	0.778442740865753	1
Rosiglitazone	Rifampicin	0.118	Inf	Moderate	1 (1/0)	The metabolism of Rosiglitazone can be increased when combined with Rifampicin.	#B32020	0.155688548173151	1
Ceftriaxone	Acenocoumarol	0.158	1.196	None	5 (3/2)	Ceftriaxone may increase the anticoagulant activities of Acenocoumarol.	#F9BCBC	0.778442740865753	1
Lorazepam	Clozapine	0.264	-1.254	Major	4 (2/2)	The risk or severity of adverse effects can be increased when Lorazepam is combined with Clozapine.	#B2D0E5	0.622754192692602	1
Trospium	Loratadine	0.218	1.196	None	10 (6/4)		#F9BCBC	1.55688548173151	1
Erythromycin	Zafirlukast	0.018	Inf	Moderate	1 (1/0)	The serum concentration of Zafirlukast can be decreased when it is combined with Erythromycin.	#B32020	0.155688548173151	1
Tizanidine	Captopril	0.159	1.063	Major	7 (4/3)	The risk or severity of hypotension can be increased when Tizanidine is combined with Captopril.	#F9BCBC	1.08981983721205	1
Propranolol	Chlorpropamide	0.5	Inf	Moderate	1 (1/0)	Propranolol may increase the hypoglycemic activities of Chlorpropamide.	#B32020	0.155688548173151	1
Cyclosporine	Glimepiride	0.164	1.595	Moderate	3 (2/1)	The metabolism of Glimepiride can be decreased when combined with Cyclosporine.	#F7B9B9	0.467065644519452	1
Fluvoxamine	Sumatriptan	0.049	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Sumatriptan.	#B32020	0.155688548173151	1
Chlorpropamide	Repaglinide	0.277	Inf	None	1 (1/0)	Chlorpropamide may increase the hypoglycemic activities of Repaglinide.	#B32020	0.155688548173151	1
Pantoprazole	Ketoconazole	0.316	-1.254	Moderate	8 (4/4)	The serum concentration of Ketoconazole can be decreased when it is combined with Pantoprazole.	#B2D0E5	1.2455083853852	1
Cyclosporine	Indomethacin	0.422	-2.508	Moderate	6 (2/4)	Indomethacin may increase the nephrotoxic activities of Cyclosporine.	#ABCBE2	0.934131289038903	1
Methylprednisolone	Itraconazole	0.485	-1.672	Major	14 (6/8)	The serum concentration of Methylprednisolone can be increased when it is combined with Itraconazole.	#AFCEE4	2.17963967442411	1
Trospium	Imipramine	0.222	Inf	Moderate	1 (1/0)		#B32020	0.155688548173151	1
Estradiol	Ursodeoxycholic acid	0.515	Inf	None	1 (1/0)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Estradiol.	#B32020	0.155688548173151	1
Sotalol	Piroxicam	0.021	Inf	Moderate	1 (1/0)	Piroxicam may decrease the antihypertensive activities of Sotalol.	#B32020	0.155688548173151	1
Lovastatin	Bezafibrate	0.332	-1.254	None	6 (3/3)	Bezafibrate may increase the myopathic rhabdomyolysis activities of Lovastatin.	#B2D0E5	0.934131289038903	1
Donepezil	Pimozide	0.126	-1.254	Moderate	2 (1/1)		#B2D0E5	0.311377096346301	1
Dihydroergotamine	Isosorbide mononitrate	0.252	-1.672	Moderate	7 (3/4)	The metabolism of Isosorbide Mononitrate can be decreased when combined with Dihydroergotamine.	#AFCEE4	1.08981983721205	1
Glycopyrronium	Rivastigmine	0.305	-6.27	None	18 (3/15)	The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Rivastigmine.	#90B6D6	2.80239386711671	1
Fluvoxamine	Imipramine	0.436	-2.508	Major	3 (1/2)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Imipramine.	#ABCBE2	0.467065644519452	1
Diltiazem	Sirolimus	0.149	-2.508	Moderate	3 (1/2)	The metabolism of Sirolimus can be decreased when combined with Diltiazem.	#ABCBE2	0.467065644519452	1
Clemastine	Galantamine	0.043	Inf	Moderate	1 (1/0)	The metabolism of Galantamine can be decreased when combined with Clemastine.	#B32020	0.155688548173151	1
Phenytoin	Clarithromycin	0.053	-1.505	Moderate	11 (5/6)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Phenytoin.	#B1CFE5	1.71257402990466	1
Ticlopidine	Carbamazepine	0.373	-2.508	Moderate	3 (1/2)	The metabolism of Ticlopidine can be increased when combined with Carbamazepine.	#ABCBE2	0.467065644519452	1
Rifampicin	Glipizide	0.286	Inf	Moderate	1 (1/0)	The serum concentration of Glipizide can be decreased when it is combined with Rifampicin.	#B32020	0.155688548173151	1
Mercaptopurine	Acenocoumarol	0.324	-1.881	None	5 (2/3)	Mercaptopurine may decrease the anticoagulant activities of Acenocoumarol.	#AECDE3	0.778442740865753	1
Metoprolol	Terbutaline	0.089	-1.254	Moderate	6 (3/3)	Metoprolol may decrease the bronchodilatory activities of Terbutaline.	#B2D0E5	0.934131289038903	1
Primidone	Dexamethasone	0.178	-1.254	Moderate	4 (2/2)	The serum concentration of Dexamethasone can be decreased when it is combined with Primidone.	#B2D0E5	0.622754192692602	1
Doxycycline	Digoxin	0.169	-1.254	Moderate	12 (6/6)	The metabolism of Digoxin can be decreased when combined with Doxycycline.	#B2D0E5	1.86826257807781	1
Theophylline	Nadolol	0.321	-1.254	Major	2 (1/1)		#B2D0E5	0.311377096346301	1
Propranolol	Rifampicin	0.223	1.196	Moderate	5 (3/2)	The metabolism of Propranolol can be increased when combined with Rifampicin.	#F9BCBC	0.778442740865753	1
Ergotamine	Josamycin	0.105	-1.254	None	2 (1/1)	The risk or severity of adverse effects can be increased when Ergotamine is combined with Josamycin.	#B2D0E5	0.311377096346301	1
Terbutaline	Doxepin	0.133	Inf	Moderate	1 (1/0)	The risk or severity of adverse effects can be increased when Doxepin is combined with Terbutaline.	#B32020	0.155688548173151	1
Doxycycline	Iron	0.335	1.329	Moderate	8 (5/3)	Doxycycline can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F8BABA	1.2455083853852	1
Felodipine	Itraconazole	0.143	1.595	Major	3 (2/1)	The serum concentration of Felodipine can be increased when it is combined with Itraconazole.	#F7B9B9	0.467065644519452	1
Ketoconazole	Clonazepam	0.191	-1.254	None	4 (2/2)	The metabolism of Clonazepam can be decreased when combined with Ketoconazole.	#B2D0E5	0.622754192692602	1
Ergotamine	Carvedilol	0.141	-1.881	Moderate	10 (4/6)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Carvedilol.	#AECDE3	1.55688548173151	1
Piroxicam	Methotrexate	0.158	Inf	Major	2 (2/0)	The serum concentration of Methotrexate can be increased when it is combined with Piroxicam.	#B32020	0.311377096346301	1
Sirolimus	Clarithromycin	0.033	Inf	Major	1 (1/0)	The metabolism of Sirolimus can be decreased when combined with Clarithromycin.	#B32020	0.155688548173151	1
Celecoxib	Lithium cation	0.135	1.063	Major	7 (4/3)	The serum concentration of Lithium can be increased when it is combined with Celecoxib.	#F9BCBC	1.08981983721205	1
Cyclosporine	Clindamycin	0.115	-3.762	Moderate	8 (2/6)	The metabolism of Clindamycin can be decreased when combined with Cyclosporine.	#A2C4DE	1.2455083853852	1
Tetracycline	Acenocoumarol	0.134	-1.003	None	9 (5/4)		#B4D1E6	1.40119693355836	1
Torasemide	Amikacin	0.055	-2.508	Major	3 (1/2)	The serum concentration of Amikacin can be increased when it is combined with Torasemide.	#ABCBE2	0.467065644519452	1
Fluvoxamine	Rizatriptan	0.077	Inf	Major	1 (1/0)	The metabolism of Rizatriptan can be decreased when combined with Fluvoxamine.	#B32020	0.155688548173151	1
Ampicillin	Methotrexate	0.038	Inf	Major	1 (1/0)	The serum concentration of Methotrexate can be increased when it is combined with Ampicillin.	#B32020	0.155688548173151	1
Sotalol	Ergotamine	0.091	Inf	Moderate	1 (1/0)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Sotalol.	#B32020	0.155688548173151	1
Verapamil	Nadolol	0.144	-1.254	Major	4 (2/2)	Verapamil may increase the hypotensive activities of Nadolol.	#B2D0E5	0.622754192692602	1
Erythromycin	Sotalol	0.07	1.595	Major	3 (2/1)	Erythromycin may increase the QTc-prolonging activities of Sotalol.	#F7B9B9	0.467065644519452	1
Oxcarbazepine	Felodipine	0.425	-1.254	Moderate	2 (1/1)		#B2D0E5	0.311377096346301	1
Primidone	Metronidazole	0.389	-1.254	Moderate	4 (2/2)	The serum concentration of Metronidazole can be decreased when it is combined with Primidone.	#B2D0E5	0.622754192692602	1
Ketoconazole	Quetiapine	0.05	-1.254	Major	4 (2/2)	The serum concentration of Quetiapine can be increased when it is combined with Ketoconazole.	#B2D0E5	0.622754192692602	1
Atenolol	Clonidine	0.213	-5.016	Major	5 (1/4)	Clonidine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#99BDDA	0.778442740865753	1
Theophylline	Sotalol	0.18	-3.762	Major	4 (1/3)	Sotalol may decrease the bronchodilatory activities of Theophylline.	#A2C4DE	0.622754192692602	1
Felodipine	Phenobarbital	0.049	-1.254	Moderate	2 (1/1)	The metabolism of Felodipine can be increased when combined with Phenobarbital.	#B2D0E5	0.311377096346301	1
Verapamil	Rifampicin	0.351	1.595	Moderate	3 (2/1)	The metabolism of Verapamil can be increased when combined with Rifampicin.	#F7B9B9	0.467065644519452	1
Nortriptyline	Terbutaline	0.401	-1.254	Moderate	4 (2/2)	The risk or severity of adverse effects can be increased when Nortriptyline is combined with Terbutaline.	#B2D0E5	0.622754192692602	1
Warfarin	Leflunomide	0.339	-1.881	Moderate	5 (2/3)	Leflunomide may increase the anticoagulant activities of Warfarin.	#AECDE3	0.778442740865753	1
Trandolapril	Lithium cation	0.345	-1.254	Moderate	2 (1/1)	The serum concentration of Lithium can be increased when it is combined with Trandolapril.	#B2D0E5	0.311377096346301	1
Galantamine	Perphenazine	0.086	-1.254	Moderate	2 (1/1)		#B2D0E5	0.311377096346301	1
Tizanidine	Quinapril	0.453	-2.508	Major	6 (2/4)	The risk or severity of hypotension can be increased when Tizanidine is combined with Quinapril.	#ABCBE2	0.934131289038903	1
Ergotamine	Itraconazole	0.305	-1.254	Major	4 (2/2)	The serum concentration of Ergotamine can be increased when it is combined with Itraconazole.	#B2D0E5	0.622754192692602	1
Venlafaxine	Frovatriptan	0.043	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Frovatriptan.	#B32020	0.155688548173151	1
Epinephrine	Rasagiline	0.166	-1.254	Moderate	2 (1/1)	Rasagiline may increase the hypertensive activities of Epinephrine.	#B2D0E5	0.311377096346301	1
Clozapine	Ciprofloxacin	0.511	-1.254	Major	2 (1/1)	Ciprofloxacin may increase the QTc-prolonging activities of Clozapine.	#B2D0E5	0.311377096346301	1
Triamcinolone	Phenobarbital	0.104	-3.135	Moderate	7 (2/5)	The metabolism of Triamcinolone can be increased when combined with Phenobarbital.	#A6C7E0	1.08981983721205	1
Trihexyphenidyl	Galantamine	0.544	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Galantamine.	#B32020	0.155688548173151	1
Labetalol	Repaglinide	0.574	-1.254	Moderate	2 (1/1)		#B2D0E5	0.311377096346301	1
Erythromycin	Triazolam	0.027	Inf	Moderate	1 (1/0)	The serum concentration of Triazolam can be increased when it is combined with Erythromycin.	#B32020	0.155688548173151	1
Galantamine	Ketoconazole	0.379	-2.508	Moderate	3 (1/2)	The metabolism of Galantamine can be decreased when combined with Ketoconazole.	#ABCBE2	0.467065644519452	1
Paroxetine	Moclobemide	0.333	Inf	None	1 (1/0)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Moclobemide.	#B32020	0.155688548173151	1
Clarithromycin	Colchicine	0.159	-3.553	Major	23 (6/17)	The serum concentration of Colchicine can be increased when it is combined with Clarithromycin.	#A3C5DF	3.58083660798246	1
Terbutaline	Nadolol	0.164	-1.881	Major	5 (2/3)		#AECDE3	0.778442740865753	1
Cyclosporine	Colchicine	0.157	-10.032	Major	9 (1/8)	The serum concentration of Colchicine can be increased when it is combined with Cyclosporine.	#76A3CB	1.40119693355836	1
Cimetidine	Clonazepam	0.138	Inf	Moderate	1 (1/0)		#B32020	0.155688548173151	1
Metoprolol	Piroxicam	0.29	Inf	Moderate	1 (1/0)	Piroxicam may decrease the antihypertensive activities of Metoprolol.	#B32020	0.155688548173151	1
Digoxin	Cyclophosphamide	0.249	-2.508	Moderate	6 (2/4)	Digoxin may decrease the cardiotoxic activities of Cyclophosphamide.	#ABCBE2	0.934131289038903	1
Cyclosporine	Terbinafine	0.07	Inf	Minor	1 (1/0)	The metabolism of Cyclosporine can be decreased when combined with Terbinafine.	#B32020	0.155688548173151	1
Fluvoxamine	Zolmitriptan	0.457	Inf	Moderate	1 (1/0)	The metabolism of Zolmitriptan can be decreased when combined with Fluvoxamine.	#B32020	0.155688548173151	1
Cimetidine	Acenocoumarol	0.298	-1.881	None	5 (2/3)	Cimetidine may increase the anticoagulant activities of Acenocoumarol.	#AECDE3	0.778442740865753	1
Itraconazole	Clarithromycin	0.581	-1.971	Moderate	18 (7/11)	The metabolism of Clarithromycin can be decreased when combined with Itraconazole.	#AECDE3	2.80239386711671	1
Indapamide	Lithium cation	0.243	-1.672	Major	7 (3/4)	Indapamide may decrease the excretion rate of Lithium which could result in a higher serum level.	#AFCEE4	1.08981983721205	1
Donepezil	Doxepin	0.038	Inf	Moderate	1 (1/0)		#B32020	0.155688548173151	1
Cyclosporine	Carbamazepine	0.065	-1.254	Major	2 (1/1)	The serum concentration of Cyclosporine can be decreased when it is combined with Carbamazepine.	#B2D0E5	0.311377096346301	1
Metoprolol	Phenobarbital	0.048	-2.508	Moderate	3 (1/2)	The serum concentration of Metoprolol can be decreased when it is combined with Phenobarbital.	#ABCBE2	0.467065644519452	1
Trospium	Cyclobenzaprine	0.142	Inf	Moderate	2 (2/0)		#B32020	0.311377096346301	1
Indomethacin	Nadolol	0.542	Inf	Moderate	2 (2/0)	Indomethacin may decrease the antihypertensive activities of Nadolol.	#B32020	0.311377096346301	1
Pyridostigmine	Hydrocortisone	0.342	-1.254	Moderate	4 (2/2)	The risk or severity of adverse effects can be increased when Hydrocortisone is combined with Pyridostigmine.	#B2D0E5	0.622754192692602	1
Fluoxetine	Selegiline	0.49	-1.254	Major	4 (2/2)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Selegiline.	#B2D0E5	0.622754192692602	1
Doxycycline	Insulin detemir	0.072	-2.508	Moderate	9 (3/6)		#ABCBE2	1.40119693355836	1
Dihydroergotamine	Itraconazole	0.129	Inf	Major	2 (2/0)	The serum concentration of Dihydroergotamine can be increased when it is combined with Itraconazole.	#B32020	0.311377096346301	1
Warfarin	Flurbiprofen	0.027	Inf	Major	1 (1/0)	Flurbiprofen may increase the anticoagulant activities of Warfarin.	#B32020	0.155688548173151	1
Tacrolimus	Clarithromycin	0.161	-1.045	Major	11 (6/5)	The serum concentration of Tacrolimus can be increased when it is combined with Clarithromycin.	#B4D1E6	1.71257402990466	1
Trospium	Azelastine	0.05	Inf	None	1 (1/0)		#B32020	0.155688548173151	1
Doxycycline	Carbamazepine	0.046	1.595	Moderate	3 (2/1)	The serum concentration of Doxycycline can be decreased when it is combined with Carbamazepine.	#F7B9B9	0.467065644519452	1
Eletriptan	Fluoxetine	0.111	Inf	Major	1 (1/0)	The metabolism of Eletriptan can be decreased when combined with Fluoxetine.	#B32020	0.155688548173151	1
Chlorthalidone	Lithium cation	0.265	1.595	Major	3 (2/1)	Chlorthalidone may decrease the excretion rate of Lithium which could result in a higher serum level.	#F7B9B9	0.467065644519452	1
Cyclosporine	Nicardipine	0.021	-1.254	Moderate	2 (1/1)	The metabolism of Nicardipine can be decreased when combined with Cyclosporine.	#B2D0E5	0.311377096346301	1
Lidocaine	Nadolol	0.053	Inf	Moderate	2 (2/0)	The serum concentration of Lidocaine can be increased when it is combined with Nadolol.	#B32020	0.311377096346301	1
Betamethasone	Phenobarbital	0.021	Inf	Moderate	1 (1/0)	The serum concentration of Betamethasone can be decreased when it is combined with Phenobarbital.	#B32020	0.155688548173151	1
Allopurinol	Mercaptopurine	0.466	-10.032	Major	9 (1/8)	The serum concentration of Mercaptopurine can be increased when it is combined with Allopurinol.	#76A3CB	1.40119693355836	1
Repaglinide	Oxprenolol	0.471	-1.254	None	2 (1/1)		#B2D0E5	0.311377096346301	1
Atenolol	Epinephrine	0.128	2.392	Moderate	4 (3/1)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#F5B2B2	0.622754192692602	1
Piroxicam	Carvedilol	0.337	-2.508	Moderate	9 (3/6)	Piroxicam may decrease the antihypertensive activities of Carvedilol.	#ABCBE2	1.40119693355836	1
Fluvoxamine	Phenytoin	0.167	-3.762	Moderate	4 (1/3)	The serum concentration of Phenytoin can be increased when it is combined with Fluvoxamine.	#A2C4DE	0.622754192692602	1
Meloxicam	Lithium cation	0.16	Inf	Major	2 (2/0)	The serum concentration of Lithium can be increased when it is combined with Meloxicam.	#B32020	0.311377096346301	1
Galantamine	Tizanidine	0.141	1.595	Moderate	3 (2/1)	Galantamine may increase the bradycardic activities of Tizanidine.	#F7B9B9	0.467065644519452	1
Phenytoin	Felodipine	0.417	-1.254	Major	2 (1/1)	The metabolism of Felodipine can be increased when combined with Phenytoin.	#B2D0E5	0.311377096346301	1
Labetalol	Glyburide	0.156	-3.762	Moderate	4 (1/3)	Labetalol may increase the hypoglycemic activities of Glyburide.	#A2C4DE	0.622754192692602	1
Fluvoxamine	Dihydroergotamine	0.025	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Fluvoxamine.	#B32020	0.155688548173151	1
Prednisolone	Acenocoumarol	0.054	-1.254	None	4 (2/2)		#B2D0E5	0.622754192692602	1
Phenytoin	Triamcinolone	0.226	-1.254	Moderate	4 (2/2)	The metabolism of Triamcinolone can be increased when combined with Phenytoin.	#B2D0E5	0.622754192692602	1
Erythromycin	Midazolam	0.114	1.595	Moderate	3 (2/1)	The serum concentration of Midazolam can be increased when it is combined with Erythromycin.	#F7B9B9	0.467065644519452	1
Paroxetine	Naratriptan	0.033	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Naratriptan.	#B32020	0.155688548173151	1
Eletriptan	Clarithromycin	0.031	Inf	Major	1 (1/0)	The serum concentration of Eletriptan can be increased when it is combined with Clarithromycin.	#B32020	0.155688548173151	1
Digoxin	Telithromycin	0.106	-1.254	Moderate	2 (1/1)	The metabolism of Digoxin can be decreased when combined with Telithromycin.	#B2D0E5	0.311377096346301	1
Erythromycin	Ergotamine	0.055	1.595	Major	3 (2/1)	The risk or severity of adverse effects can be increased when Ergotamine is combined with Erythromycin.	#F7B9B9	0.467065644519452	1
Methylphenidate	Carbamazepine	0.667	-1.254	None	2 (1/1)		#B2D0E5	0.311377096346301	1
Celecoxib	Rifampicin	0.444	Inf	Moderate	3 (3/0)	The metabolism of Celecoxib can be increased when combined with Rifampicin.	#B32020	0.467065644519452	1
Citalopram	Moclobemide	0.067	Inf	None	1 (1/0)	The serum concentration of Citalopram can be increased when it is combined with Moclobemide.	#B32020	0.155688548173151	1
Digoxin	Sulfasalazine	0.158	-2.508	Moderate	6 (2/4)	The serum concentration of Digoxin can be increased when it is combined with Sulfasalazine.	#ABCBE2	0.934131289038903	1
Rifabutin	Atorvastatin	0.294	-1.254	Moderate	2 (1/1)	The metabolism of Atorvastatin can be increased when combined with Rifabutin.	#B2D0E5	0.311377096346301	1
Rifampicin	Propafenone	0.235	-1.254	Moderate	2 (1/1)	The serum concentration of Propafenone can be decreased when it is combined with Rifampicin.	#B2D0E5	0.311377096346301	1
Cyclosporine	Itraconazole	0.125	Inf	Major	1 (1/0)	The metabolism of Cyclosporine can be decreased when combined with Itraconazole.	#B32020	0.155688548173151	1
Fluconazole	Warfarin	0.171	1.063	Major	7 (4/3)	The serum concentration of Warfarin can be increased when it is combined with Fluconazole.	#F9BCBC	1.08981983721205	1
Nortriptyline	Rasagiline	0.088	Inf	Major	1 (1/0)	Rasagiline may increase the serotonergic activities of Nortriptyline.	#B32020	0.155688548173151	1
Amitriptyline	Epinephrine	0.069	Inf	Major	2 (2/0)	Amitriptyline may decrease the antihypertensive activities of Epinephrine.	#B32020	0.311377096346301	1
Nortriptyline	Terbinafine	0.074	Inf	Moderate	1 (1/0)	The metabolism of Nortriptyline can be decreased when combined with Terbinafine.	#B32020	0.155688548173151	1
Fluconazole	Flurazepam	0.06	1.595	None	3 (2/1)	The metabolism of Flurazepam can be decreased when combined with Fluconazole.	#F7B9B9	0.467065644519452	1
Haloperidol	Ketoconazole	0.084	-2.508	Major	3 (1/2)	The metabolism of Haloperidol can be decreased when combined with Ketoconazole.	#ABCBE2	0.467065644519452	1
Trospium	Desloratadine	0.128	-1.254	None	4 (2/2)	The risk or severity of adverse effects can be increased when Trospium is combined with Desloratadine.	#B2D0E5	0.622754192692602	1
Atenolol	Ampicillin	0.063	-1.881	Moderate	5 (2/3)	The bioavailability of Atenolol can be decreased when combined with Ampicillin.	#AECDE3	0.778442740865753	1
Fentanyl	Ketoconazole	0.294	-5.016	Major	10 (2/8)	The serum concentration of Fentanyl can be increased when it is combined with Ketoconazole.	#99BDDA	1.55688548173151	1
Codeine	Naltrexone	1	Inf	Major	1 (1/0)	The therapeutic efficacy of Codeine can be decreased when used in combination with Naltrexone.	#B32020	0.155688548173151	1
Ofloxacin	Iron	0.3	Inf	None	2 (2/0)		#B32020	0.311377096346301	1
Ketoconazole	Budesonide	0.302	-2.508	Major	9 (3/6)	The serum concentration of Budesonide can be increased when it is combined with Ketoconazole.	#ABCBE2	1.40119693355836	1
Doxycycline	Insulin glulisine	0.146	-2.508	Moderate	3 (1/2)		#ABCBE2	0.467065644519452	1
Doxycycline	Methotrexate	0.323	-1.881	Moderate	5 (2/3)		#AECDE3	0.778442740865753	1
Galantamine	Cyclobenzaprine	0.225	2.392	Moderate	4 (3/1)		#F5B2B2	0.622754192692602	1
Nortriptyline	Pseudoephedrine	0.048	Inf	None	1 (1/0)	Nortriptyline may decrease the antihypertensive activities of Pseudoephedrine.	#B32020	0.155688548173151	1
Doxycycline	Phenobarbital	0.047	-5.016	Moderate	5 (1/4)	The serum concentration of Doxycycline can be decreased when it is combined with Phenobarbital.	#99BDDA	0.778442740865753	1
Testosterone	Acenocoumarol	0.235	-35.113	None	29 (1/28)	Testosterone may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	4.51496789702137	1
Fluconazole	Ergotamine	0.056	1.595	Moderate	3 (2/1)	The metabolism of Ergotamine can be decreased when combined with Fluconazole.	#F7B9B9	0.467065644519452	1
Doxycycline	Warfarin	0.246	1.595	Moderate	3 (2/1)	The metabolism of Warfarin can be decreased when combined with Doxycycline.	#F7B9B9	0.467065644519452	1
Carbamazepine	Josamycin	0.136	-1.254	None	2 (1/1)	The metabolism of Carbamazepine can be decreased when combined with Josamycin.	#B2D0E5	0.311377096346301	1
Trifluoperazine	Levofloxacin	0.058	-1.254	Moderate	2 (1/1)		#B2D0E5	0.311377096346301	1
Citalopram	Naratriptan	0.533	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Citalopram is combined with Naratriptan.	#B32020	0.155688548173151	1
Perindopril	Lithium cation	0.222	-1.254	Moderate	2 (1/1)	The serum concentration of Lithium can be increased when it is combined with Perindopril.	#B2D0E5	0.311377096346301	1
Repaglinide	Rifampicin	0.294	-1.881	Moderate	5 (2/3)	The serum concentration of Repaglinide can be decreased when it is combined with Rifampicin.	#AECDE3	0.778442740865753	1
Mefenamic acid	Acenocoumarol	0.277	-2.508	None	3 (1/2)	Mefenamic acid may increase the anticoagulant activities of Acenocoumarol.	#ABCBE2	0.467065644519452	1
Ranitidine	Ketoconazole	0.105	-1.254	Moderate	4 (2/2)	The serum concentration of Ketoconazole can be decreased when it is combined with Ranitidine.	#B2D0E5	0.622754192692602	1
Clemastine	Donepezil	0.229	-1.254	Moderate	2 (1/1)	The metabolism of Donepezil can be decreased when combined with Clemastine.	#B2D0E5	0.311377096346301	1
Cimetidine	Fentanyl	0.405	-1.254	Moderate	2 (1/1)		#B2D0E5	0.311377096346301	1
Trandolapril	Tizanidine	0.042	Inf	Major	1 (1/0)	The risk or severity of hypotension can be increased when Tizanidine is combined with Trandolapril.	#B32020	0.155688548173151	1
Fluconazole	Dihydroergotamine	0.11	Inf	Moderate	2 (2/0)	The metabolism of Dihydroergotamine can be decreased when combined with Fluconazole.	#B32020	0.311377096346301	1
Quinapril	Lithium cation	0.107	-2.508	Moderate	3 (1/2)	The serum concentration of Lithium can be increased when it is combined with Quinapril.	#ABCBE2	0.467065644519452	1
Frovatriptan	Sertraline	0.133	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Frovatriptan is combined with Sertraline.	#B32020	0.155688548173151	1
Labetalol	Salmeterol	0.637	-3.762	Major	4 (1/3)	Labetalol may decrease the vasoconstricting activities of Salmeterol.	#A2C4DE	0.622754192692602	1
Metoprolol	Lidocaine	0.052	1.595	Moderate	3 (2/1)	The serum concentration of Metoprolol can be increased when it is combined with Lidocaine.	#F7B9B9	0.467065644519452	1
Almotriptan	Itraconazole	0.053	Inf	Moderate	1 (1/0)	The serum concentration of Almotriptan can be increased when it is combined with Itraconazole.	#B32020	0.155688548173151	1
Cyclosporine	Erythromycin	0.077	Inf	Major	1 (1/0)	The metabolism of Cyclosporine can be decreased when combined with Erythromycin.	#B32020	0.155688548173151	1
Spironolactone	Cilazapril	0.411	1.595	None	3 (2/1)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Cilazapril.	#F7B9B9	0.467065644519452	1
Labetalol	Formoterol	0.018	Inf	Major	1 (1/0)	Labetalol may decrease the vasoconstricting activities of Formoterol.	#B32020	0.155688548173151	1
Phenobarbital	Estriol	0.053	Inf	None	1 (1/0)		#B32020	0.155688548173151	1
Fluconazole	Eplerenone	0.043	-2.508	Moderate	6 (2/4)	The serum concentration of Eplerenone can be increased when it is combined with Fluconazole.	#ABCBE2	0.934131289038903	1
Etidronic acid	Iron	0.167	Inf	None	1 (1/0)		#B32020	0.155688548173151	1
Cyclosporine	Naproxen	0.051	-2.508	Moderate	9 (3/6)	Naproxen may increase the nephrotoxic activities of Cyclosporine.	#ABCBE2	1.40119693355836	1
Prednisone	Estradiol	0.115	Inf	Moderate	2 (2/0)	The serum concentration of Prednisone can be increased when it is combined with Estradiol.	#B32020	0.311377096346301	1
Donepezil	Perphenazine	0.295	-2.508	Moderate	3 (1/2)		#ABCBE2	0.467065644519452	1
Torasemide	Tobramycin	0.223	-2.508	Major	3 (1/2)	The serum concentration of Tobramycin can be increased when it is combined with Torasemide.	#ABCBE2	0.467065644519452	1
Methylprednisolone	Ketoconazole	0.19	-2.508	Major	3 (1/2)	The serum concentration of Methylprednisolone can be increased when it is combined with Ketoconazole.	#ABCBE2	0.467065644519452	1
Nabumetone	Warfarin	0.14	-3.762	Major	8 (2/6)	Nabumetone may increase the anticoagulant activities of Warfarin.	#A2C4DE	1.2455083853852	1
Rifampicin	Etoricoxib	0.151	1.595	None	3 (2/1)	The metabolism of Etoricoxib can be increased when combined with Rifampicin.	#F7B9B9	0.467065644519452	1
Digoxin	Minocycline	0.138	-2.508	Moderate	6 (2/4)		#ABCBE2	0.934131289038903	1
Eletriptan	Paroxetine	0.129	-1.254	Major	2 (1/1)	The metabolism of Eletriptan can be decreased when combined with Paroxetine.	#B2D0E5	0.311377096346301	1
Tizanidine	Rivastigmine	0.23	-1.254	Moderate	4 (2/2)	Tizanidine may increase the bradycardic activities of Rivastigmine.	#B2D0E5	0.622754192692602	1
Tacrolimus	Felodipine	0.087	-3.762	Moderate	4 (1/3)	The serum concentration of Tacrolimus can be increased when it is combined with Felodipine.	#A2C4DE	0.622754192692602	1
Sulindac	Furosemide	0.323	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Furosemide can be decreased when used in combination with Sulindac.	#B32020	0.155688548173151	1
Citalopram	Frovatriptan	0.321	-1.254	Major	2 (1/1)	The risk or severity of adverse effects can be increased when Citalopram is combined with Frovatriptan.	#B2D0E5	0.311377096346301	1
Pimozide	Sertraline	0.514	-3.762	Major	4 (1/3)	Sertraline may increase the QTc-prolonging activities of Pimozide.	#A2C4DE	0.622754192692602	1
Phenytoin	Estriol	0.25	Inf	None	1 (1/0)		#B32020	0.155688548173151	1
Fluvastatin	Colchicine	0.151	-8.778	Major	16 (2/14)	Colchicine may increase the myopathic rhabdomyolysis activities of Fluvastatin.	#7FA9CF	2.49101677077041	1
Theophylline	Terbinafine	0.12	-3.762	Moderate	4 (1/3)	The metabolism of Theophylline can be decreased when combined with Terbinafine.	#A2C4DE	0.622754192692602	1
Diltiazem	Triazolam	0.75	-1.254	Moderate	2 (1/1)	The metabolism of Triazolam can be decreased when combined with Diltiazem.	#B2D0E5	0.311377096346301	1
Colestipol	Hydrocortisone	0.417	-1.254	Moderate	2 (1/1)	Colestipol can cause a decrease in the absorption of Hydrocortisone resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B2D0E5	0.311377096346301	1
Metoprolol	Hydralazine	0.343	-1.254	Minor	2 (1/1)	Hydralazine may increase the hypotensive activities of Metoprolol.	#B2D0E5	0.311377096346301	1
Acetaminophen	Imatinib	0.21	-1.254	Moderate	2 (1/1)	Acetaminophen may increase the hepatotoxic activities of Imatinib.	#B2D0E5	0.311377096346301	1
Erythromycin	Tacrolimus	0.149	-1.254	Major	4 (2/2)	The serum concentration of Tacrolimus can be increased when it is combined with Erythromycin.	#B2D0E5	0.622754192692602	1
Theophylline	Propranolol	0.211	-6.27	Major	12 (2/10)	The metabolism of Propranolol can be decreased when combined with Theophylline.	#90B6D6	1.86826257807781	1
Famotidine	Itraconazole	0.385	-2.508	Moderate	3 (1/2)	The serum concentration of Itraconazole can be decreased when it is combined with Famotidine.	#ABCBE2	0.467065644519452	1
Trospium	Clomipramine	0.339	-1.254	Moderate	2 (1/1)		#B2D0E5	0.311377096346301	1
Cyclosporine	Lovastatin	1	Inf	Major	1 (1/0)	The serum concentration of Lovastatin can be increased when it is combined with Cyclosporine.	#B32020	0.155688548173151	1
Phenytoin	Sucralfate	0.327	-3.762	Moderate	4 (1/3)		#A2C4DE	0.622754192692602	1
Itraconazole	Phenobarbital	0.026	-1.254	Moderate	2 (1/1)	The serum concentration of Itraconazole can be decreased when it is combined with Phenobarbital.	#B2D0E5	0.311377096346301	1
Phenytoin	Tacrolimus	0.236	-5.016	Major	5 (1/4)	The serum concentration of Tacrolimus can be decreased when it is combined with Phenytoin.	#99BDDA	0.778442740865753	1
Warfarin	Itraconazole	0.13	-3.135	Moderate	7 (2/5)	The serum concentration of Warfarin can be increased when it is combined with Itraconazole.	#A6C7E0	1.08981983721205	1
Ranolazine	Verapamil	0.479	-1.254	Major	2 (1/1)	The serum concentration of Ranolazine can be increased when it is combined with Verapamil.	#B2D0E5	0.311377096346301	1
Telithromycin	Acenocoumarol	0.083	-2.508	None	3 (1/2)	The metabolism of Acenocoumarol can be decreased when combined with Telithromycin.	#ABCBE2	0.467065644519452	1
Fluconazole	Ranolazine	0.125	-2.508	Major	3 (1/2)	The serum concentration of Ranolazine can be increased when it is combined with Fluconazole.	#ABCBE2	0.467065644519452	1
Citalopram	Pimozide	0.157	-3.762	Major	4 (1/3)	The risk or severity of QTc prolongation can be increased when Citalopram is combined with Pimozide.	#A2C4DE	0.622754192692602	1
Fluphenazine	Levofloxacin	0.157	-2.508	Moderate	3 (1/2)		#ABCBE2	0.467065644519452	1
Erythromycin	Itraconazole	0.514	-2.508	Major	6 (2/4)	The metabolism of Erythromycin can be decreased when combined with Itraconazole.	#ABCBE2	0.934131289038903	1
Tenoxicam	Acenocoumarol	0.287	-1.881	None	5 (2/3)	Tenoxicam may increase the anticoagulant activities of Acenocoumarol.	#AECDE3	0.778442740865753	1
Phenytoin	Itraconazole	0.137	-2.508	Moderate	3 (1/2)	The serum concentration of Itraconazole can be decreased when it is combined with Phenytoin.	#ABCBE2	0.467065644519452	1
Alprazolam	Cimetidine	0.119	-2.508	Moderate	3 (1/2)		#ABCBE2	0.467065644519452	1
Piroxicam	Acenocoumarol	0.09	-2.926	None	10 (3/7)	Piroxicam may increase the anticoagulant activities of Acenocoumarol.	#A8C8E1	1.55688548173151	1
Glimepiride	Rifampicin	0.306	-1.254	Moderate	2 (1/1)	The serum concentration of Glimepiride can be decreased when it is combined with Rifampicin.	#B2D0E5	0.311377096346301	1
Colestipol	Digoxin	0.402	-3.762	Moderate	4 (1/3)	Colestipol can cause a decrease in the absorption of Digoxin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#A2C4DE	0.622754192692602	1
Theophylline	Acyclovir	0.086	-5.016	Minor	5 (1/4)		#99BDDA	0.778442740865753	1
Erythromycin	Felodipine	0.04	-2.508	Moderate	3 (1/2)	The metabolism of Felodipine can be decreased when combined with Erythromycin.	#ABCBE2	0.467065644519452	1
Telithromycin	Atorvastatin	0.036	-2.508	Major	3 (1/2)	The risk or severity of adverse effects can be increased when Telithromycin is combined with Atorvastatin.	#ABCBE2	0.467065644519452	1
Salbutamol	Oxprenolol	0.065	-5.016	None	5 (1/4)	Oxprenolol may decrease the bronchodilatory activities of Salbutamol.	#99BDDA	0.778442740865753	1
Minocycline	Cloxacillin	0.713	-5.016	Moderate	5 (1/4)	The therapeutic efficacy of Cloxacillin can be decreased when used in combination with Minocycline.	#99BDDA	0.778442740865753	1
Haloperidol	Glycopyrronium	0.08	-5.016	Moderate	5 (1/4)	The serum concentration of Haloperidol can be decreased when it is combined with Glycopyrronium.	#99BDDA	0.778442740865753	1
Codeine	Cimetidine	0.377	-2.508	Moderate	3 (1/2)	The therapeutic efficacy of Codeine can be decreased when used in combination with Cimetidine.	#ABCBE2	0.467065644519452	1
Eplerenone	Itraconazole	0.053	Inf	Major	1 (1/0)	The serum concentration of Eplerenone can be increased when it is combined with Itraconazole.	#B32020	0.155688548173151	1
Fluconazole	Cilostazol	0.083	-3.762	Major	4 (1/3)	The serum concentration of Cilostazol can be increased when it is combined with Fluconazole.	#A2C4DE	0.622754192692602	1
Lovastatin	Josamycin	0.034	-2.508	None	3 (1/2)	The serum concentration of Lovastatin can be increased when it is combined with Josamycin.	#ABCBE2	0.467065644519452	1
Cyclosporine	Glyburide	0.15	-3.762	Moderate	4 (1/3)	The therapeutic efficacy of Glyburide can be decreased when used in combination with Cyclosporine.	#A2C4DE	0.622754192692602	1
Ergotamine	Isosorbide mononitrate	0.37	-1.254	Moderate	2 (1/1)		#B2D0E5	0.311377096346301	1
Tetracycline	Iron	0.225	-1.254	Moderate	2 (1/1)		#B2D0E5	0.311377096346301	1
Warfarin	Meloxicam	0.106	1.595	Major	3 (2/1)	Meloxicam may increase the anticoagulant activities of Warfarin.	#F7B9B9	0.467065644519452	1
Pseudoephedrine	Rasagiline	0.051	-3.762	Moderate	4 (1/3)	Rasagiline may increase the hypertensive activities of Pseudoephedrine.	#A2C4DE	0.622754192692602	1
Moxifloxacin	Josamycin	0.523	-5.016	None	5 (1/4)		#99BDDA	0.778442740865753	1
Ketoprofen	Acenocoumarol	0.134	-3.135	None	7 (2/5)	Ketoprofen may increase the anticoagulant activities of Acenocoumarol.	#A6C7E0	1.08981983721205	1
Trospium	Tiotropium	0.405	-25.081	Moderate	21 (1/20)	Trospium may increase the anticholinergic activities of Tiotropium.	#1E61A5	3.26945951163616	1
Donepezil	Glycopyrronium	0.399	-5.016	None	5 (1/4)	The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Donepezil.	#99BDDA	0.778442740865753	1
Fluvastatin	Cholestyramine	0.175	-5.016	Moderate	5 (1/4)	The serum concentration of Fluvastatin can be decreased when it is combined with Cholestyramine.	#99BDDA	0.778442740865753	1
Trospium	Risperidone	0.26	-5.016	Moderate	5 (1/4)		#99BDDA	0.778442740865753	1
Carbamazepine	Itraconazole	0.492	-2.508	Moderate	3 (1/2)	The serum concentration of Itraconazole can be decreased when it is combined with Carbamazepine.	#ABCBE2	0.467065644519452	1
Warfarin	Terbinafine	0.236	-6.27	Moderate	6 (1/5)		#90B6D6	0.934131289038903	1
Erythromycin	Colchicine	0.238	-8.778	Major	8 (1/7)	The serum concentration of Colchicine can be increased when it is combined with Erythromycin.	#7FA9CF	1.2455083853852	1
Flurbiprofen	Acenocoumarol	0.224	-7.524	None	7 (1/6)	Flurbiprofen may increase the anticoagulant activities of Acenocoumarol.	#86AFD2	1.08981983721205	1
Prednisone	Ketoconazole	0.397	-28.843	Moderate	24 (1/23)	The serum concentration of Prednisone can be increased when it is combined with Ketoconazole.	#1E61A5	3.73652515615561	1
Diazepam	Ketoconazole	0.129	-10.032	Moderate	9 (1/8)	The metabolism of Diazepam can be decreased when combined with Ketoconazole.	#76A3CB	1.40119693355836	1
Ceftazidime	Tobramycin	1	-Inf	Moderate	2 (0/2)		#1E61A5	0.311377096346301	0.00752217108396676
Triazolam	Telithromycin	0.667	-Inf	Major	2 (0/2)	The serum concentration of Triazolam can be increased when it is combined with Telithromycin.	#1E61A5	0.311377096346301	0.959315435352676
Ziprasidone	Pimozide	0.741	-Inf	Major	1 (0/1)	The serum concentration of Pimozide can be increased when it is combined with Ziprasidone.	#1E61A5	0.155688548173151	1
Trimipramine	Donepezil	0.054	-Inf	Moderate	1 (0/1)		#1E61A5	0.155688548173151	1
Clozapine	Midazolam	0.048	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Midazolam is combined with Clozapine.	#1E61A5	0.155688548173151	1
Methotrexate	Sulindac	0.5	-Inf	Major	1 (0/1)	The serum concentration of Methotrexate can be increased when it is combined with Sulindac.	#1E61A5	0.155688548173151	1
Ergotamine	Nadolol	0.154	-Inf	Moderate	3 (0/3)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Nadolol.	#1E61A5	0.467065644519452	1
Procainamide	Amiodarone	0.046	-Inf	Major	2 (0/2)	Amiodarone may increase the QTc-prolonging activities of Procainamide.	#1E61A5	0.311377096346301	1
Theophylline	Primidone	0.156	-Inf	Moderate	8 (0/8)	The metabolism of Theophylline can be increased when combined with Primidone.	#1E61A5	1.2455083853852	1
Alfuzosin	Itraconazole	0.089	-Inf	Major	22 (0/22)	The serum concentration of Alfuzosin can be increased when it is combined with Itraconazole.	#1E61A5	3.42514805980931	1
Disopyramide	Rivastigmine	0.2	-Inf	Moderate	1 (0/1)		#1E61A5	0.155688548173151	1
Pyridostigmine	Prednisolone	0.083	-Inf	Moderate	1 (0/1)	The risk or severity of adverse effects can be increased when Prednisolone is combined with Pyridostigmine.	#1E61A5	0.155688548173151	1
Trospium	Flavoxate	0.333	-Inf	Moderate	1 (0/1)		#1E61A5	0.155688548173151	1
Phenytoin	Vigabatrin	0.2	-Inf	Minor	1 (0/1)	The serum concentration of Phenytoin can be decreased when it is combined with Vigabatrin.	#1E61A5	0.155688548173151	1
Methotrexate	Phenylbutazone	0.125	-Inf	Major	1 (0/1)	The serum concentration of Methotrexate can be increased when it is combined with Phenylbutazone.	#1E61A5	0.155688548173151	1
Clonidine	Clomipramine	0.25	-Inf	Major	1 (0/1)	Clomipramine may decrease the antihypertensive activities of Clonidine.	#1E61A5	0.155688548173151	1
Bromocriptine	Methotrimeprazine	0.095	-Inf	Moderate	1 (0/1)	The therapeutic efficacy of Methotrimeprazine can be decreased when used in combination with Bromocriptine.	#1E61A5	0.155688548173151	1
Erythromycin	Rifampicin	0.538	-Inf	Moderate	6 (0/6)	The metabolism of Erythromycin can be increased when combined with Rifampicin.	#1E61A5	0.934131289038903	1
Doxycycline	Isotretinoin	0.222	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Doxycycline is combined with Isotretinoin.	#1E61A5	0.155688548173151	1
Primidone	Methylprednisolone	0.32	-Inf	Moderate	9 (0/9)	The serum concentration of Methylprednisolone can be decreased when it is combined with Primidone.	#1E61A5	1.40119693355836	1
Cyclosporine	Pyrazinamide	0.036	-Inf	Moderate	1 (0/1)	The serum concentration of Cyclosporine can be increased when it is combined with Pyrazinamide.	#1E61A5	0.155688548173151	1
Clozapine	Sertraline	0.654	-Inf	Major	2 (0/2)	The serum concentration of Clozapine can be increased when it is combined with Sertraline.	#1E61A5	0.311377096346301	1
Cyclosporine	Ticlopidine	0.204	-Inf	Moderate	2 (0/2)	The metabolism of Cyclosporine can be decreased when combined with Ticlopidine.	#1E61A5	0.311377096346301	1
Phenytoin	Doxycycline	0.077	-Inf	Moderate	6 (0/6)	The serum concentration of Doxycycline can be decreased when it is combined with Phenytoin.	#1E61A5	0.934131289038903	1
Digoxin	Prazosin	0.217	-Inf	None	4 (0/4)		#1E61A5	0.622754192692602	1
Sirolimus	Rifampicin	0.667	-Inf	Major	1 (0/1)	The metabolism of Sirolimus can be increased when combined with Rifampicin.	#1E61A5	0.155688548173151	1
Citalopram	Clozapine	0.469	-Inf	Major	2 (0/2)	The serum concentration of Clozapine can be increased when it is combined with Citalopram.	#1E61A5	0.311377096346301	1
Metoprolol	Telithromycin	1	-Inf	Moderate	1 (0/1)	The serum concentration of Metoprolol can be increased when it is combined with Telithromycin.	#1E61A5	0.155688548173151	1
Clozapine	Donepezil	0.667	-Inf	Moderate	1 (0/1)	The metabolism of Donepezil can be decreased when combined with Clozapine.	#1E61A5	0.155688548173151	1
Cyclosporine	Phenobarbital	0.392	-Inf	Moderate	2 (0/2)	The metabolism of Cyclosporine can be increased when combined with Phenobarbital.	#1E61A5	0.311377096346301	1
Warfarin	Mefenamic acid	0.2	-Inf	Major	1 (0/1)	Mefenamic acid may increase the anticoagulant activities of Warfarin.	#1E61A5	0.155688548173151	1
Trospium	Trihexyphenidyl	0.143	-Inf	Moderate	1 (0/1)	The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Trospium.	#1E61A5	0.155688548173151	1
Flutamide	Acenocoumarol	0.448	-Inf	None	12 (0/12)		#1E61A5	1.86826257807781	1
Indomethacin	Bumetanide	0.276	-Inf	Moderate	2 (0/2)	The therapeutic efficacy of Bumetanide can be decreased when used in combination with Indomethacin.	#1E61A5	0.311377096346301	1
Phenytoin	Midazolam	0.261	-Inf	Moderate	3 (0/3)	The serum concentration of Phenytoin can be increased when it is combined with Midazolam.	#1E61A5	0.467065644519452	1
Cyclosporine	Sulfasalazine	0.018	-Inf	Major	1 (0/1)	Sulfasalazine may increase the nephrotoxic activities of Cyclosporine.	#1E61A5	0.155688548173151	1
Prazosin	Carvedilol	0.3	-Inf	Moderate	3 (0/3)	Prazosin may increase the antihypertensive activities of Carvedilol.	#1E61A5	0.467065644519452	1
Clozapine	Diazepam	0.12	-Inf	Major	2 (0/2)	The risk or severity of adverse effects can be increased when Diazepam is combined with Clozapine.	#1E61A5	0.311377096346301	1
Fluoxetine	Frovatriptan	1	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Frovatriptan.	#1E61A5	0.155688548173151	1
Carbamazepine	Felodipine	0.298	-Inf	Moderate	3 (0/3)	The metabolism of Felodipine can be increased when combined with Carbamazepine.	#1E61A5	0.467065644519452	1
Carbamazepine	Danazol	0.412	-Inf	Moderate	1 (0/1)	The metabolism of Carbamazepine can be decreased when combined with Danazol.	#1E61A5	0.155688548173151	1
Theophylline	Disulfiram	0.108	-Inf	Moderate	2 (0/2)	The serum concentration of Theophylline can be increased when it is combined with Disulfiram.	#1E61A5	0.311377096346301	1
Flutamide	Warfarin	0.118	-Inf	Moderate	3 (0/3)		#1E61A5	0.467065644519452	1
Erythromycin	Lincomycin	0.111	-Inf	Moderate	1 (0/1)	The therapeutic efficacy of Erythromycin can be decreased when used in combination with Lincomycin.	#1E61A5	0.155688548173151	1
Disulfiram	Acenocoumarol	0.141	-Inf	None	8 (0/8)	The serum concentration of Acenocoumarol can be increased when it is combined with Disulfiram.	#1E61A5	1.2455083853852	1
Sucralfate	Ofloxacin	0.202	-Inf	Moderate	3 (0/3)		#1E61A5	0.467065644519452	1
Triazolam	Itraconazole	1	-Inf	Major	1 (0/1)	The serum concentration of Triazolam can be increased when it is combined with Itraconazole.	#1E61A5	0.155688548173151	1
Frovatriptan	Escitalopram	0.143	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Frovatriptan is combined with Escitalopram.	#1E61A5	0.155688548173151	1
Tacrolimus	Danazol	0.286	-Inf	Moderate	1 (0/1)	The serum concentration of Tacrolimus can be increased when it is combined with Danazol.	#1E61A5	0.155688548173151	1
Fluvoxamine	Warfarin	0.258	-Inf	Moderate	3 (0/3)	The metabolism of Warfarin can be decreased when combined with Fluvoxamine.	#1E61A5	0.467065644519452	1
Cyclosporine	Piroxicam	0.03	-Inf	Moderate	1 (0/1)	Piroxicam may increase the nephrotoxic activities of Cyclosporine.	#1E61A5	0.155688548173151	1
Fluvoxamine	Ergotamine	0.588	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Ergotamine is combined with Fluvoxamine.	#1E61A5	0.155688548173151	1
Chlorpropamide	Carvedilol	0.078	-Inf	Moderate	2 (0/2)	Carvedilol may increase the hypoglycemic activities of Chlorpropamide.	#1E61A5	0.311377096346301	1
Theophylline	Rifampicin	0.35	-Inf	Moderate	3 (0/3)	The metabolism of Theophylline can be increased when combined with Rifampicin.	#1E61A5	0.467065644519452	1
Conjugated estrogens	Prednisone	0.5	-Inf	Moderate	1 (0/1)	The serum concentration of Prednisone can be increased when it is combined with Conjugated estrogens.	#1E61A5	0.155688548173151	1
Ranolazine	Sotalol	0.518	-Inf	Major	2 (0/2)	Ranolazine may increase the QTc-prolonging activities of Sotalol.	#1E61A5	0.311377096346301	1
Alfuzosin	Ketoconazole	0.142	-Inf	Major	3 (0/3)	The serum concentration of Alfuzosin can be increased when it is combined with Ketoconazole.	#1E61A5	0.467065644519452	1
Imipramine	Rasagiline	0.357	-Inf	Major	2 (0/2)	Rasagiline may increase the serotonergic activities of Imipramine.	#1E61A5	0.311377096346301	1
Disopyramide	Levofloxacin	0.071	-Inf	Major	1 (0/1)	Levofloxacin may increase the QTc-prolonging activities of Disopyramide.	#1E61A5	0.155688548173151	1
Prazosin	Verapamil	0.182	-Inf	Moderate	1 (0/1)	The risk or severity of hypotension can be increased when Prazosin is combined with Verapamil.	#1E61A5	0.155688548173151	1
Terbutaline	Oxprenolol	0.074	-Inf	None	1 (0/1)	Oxprenolol may decrease the bronchodilatory activities of Terbutaline.	#1E61A5	0.155688548173151	1
Doxycycline	Primidone	0.119	-Inf	Moderate	2 (0/2)	The serum concentration of Doxycycline can be decreased when it is combined with Primidone.	#1E61A5	0.311377096346301	1
Fluconazole	Triazolam	0.5	-Inf	Major	1 (0/1)	The metabolism of Triazolam can be decreased when combined with Fluconazole.	#1E61A5	0.155688548173151	1
Ticlopidine	Theophylline	0.6	-Inf	Moderate	2 (0/2)	The metabolism of Theophylline can be decreased when combined with Ticlopidine.	#1E61A5	0.311377096346301	1
Pyridostigmine	Dexamethasone	0.047	-Inf	Moderate	3 (0/3)	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Pyridostigmine.	#1E61A5	0.467065644519452	1
Griseofulvin	Acenocoumarol	0.037	-Inf	None	2 (0/2)	The serum concentration of Acenocoumarol can be decreased when it is combined with Griseofulvin.	#1E61A5	0.311377096346301	1
Cyclosporine	Oxcarbazepine	0.083	-Inf	Moderate	1 (0/1)		#1E61A5	0.155688548173151	1
Cilostazol	Itraconazole	0.069	-Inf	Major	4 (0/4)	The serum concentration of Cilostazol can be increased when it is combined with Itraconazole.	#1E61A5	0.622754192692602	1
Indomethacin	Sotalol	0.083	-Inf	Moderate	3 (0/3)	Indomethacin may decrease the antihypertensive activities of Sotalol.	#1E61A5	0.467065644519452	1
Fluconazole	Everolimus	0.037	-Inf	Major	1 (0/1)	The serum concentration of Everolimus can be increased when it is combined with Fluconazole.	#1E61A5	0.155688548173151	1
Carbamazepine	Ketoconazole	0.03	-Inf	Moderate	1 (0/1)	The metabolism of Ketoconazole can be increased when combined with Carbamazepine.	#1E61A5	0.155688548173151	1
Tetracycline	Quinapril	0.034	-Inf	Moderate	1 (0/1)		#1E61A5	0.155688548173151	1
Clemastine	Rivastigmine	0.083	-Inf	Moderate	1 (0/1)		#1E61A5	0.155688548173151	1
Hydrocortisone	Primidone	0.245	-Inf	Moderate	3 (0/3)	The serum concentration of Hydrocortisone can be decreased when it is combined with Primidone.	#1E61A5	0.467065644519452	1
Sucralfate	Ketoconazole	0.273	-Inf	Minor	1 (0/1)	Sucralfate can cause a decrease in the absorption of Ketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.	#1E61A5	0.155688548173151	1
Minocycline	Iron	0.387	-Inf	Moderate	3 (0/3)	Minocycline can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.	#1E61A5	0.467065644519452	1
Rifabutin	Simvastatin	0.292	-Inf	None	2 (0/2)	The metabolism of Simvastatin can be increased when combined with Rifabutin.	#1E61A5	0.311377096346301	1
Cyclosporine	Phenytoin	0.333	-Inf	Moderate	1 (0/1)	The metabolism of Cyclosporine can be increased when combined with Phenytoin.	#1E61A5	0.155688548173151	1
Phenytoin	Mebendazole	0.02	-Inf	Moderate	1 (0/1)	The serum concentration of Mebendazole can be decreased when it is combined with Phenytoin.	#1E61A5	0.155688548173151	1
Halazepam	Itraconazole	0.053	-Inf	None	1 (0/1)		#1E61A5	0.155688548173151	1
Salbutamol	Moclobemide	0.333	-Inf	None	1 (0/1)	The risk or severity of adverse effects can be increased when Moclobemide is combined with Salbutamol.	#1E61A5	0.155688548173151	1
Rifampicin	Fluvastatin	0.139	-Inf	Moderate	2 (0/2)	The metabolism of Fluvastatin can be increased when combined with Rifampicin.	#1E61A5	0.311377096346301	1
Ranolazine	Itraconazole	0.09	-Inf	Major	2 (0/2)	The serum concentration of Ranolazine can be increased when it is combined with Itraconazole.	#1E61A5	0.311377096346301	1
Morphine	Rifampicin	0.243	-Inf	Moderate	2 (0/2)	The serum concentration of Morphine can be decreased when it is combined with Rifampicin.	#1E61A5	0.311377096346301	1
Phenytoin	Fluorouracil	0.022	-Inf	Moderate	1 (0/1)	The serum concentration of Phenytoin can be increased when it is combined with Fluorouracil.	#1E61A5	0.155688548173151	1
Lamotrigine	Rifampicin	0.057	-Inf	Moderate	1 (0/1)	The metabolism of Lamotrigine can be increased when combined with Rifampicin.	#1E61A5	0.155688548173151	1
Metoprolol	Verapamil	0.062	-Inf	Major	2 (0/2)	The serum concentration of Metoprolol can be increased when it is combined with Verapamil.	#1E61A5	0.311377096346301	1
Digoxin	Tetracycline	0.292	-Inf	Moderate	2 (0/2)		#1E61A5	0.311377096346301	1
Ampicillin	Warfarin	0.1	-Inf	Moderate	1 (0/1)	Ampicillin may increase the anticoagulant activities of Warfarin.	#1E61A5	0.155688548173151	1
Telithromycin	Amiodarone	0.1	-Inf	Major	1 (0/1)	Telithromycin may increase the QTc-prolonging activities of Amiodarone.	#1E61A5	0.155688548173151	1
Testosterone	Warfarin	0.179	-Inf	Major	2 (0/2)	Testosterone may increase the anticoagulant activities of Warfarin.	#1E61A5	0.311377096346301	1
Galantamine	Glycopyrronium	0.203	-Inf	None	3 (0/3)	The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Galantamine.	#1E61A5	0.467065644519452	1
Tobramycin	Cefuroxime	0.2	-Inf	Moderate	1 (0/1)		#1E61A5	0.155688548173151	1
Erythromycin	Eplerenone	0.053	-Inf	Moderate	3 (0/3)	The serum concentration of Eplerenone can be increased when it is combined with Erythromycin.	#1E61A5	0.467065644519452	1
Warfarin	Disulfiram	0.111	-Inf	Moderate	1 (0/1)	The serum concentration of Warfarin can be increased when it is combined with Disulfiram.	#1E61A5	0.155688548173151	1
Disulfiram	Metronidazole	0.5	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Disulfiram is combined with Metronidazole.	#1E61A5	0.155688548173151	1
Theophylline	Isoniazid	0.15	-Inf	Moderate	1 (0/1)	The serum concentration of Theophylline can be increased when it is combined with Isoniazid.	#1E61A5	0.155688548173151	1
Cyclophosphamide	Warfarin	0.071	-Inf	Moderate	1 (0/1)		#1E61A5	0.155688548173151	1
Eplerenone	Ketoconazole	0.062	-Inf	Major	1 (0/1)	The serum concentration of Eplerenone can be increased when it is combined with Ketoconazole.	#1E61A5	0.155688548173151	1
Phenytoin	Rifampicin	0.1	-Inf	Major	1 (0/1)	The serum concentration of Phenytoin can be decreased when it is combined with Rifampicin.	#1E61A5	0.155688548173151	1
Warfarin	Tetracycline	0.083	-Inf	Moderate	1 (0/1)		#1E61A5	0.155688548173151	1
Tetracycline	Insulin detemir	0.067	-Inf	Moderate	1 (0/1)		#1E61A5	0.155688548173151	1
Fluvoxamine	Rasagiline	0.348	-Inf	Major	1 (0/1)	The serum concentration of Rasagiline can be increased when it is combined with Fluvoxamine.	#1E61A5	0.155688548173151	1
Terbinafine	Rifampicin	0.5	-Inf	Minor	1 (0/1)	The serum concentration of Terbinafine can be decreased when it is combined with Rifampicin.	#1E61A5	0.155688548173151	1
Acetylsalicylic acid	Heparin	0.062	-Inf	Moderate	1 (0/1)	Acetylsalicylic acid may increase the anticoagulant activities of Heparin.	#1E61A5	0.155688548173151	1
Ziprasidone	Amiodarone	0.077	-Inf	Major	1 (0/1)	The risk or severity of QTc prolongation can be increased when Ziprasidone is combined with Amiodarone.	#1E61A5	0.155688548173151	1
Isotretinoin	Acenocoumarol	0.111	-Inf	None	1 (0/1)		#1E61A5	0.155688548173151	1
Eplerenone	Lithium cation	0.048	-Inf	Moderate	1 (0/1)	The serum concentration of Lithium can be increased when it is combined with Eplerenone.	#1E61A5	0.155688548173151	1
Salmeterol	Oxprenolol	0.212	-Inf	None	1 (0/1)	Oxprenolol may decrease the bronchodilatory activities of Salmeterol.	#1E61A5	0.155688548173151	1
Metronidazole	Lithium cation	0.2	-Inf	Moderate	1 (0/1)		#1E61A5	0.155688548173151	1
Fluvastatin	Bezafibrate	0.077	-Inf	None	1 (0/1)	Bezafibrate may increase the myopathic rhabdomyolysis activities of Fluvastatin.	#1E61A5	0.155688548173151	1
Ketoconazole	Tolterodine	0.25	-Inf	Moderate	1 (0/1)	The serum concentration of Tolterodine can be increased when it is combined with Ketoconazole.	#1E61A5	0.155688548173151	1
Tetracycline	Insulin aspart	0.071	-Inf	Moderate	1 (0/1)		#1E61A5	0.155688548173151	1
Triamcinolone	Primidone	0.474	-Inf	Moderate	1 (0/1)	The metabolism of Triamcinolone can be increased when combined with Primidone.	#1E61A5	0.155688548173151	1
Triamcinolone	Rifampicin	0.143	-Inf	Moderate	1 (0/1)	The metabolism of Triamcinolone can be increased when combined with Rifampicin.	#1E61A5	0.155688548173151	1
Fluorouracil	Warfarin	0.059	-Inf	Major	1 (0/1)	The serum concentration of Warfarin can be increased when it is combined with Fluorouracil.	#1E61A5	0.155688548173151	1
Indomethacin	Lithium cation	0.067	-Inf	Major	1 (0/1)	The serum concentration of Lithium can be increased when it is combined with Indomethacin.	#1E61A5	0.155688548173151	1
Warfarin	Ofloxacin	0.25	-Inf	Major	1 (0/1)		#1E61A5	0.155688548173151	1
